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Abstract
Liposomes are spherical bilayer vesicles formed from dispersion of polar lipids in
aqueous solvents and have been studied for their ability to act as drug delivery vehicles
by shielding reactive or sensitive compounds prior to release. In the food industry,
liposomes have been used to deliver food flavors and nutrients; more recently they have
been investigated for their ability to incorporate food antimicrobials.
Thermal stability of liposomes, in the presence and absence of nisin, was
evaluated using differential scanning calorimetry (DSC) and low-intensity ultrasonic
spectroscopy (US). Observed phase transition temperatures for liposomes measured via
DSC and US were in close agreement, suggesting the utility of US for the non-destructive
characterization of liposome vesicles.
Ability of liposomes to maintain integrity was tested by encapsulation efficiency
(EE), zeta potential, and vesicle size. PC, PC/PG 8/2, and PC/PG 6/4 (mol fraction)
liposomes retained between ~70-90% EE despite exposure to elevated temperature or
extreme pH. Liposome size averaged between 100-240 nm. Zeta potential depended
primarily on phospholipid composition and changed little with inclusion of nisin.
Nisin was entrapped in phospholipid liposomes at varying concentrations. Nisin
was entrapped at 5 and 10 µg/ml and then added to media seeded with L. monocytogenes
Scott A or 310. L. monocytogenes inhibition was observed to be only slightly dependent
upon dose, but was heavily dependent upon phospholipid constituents of liposomes. Near
complete inhibition of E. coli O157:H7 with liposomal antimicrobial and chelator at
concentrations below those reported necessary for naked antimicrobial and chelator
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suggest that liposome encapsulation of antimicrobials may allow for control of foodborne
pathogens and increase the spectrum of activity for some antimicrobials.
Liposomal nisin and chelator were added to milk samples of varying fat levels
containing the pathogens L. monocytogenes and E. coli O157:H7 and incubated at 25°C
for 48 hr and survivors enumerated. Liposomal nisin was inhibitory to L. monocytogenes
strains, and effects on strains were equivalent, regardless of milk fat level. Encapsulation
of nisin and chelator in liposomes abolished antimicrobial effects against both Grampositive and Gram-negative strains.
Data indicate liposomes are useful candidates for the long-term control of
foodborne pathogens in food.
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1. Review of Current Literature

1

“Portions of the following have been reproduced with permission from Taylor and
Francis Group, New York, NY. Taylor, T.M., P.M. Davidson, B.D. Bruce, and J. Weiss.
2005. Liposomal nanocapsules in food science and agriculture. Crit Rev Food Sci Nutr.
17: 587-605.”

1.1.

Introduction
Liposomes or lipid vesicles, formed from polar lipids available in abundance in

nature, can incorporate a wide variety of functional components in their interior.
Liposomes are spherical particles with sizes in the nanometer to micrometer range (New,
1990a). The vesicular particles may consist of one or several bilayer membranes.
Initially, liposomes served primarily as model membrane systems because their bilayer
structure could be manipulated to closely resemble the lipid fraction of biological cell
membranes. The ability to simulate the behavior of natural cell membranes is, for
example, useful in developing drugs that are able to target membranes with a specific
composition or investigate membrane stability and degradation mechanisms that may be
of importance in key biochemical reactions (Lasic, 1998; Sharma and Sharma, 1997;
Wilschut and Hoekstra, 1986). More recently, liposomes and proteoliposomes (liposomes
incorporating or encapsulating one or more proteins) have been shown to be extremely
suitable systems to deliver a wide variety of substances to targets of biological,
biochemical, pharmacological, and agricultural interest (Chonn and Cullis, 1998; Gibbs
et al., 1999; Gregoriadis et al., 2003; Reineccius, 1995; Schreier and Sawyer, 1996;
Sharma and Sharma, 1997). Such compounds include pharmaceuticals, enzymes,
pesticides, and antimicrobials (Akhtar et al., 2000; Chonn and Cullis, 1998; Law and
Wigmore, 1982; Rao et al., 1995; Suwalsky et al., 2001; Were et al., 2003).
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To date however, little use of liposomes in food systems has been made. This is
primarily based on the fact that the interaction of liposomes with food components is
quite poorly understood and that manufacturing of liposomes was expensive due to costs
of raw materials and manufacturing processes. Nevertheless with the growing
understanding of the functional properties of liposomes, such as their physicochemical
properties, kinetic and thermodynamic stability, interaction with food constituents,
improved manufacturing technologies, such as continuous high pressure or membrane
homogenization, it has become feasible to use liposomes to deliver functional
components such as nutraceuticals, antimicrobials, and flavors to foods (Hsieh et al.,
2002; Kirby, 1991; Kirby et al., 1987; Kirby et al., 1991; Laridi et al., 2003; Picón et al.,
1994; Picón et al., 1997; Rao et al., 1995; Were et al., 2003).
The main objective of this review is to provide the reader with an introduction
into the field of liposomal research; special attention will be paid to the use of liposomes
for the encapsulation of food-grade antimicrobial polypeptides. The properties,
manufacturing techniques, and key applications of liposomes in food and non-food
systems are discussed. Historical perspective on the development of liposomes will be
given via discussion on past applications of liposomes and the development of different
processes for the manufacture of liposomes. Current pertinent literature will be discussed
in light of its ability to demonstrate the utility of liposomes as carriers for antimicrobial
compounds that may be applied for the protection of food safety and quality from
bacterial food pathogens. Finally, an in-depth discussion of the utility of liposomes for
the delivery of those antimicrobials utilized in the following chapters, as opposed to other
types of food antimicrobials, will be offered.
3

1.2.

Properties of Liposomes
Liposomes or lipid vesicles are aggregates formed from aqueous dispersions of

amphiphilic molecules such as polar lipids that tend to self-assemble into bilayerstructures (Lasch et al., 2003). Liposomes are typically spherical in shape and may
contain a single or multiple layers of amphiphilic polymolecular membranes. Because of
their spherical shape, liposomes were originally called “spherulites.” Liposomes that
contain only a single bilayer membrane are called small (<30 nm) or large (30-100nm)
unilamellar vesicles, or SUVs and LUVs, respectively (New, 1990b). Liposomes that
contain more than one bilayer membrane are referred to as multilamellar vesicles (MLV)
if all layers are concentric, or multivesicular vesicles (MVV) in which case a number of
randomly sized vesicles may be enclosed in the interior of another vesicle (Fig. 1.1)
(New, 1990b).
The interior of liposomes is aqueous in nature, in contrast to the interior of
surfactant micelles that provide a hydrophobic environment. This is because the polar
lipids are oriented such that polar headgroups in both the inner and outer surface of the
membranes are exposed to the inner and the outer solvent phase (Fig. 1.1). Therefore, the
interior of liposomes consists of an aqueous solution that has the same chemical
composition as the medium in which the liposomes are first formed.
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Figure 1.1: Representation of the structure of large and small unilamellar vesicles
(SUV/LUV), multilamellar vesicles (MLV) and multivesicular vesicles (MVV).
Liposomes larger than ~300 nm will scatter light sufficiently to allow them to be
seen by the naked eye and these samples will have a cloudy white appearance. However,
additional processing using the manufacturing methods that will be discussed later, e.g.,
sonication or extrusion, may produce smaller liposomes. These liposomes may have sizes
below 300 nm and a solution of such liposomes will appear clear or have a slight blue
tinge. Therefore, one of the key characteristics of liposomes is particle size distribution
after formation and during storage. Table 1.1 shows an overview over the different
classifications of liposomes, their characteristic properties and the primary methods used
to formulate them.
Chemically, liposomes are primarily composed of phospholipids, although other
lipids such as galactolipids may also be incorporated. The major components of
biological membranes, phospholipids exist as either sphingolipids or phosphodiglycerides
(Barenholz et al., 1977; Lasch et al., 2003).
5

Table 1.1: Classification, formulation, and characteristics of liposomes.
Liposome

Formulation Methods

Characteristics

MLV

Thin-film
dehydration/rehydration.

Low energy input required for
formation. Useful for larger batch
formulations. Good entrapment
efficiency. No significant technical
training required to form and low cost of
reagents and equipment. Maximum
storage stability.

LUV

Membrane extrusion of
MLVs; may bud-off from
MLVs in suspension. Can
also be formed from
detergent depletion (dialysis)
methods.

High energy input not required for
formation. Good encapsulation
efficiency. Longer storage stability vs.
SUV liposomes due to reduced
curvature stress.

SUV

Membrane extrusion of
MLVs or LUVs;
Ultrasonication (probe or
bath) of MLVs or LUVs;
dialysis of MLVs; high
pressure homogenization.

Increased homogeneity of liposomes.
Increased circulation times/half-life.

References: (Barenholz et al., 1977; Lasch et al., 2003; Mason et al., 1983; Parente and
Lentz, 1984; Sharma and Sharma, 1997; Vemuri and Rhodes, 1995).
The most abundant phospholipid is phosphatidylcholine (PC), also known as lecithin
(Koynova and Caffrey, 1998). In PC, two acyl hydrocarbon chains are linked to the sn-1
and sn-2 position of glycerol via an ester linkage, with the third glycerol carbon attached
to a phosphate at the sn-3 position which is then linked to a choline group. The two
hydrocarbon chains provide the hydrophobic tail of the amphiphile while the hydrophilic
phosphocholine provides the polar head group. Sphingolipids, key components in nerve
signal transmission, are obtained through the combination of a phospholipid and a
ceramide (sphingosine amino alcohol linked to a fatty acid) (Koynova and Caffrey,
1995). A prominent example of a sphingolipid is sphingomyelin. Other polar lipids used
6

in liposomes are kephalins (phosphatidyl-ethanolamines) in combination with
phosphatidyl-serine and phosphatidyl-inositol and sterols such as cholesterol and
sitosterol (Koynova, 1997; Koynova and Caffrey, 1994a; Koynova and Caffrey, 1994b).
Phospholipid-containing systems have complex phase behaviors; they can exist in
one or more liquid-crystalline or mesomorphic forms depending on temperature and
composition (Caffrey and Hogan, 1992). One of the key parameters for liposomal
systems is the so-called gel-to-liquid crystalline transition temperature (Tm) where the
bilayer loses much of its ordered packing structure due to a “melting” of the hydrocarbon
chains. Typically, longer hydrocarbon chain lengths translate into higher phase transition
temperatures (Marelja and Wolfe, 1979; New, 1990a). It should be noted that most
natural phospholipids contain hydrocarbon chains that are asymmetric; that is, the fatty
acid chains may differ in length. Thus transitions may occur over a range of temperatures.
The degree of fatty acid unsaturation in the hydrocarbon chain also influences the phase
transition. The Tm decreases with increasing un-saturation. Finally, strong head group
interactions may increase the phase transition temperature as well (Marelja and Wolfe,
1979; New, 1990a). Consequently, the phase transition behavior of liposomes with bi- or
multi-component compositions can be quite complex. For example, cholesterol is often
added to liposomes to improve their in vivo and in vitro stability. Cholesterol provides the
membrane with fluidity by changing interactions between both the polar head groups and
the hydrocarbon chain and a decrease in both Tm and the transition enthalpy is observed
when cholesterol is added.
The functionality of liposomes depends on their interaction with other compounds
which is largely determined by the liposome’s interfacial properties, i.e., interfacial
7

rheological properties, hydrophobicity and surface charge. The interfacial properties of
liposomes depend on the chemical composition of the bilayer and environmental
conditions such as solvent type, ionic strength and temperature. As previously mentioned,
bilayer structures may undergo complex phase transitions upon heating. In the process,
their interfacial rheological properties dramatically change and the liposomes become
very susceptible to mechanical stresses that may cause disintegration and release of
entrapped compounds (Allen et al., 2002; Biltonen and Lichtenberg, 1993; Marelja and
Wolfe, 1979). The surface charge of liposomes influences the electrostatic interaction of
the lipid particles with other charged compounds (Boguslavsky et al., 2003; Breukink et
al., 2000; Campbell et al., 2001a). Charged liposomal membranes may, for example,
prevent passage of similarly charged compounds into the interior of the liposomes, which
is one of the reasons why substances encapsulated in the interior of liposomes may be
protected from compounds in the continuous solvent phase (Campbell et al., 2002;
Heurtault et al., 2003). Interestingly, the head group of PC, one of the most commonly
used phospholipids, is zwitterionic with a supposed net charge of zero over a wide range
of pH values. However, measured electrophoretic mobilities in the presence of various
salts range from +0.2 to -0.7 µms-1 V-1cm and decrease significantly if the liposomes go
through a phase transition (Koynova and Caffrey, 1998). In a model proposed by Makino
et al. (1991), the orientation of the zwitterionic head group at the interface of the
liposome changed as a function of temperature and ionic strength indicating that the
actual surface charge of liposomes does not solely depend on the properties of the
phospholipid molecule but the interactions between the molecules in the membrane.
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From a biochemical perspective, the interactions of bilayer structures with
proteins play a key role in some of the most important metabolic reactions such as the
generation of ATP. For example, proteins may be fully integrated in the membrane
(membrane spanning proteins) and bridge the outer and inner phases of the liposome or
they can be an “integral” part of the membrane in which case they are located at either
the internal or external surface of the membrane (Fig. 1.2). The spatial orientation of
proteins within these membranes, which is governed by the molecular properties of the
protein and the polar lipids as well as environmental conditions, is one of the prerequisites to ensure the proper functioning of complex biological systems.

Peripheral Membrane
Protein
Integral Membrane
Protein

Lipid Bilayer
Membrane

Membrane-Spanning Proteins

Figure 1.2: Overview of the different classes of membrane proteins including
membrane-spanning proteins, peripheral membrane proteins and integral
membrane proteins.

9

Hence, liposomal properties and functionalities depend on extrinsic parameters
(e.g., pH, ionic strength, temperature) and intrinsic parameters that include phospholipid
concentration, composition, and nature and concentration of entrapped compound. These
characteristics influence the chemical and physical stability of liposomes. Chemical
instability may arise due to oxidation and hydrolysis of polar lipids. Liposomes may be
physically destabilized if they undergo phase transitions or if bilayer structures merge,
which results in loss of entrapped components and increased liposomal size distributions.
Food manufacturers planning to entrap functional components in liposomes therefore
need to carefully choose phospholipid/functional component combinations to optimize
the stability of capsules under specific processing and application conditions.

1.3.

Manufacture of Liposomes
In contrast to other surfactant aggregates such as spherical and non-spherical

micelles or hexagonal phases, liposomes do not form spontaneously in aqueous media
and are therefore not thermodynamically favorable structures (Bangham et al., 1974;
Barenholz et al., 1977; Lasch et al., 2003). Formation of liposomes requires energy.
Depending on which type of liposome is produced, the required energy input can greatly
vary. MLVs form readily when bilayer-forming polar lipids are dispersed in aqueous
media under mild agitation (New, 1990b). In order to produce LUVs and SUVs,
substantial energy inputs are required that are sufficient to disrupt MLV and MVV
structures and force the generation of unimodal vesicles (New, 1990b). Generally,
liposomes are only stable for a defined period of time; i.e., they are said to be “kinetically
stable” similar to emulsions. Because of this, many of the principles of emulsion
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formation also apply to the formation of liposomes and the techniques used to produce
emulsions may often be used to produce liposomes. The most commonly applied
techniques are based on the input of mechanical energy in the system, e.g., high-intensity
ultrasonication, high-pressure homogenization, extrusion, and membrane homogenization
(Fig. 1.3). Non-mechanical methods include reverse phase evaporation, removal of
detergents from mixed detergent/lipid micelles and freeze-drying followed by
rehydration. Table 1.2 shows a comprehensive overview over the available methods to
form liposomes and the inherent strengths and weaknesses of liposomes that are obtained
with each of these methodologies.

Figure 1.3: Overview over the most commonly used mechanical production methods
to manufacture liposomes.
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Table 1.2: Methods to form liposomes and inherent strengths/weaknesses of liposomes produced with these methodologies.
METHODS

STRENGTHS

WEAKNESSES
Highly heterogeneous dispersion; lower
encapsulation efficiency vs. LUVs. Nearly
impossible to determine mass
encapsulated/vesicle and surface area.

Thin-Film
Rehydration

Rapidly formed; low energy
input to form. Highest stability
and transition cooperativity.

Freeze-Dried
Rehydration Vesicles

High entrapment efficiency.
Improved homogeneity in
mixing of lipid species/liposome.
Useful for forming antigenentrapping vesicles.

Dehydration best controlled by freezedrying; long time to process.

(Kirby and
Gregoriadis,
1984; Lasch et
al., 2003; New,
1990b)

Reverse-Phase
Evaporation

Higher entrapment efficiency
reported for variety of molecules
then MLVs (proteins, nucleic
acids, etc.).

Heterogeneous distribution of MLVs and
unilamellar vesicles; additional
homogenization required. Solvent exposure
may inhibit protein activity. Possible
incomplete removal of organic solvent.
Entrapment above 50% very difficult.

(New, 1990a;
Szoka and
Papahadjopoulos,
1978)

Detergent-Depletion

No solvent used; protein activity
retained. No mechanical energy
input. Homogenous distribution
of liposomes. Useful for multiple
lipids and molecules for
encapsulation. Best for
entrapping membrane-associated
proteins.

Limited number of useful detergents.
Dialysis is very slow process and some
detergent is likely to remain in the sample.
Detergent may negatively interact with
molecule of interest.
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Table 1.2: Continued.
METHODS

Membrane Extrusion

High-Pressure
Homogenization,
Microfluidization

Ultrasonication:
Probe

Ultrasonication: Bath

STRENGTHS
Homogenization of liposomes
improved over other methods;
rapid preparation of unilamellar
vesicles from MLVs. Equipment
for small-large batches is readily
available.
Can process high lipid
concentration (~150 mg/ml). Lab
data is easily inferred to
processing plant. High
reproducibility. Most useful for
large-scale production of
liposomes.
Can be performed directly on
hydrated MLVs. Preferred
method to form SUVs. Excellent
for reduction of large MLVs to
more homogenous dispersion of
SUVs.
Less destructive to liposomes vs.
probe method. Greater
reproducibility and more
homogenous product vs. probe
sonicator. Increased sample
volume capability. Increased
control over sample temperature.

WEAKNESSES
Liposomes must be held above TM to
facilitate extrusion. Manual extruders
handle only small volumes (1 ml). Solute
leakage can occur during extrusion. High
salt concentration (>150 mM) can preclude
liposome formation.
Solvent ionic strength must be carefully
controlled to control liposome size.
Complete homogenization is time
consuming in microfluidizer.
Probe sonication can degrade
sample/localized overheating. Requires
constant cooling. Liposomes are metastable
(low storage-stability). Low volume
required for effective treatment.
Requires extensive sonication to obtain
minimum size limit of SUV; not always
possible. Non-homogenous product;
requires removal of larger vesicles via
chromatographic or centrifugal methods.
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Generally, the mesoscale shape taken by the liposomal aggregates is a balance
between applied mechanical forces and the tendency to assume specific self-assembled
structures (Winterhalter and Lasic, 1993). Unfortunately, most mathematical descriptions
of liposomal formation processes are empirical in nature rather than theoretical.
Nevertheless, some thermodynamic concepts yield some indication about the factors that
determine the equilibrium size of liposomes. For example, the optimum size of liposomes
may be governed by their thermodynamic equilibrium properties; the molecules in the
bilayer have to be in equilibrium with the surrounding solvent molecules and the lipid
molecules. Given that µ0 is the chemical potential of the lipid molecule in the aqueous
phase and µ1 is the chemical potential in the lipid phase, then the probability ω of finding
a liposome of size containing N lipid molecules is

ω ( n) =

⎛
µ ⎞⎞
1
⎛
exp⎜⎜ − N ⎜ µ 0 − 1 ⎟ ⎟⎟
N0
kT ⎠ ⎠
⎝
⎝

(1)

Where N0 is the mean number of lipid molecules in one liposome. Generally, the
formation of such liposomes is favored if µ0-µ1 < 0 and unfavorable if µ0-µ1 > 0. Based
on the fact that N=8πR2/a0 with a0 the area per lipid molecule we obtain the
corresponding distribution based on the vesicle radii

⎛
R
R
ω ( R) = 2 exp⎜⎜ −
Rm
⎝ 2 Rm

⎞
⎟⎟
⎠

2

(2)

where Rm is the radius at the maximum of the probability distribution.
This thermodynamic model reflects the relationship between the entropic
contribution and the energy of condensation but unfortunately fails to accurately predict
the size of liposomes because it does not account for geometrical constraints that are due
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to the specific shape of the polar lipids. A more accurate description was obtained by
Helfrich more than 30 years ago using an energetic approach that took into account
entropic contributions due to the organization and enthalpic contributions due to the
elastic energy stored in the membrane (Lasic, 1990). Based on a minimization of the free
energy of the dispersed system, a theoretical size distribution of:
⎛ 3R 2
9R 3
ω ( R) =
exp⎜⎜ −
2
2 Rm4
⎝ 2 Rm

⎞
⎟
⎟
⎠

(3)

Finally, a purely statistical approach was used by Tenchov and coworkers who
considered the size of liposomes as a metastable state of aggregation of lipid fragments
with a lower size limit that depended on the curvature of these single fragments. In this
case, the size distribution is given as:
⎛ δ ⎞⎛ d − d 0
ω (d ) = ⎜⎜ ⎟⎟⎜⎜
⎝ η ⎠⎝ η

⎞
⎟⎟
⎠

δ −1

⎛ d − d0
exp⎜⎜
⎝ η

⎞
⎟⎟
⎠

δ

(4)

where d0 is the minimal size and δ and η are fitting parameters. Obviously, the use of
such a model is limited as it is not based on any physical description of the liposomal
dispersion.

1.3.1. Mechanical Methods of Liposome Formulation

1.3.1.1.

High-Intensity Ultrasonication: Application of high-intensity ultrasound to

aqueous dispersions of polar lipids can result in formation of small lipid vesicles (Lasch
et al., 2003; New, 1990b). High-intensity ultrasonication is based on the propagation of
15

sound waves with frequencies between 16 and several hundred kHz through an aqueous
dispersion of polar lipids. The propagation of the sound wave through the media results
in the spontaneous generation and collapse of small cavities, a process better known as
cavitation. The cyclic formation and destruction of cavities causes extreme pressure and
temperature rises inside the cavity and highly turbulent flow conditions in close
proximities to the collapsing cavities. The turbulent flow conditions exert high shear
forces on large pro-liposomes, particles that are spontaneously formed upon contact of
the dry free-flowing lipid with aqueous media (Payne et al., 1986; Payne et al., 1986).
Eventually, these forces are high enough to cause a disruption of the pro-liposomal
structures followed by a reformation of smaller, less stress-susceptible vesicles (New,
1990b).
Two types of ultrasonic homogenization systems are available: direct tip
sonicators and indirect bath sonicators (Fig. 1.3). Direct probe systems consist of an
ultrasonic generator that is connected to a stainless steel or titanium probe that is directly
immersed in the lipid dispersion. This type of system is able to transmit very high
energies into the system and generally produces smaller vesicles. However, energy
distribution throughout the sonicated solution is non-homogeneous; hence the liposomal
particle size distributions are less uniform or often multimodal. Consequently
reproducibility may be low (Barenholz et al., 1977). Because of the high energy input,
overheating can occur and accurate temperature control is often difficult
(Papahadjopoulos and Watkins, 1967). Furthermore, the eventual degradation of the
metal tip of the probe under the influence of high-intensity ultrasound may lead to
increases in metal ion concentrations in the system that may interfere with functional
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components such as enzymes (Papahadjopoulos and Watkins, 1967). Bath sonicators are
the preferred systems used for production of liposomes because they have a fairly
uniform energy distribution throughout the system which results in formation of
liposomes with uniform and unimodal particle size distributions (New, 1990b;
Papahadjopoulos and Watkins, 1967). In addition, contamination of polar lipid
dispersions may be minimized since no direct contact between dispersions and probes is
required. Bath sonicators usually offer better temperature control because the bath may
be directly equipped with a heating or cooling unit (Lasch et al., 2003).
High-intensity ultrasound has proven to be a very effective mean to produce small
quantities of stable SUVs. Encapsulation efficiencies are typically very high using
ultrasound but three problems may be encountered in the production. First, sonication of
some polar lipids dispersions has been reported to cause extensive foaming which results
in loss of lipids (New, 1990a; New, 1990b). Secondly, sonication can lead to a
modification of the functional properties of the encapsulated material itself; sonication
has been reported to reduce the activity of enzymes to be incorporated in the interior of
the liposomes (Barnadas-Rodríguez and Sabés, 2001). Thirdly, sonicated small vesicles
are mostly metastable; vesicles may grow over time to reduce the high curvature energy
associated with the large bending of the lipid bilayer (Barnadas-Rodríguez and Xamani,
2003; Qiu and MacDonald, 1994). Generally, it is recommended to store ultrasonically
produced liposomes for >24 hours to allow the vesicles to relax to a more stable size.

1.3.1.2.

High Pressure Homogenization & Colloid Mills: Liposomal size reduction in

a high pressure homogenizer occurs within a homogenization valve that is composed of
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an adjustable valve stem (core) and a fixed outer valve wall. Because of this, the
homogenization valve can have various geometries with externally adjustable gap sizes.
Pro-liposomes, dry granules that form a liposomal dispersion upon contacting water or
another aqueous solution, are pumped into the valve annulus formed between the stem
and the wall with pressures between 10 – 100 MPa (Brandl et al., 1998). Within the
annulus, velocities may exceed more than 200 m/s (Jung et al., 2002). The average
residence time of the liposomal premix in the valve is less than a few milliseconds
(Brandl et al., 1998). Due to the fast acceleration of the liquid in the annulus, the
hydrostatic pressure in the annulus can drop below the vapor pressure of the liquid. As a
consequence steam bubbles may be formed. The formation of steam bubbles is transient
and the bubbles collapse in the rear part of the annulus where pressure and temperature
again increase (Barnadas-Rodríguez and Xamani, 2003). The collapse of cavitational
bubbles is the primary source of the mechanical energy that causes the pro-liposomes to
be disrupted. The effectiveness of the liposomal disruption in a high-pressure valve
homogenizer can be directly related to the applicable pressure difference between the
homogenization valve inlet and outlet. A specialized high-pressure homogenizer is the
so-called microfluidizer (Barnadas-Rodríguez and Sabés, 2001; Barnadas-Rodríguez and
Xamani, 2003). In a microfluidizer, the size reduction is caused by the collision of two
high-velocity fluid streams of the lipid dispersion in an interaction chamber.
Microfluidizers have high efficiencies and usually produce smaller particle sizes than
comparable high-pressure homogenizers (Barnadas-Rodríguez and Xamani, 2003).
Colloid mills are rotor-stator systems that can be used to reduce the particle size
distribution of both liquid dispersions such as pro-liposomes and emulsions as well as
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solid dispersions (suspensions). The dispersion is pumped through a narrow gap that is
formed by a rotating inner cone and a stationary outer cone. The width of the annulus can
be adjusted by changing the relative position of the two cones. The principal size
reduction in colloid mills is due to the high shear forces that are caused by the velocity
difference between the rotor and the stator surfaces (New, 1990b). To increase wall
friction and reduce slip, surfaces are usually not smooth but are roughened or toothed,
which in turn changes the flow conditions from laminar to turbulent thereby increasing
the shear forces in the annulus (New, 1990b).

1.3.1.3.

Extrusion and Membrane Homogenization: In extrusion or membrane

homogenization, the dispersed phase containing large liposomes is forced to pass through
a membrane or a filter with a uniform pore size distribution generating a homogeneous
population of smaller vesicles. This is because the forced passage through the capillaries
of the membrane or filter exerts shear forces that cause a rupture of the membranes,
followed by a rapid resealing (Brandl et al., 1998; Lamprecht et al., 1999). Because of
this, substances that are entrapped in the larger vesicles prior to passage through the
capillaries will leak out during the extraction process. Extrusion therefore has to be
performed in the presence of the substance that is to be encapsulated. Extrusion and
membrane homogenization is influenced by the temperature and extrinsic properties such
as the size of the pores, the applied pressure across the membrane of filter and the flow
rate (Barnadas-Rodríguez and Sabés, 2001). The interfacial rheological behavior of the
lipid membranes changes significantly depending on whether the temperature is above or
below the gel-liquid crystalline phase transition temperature of the polar lipids. While not
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impossible, extrusion and membrane homogenization is often unsuccessful if the
temperature is below the transition temperature (Barnadas-Rodríguez and Sabés, 2001).
Since the transition temperatures depends on the molecular properties of the polar lipids,
the required process temperature may have to be adjusted if the composition of polar
lipids changes. Furthermore, the size of liposomes decreases as the diameter of the pore
decreases and the flow rate and the pressure increases. Because of the high pressure
applied across the membrane, not all filter materials are suitable but materials such as
polycarbonates have been used with success (Barenholz et al., 1977).

1.3.2. Non-Mechanical Methods of Liposome Formation

1.3.2.1.

Reverse Phase Evaporation: In the reverse-phase evaporation (REV)

procedure, bilayer forming polar lipids are dispersed in an organic solvent with a low
boiling point, e.g., diethyl ether, isopropyl ether, chloroform or methanol (Lasch et al.,
2003; Szoka and Papahadjopoulos, 1978). An aqueous solution containing the substance
to be encapsulated is added to the organic phase and the system is briefly homogenized
(vortexer or low energy sonicator) to form an emulsion. The emulsion structure is similar
to that of a reversed micellar or water-in-oil microemulsion system where the hydrophilic
headgroups of the polar lipids are in contact with the aqueous droplets that contain the
active ingredients while the fatty acid chains interact with the organic solvent (Szoka and
Papahadjopoulos, 1978). Upon evaporation of the solvent under reduced pressure, the
system is converted to an aqueous dispersion of vesicles. While entrapment efficiencies
are quite high, a complete removal of the organic solvent is often impossible and particle
size distributions of vesicles are multimodal and broad. Consequently, liposomes
20

produced via REV are often subjected to a second extrusion step to obtain smaller and
more homogenous dispersions (New, 1990b).

1.3.2.2.

Depletion of Mixed-Detergent Lipid Micelles: The detergent dialysis method

is based on the production of mixed small surfactant – polar lipid micelles that are
formed if an excess of surfactant compared to the lipid is present in the system (New,
1990b). A dynamic equilibrium between concentration of monomers dispersed in the
aqueous phase and surfactant molecules in the mixed micelles exists. As surfactant
monomers are removed from the aqueous phase through dialysis, surfactant molecules in
the mixed micelle will be gradually removed. As a consequence, the mixed micelle is
first transformed into a mixed surfactant-polar lipid vesicle and eventually (after
complete removal of the surfactant) into a surfactant free liposome (Schubert, 2003).
Detergent-dialysis vesicles (DVV) are typically very homogeneous and the method has
proven to be suitable for a wide range of polar lipids (Milsmann et al., 1978; Schubert,
2003). Since no mechanical forces and no organic solvent is involved in the production of
DVVs, activity of encapsulated compounds is usually retained, in contrast to liposomes
produced with for example ultrasound. The disadvantages of the technique are that it is
time consuming and a small concentration of surfactants may remain in the system
(Schubert, 2003). Finally, the final particle size of liposomes depends on the type of
surfactant used, the surfactant to lipid ratio, and the rate of surfactant removal from the
system. Hence, precise control of the production process is difficult.
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1.3.2.3.

Freeze-Drying Rehydration and Freeze-Thawing: These techniques are used

more to refine preformed liposomes and improve their properties rather than produce
them. Freeze-dried rehydrated liposomes are formed from existing, preformed liposomes
that have been subjected to dehydration – rehydration cycles. The rehydration above the
gel-liquid crystalline phase transition temperature results in a fusion of small, preformed
vesicles to produce MLVs. While the MLVs are significantly larger than the initial
liposomes (often > 1 µm), concentration of entrapped matter is very high, i.e., entrapment
efficiencies of up to 45% have been reported (Gregoriadis et al., 2003). Entrapment
efficiencies may also be improved by repeated freezing and thawing at a temperature
above the phase transition temperature Tm (Kirby and Gregoriadis, 1984). It is thought
that the resulting fusion process leads to a reduction in the number of very small
liposomes and the formation of multivesicular vesicles with high entrapment efficiencies.

1.4.

Industrial and Research Applications of Liposomes

1.4.1. Liposomes in the Pharmaceutical Industry

1.4.1.1.

Introduction: Liposomes have been recognized by many as a powerful tool in

the treatment of diseases. Their ability to entrap, sequester, and deliver therapeutics either
at a specific site within the body or to release their contents based on physiological
conditions (e.g., temperature, pH, antibody recognition) has led to their use in the
treatment of multiple diseases. Consequently, research has focused on improved
engineering of their release profiles and better understanding of their physicochemical
characteristics. Due to the vast amount of published literature in the medical and
pharmaceutical sciences, a comprehensive review of literature on the use of liposomes is
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far beyond the scope of this paper. Rather, we will direct the reader to several recently
published key papers and reviews that highlight and summarize significant achievements
in this area. These publications discuss specifically ongoing research efforts to develop
liposomes to treat a variety of diseases (Akhtar et al., 2000; Bendas, 2001; Chonn and
Cullis, 1998; El-Aneed, 2004; Hafez and Cullis, 2001; Kaneda, 2000; Storm et al., 1997).

1.4.1.2.

Liposomes Engineered to Release on Demand: Multiple studies have

confirmed that liposomal stability may be lost if the system is subjected to environmental
conditions of physiological significance such as extreme temperature and pH (Allen and
Cleland, 1980; Hsieh et al., 2002). Conversely, under conditions that more closely
approximate physiological temperature and/or pH, release of the liposomal contents may
be easily induced via modification of the vesicle in some fashion (Connor and Huang,
1985; Gerasimov et al., 1999; Hayashi et al., 1996; Kitano et al., 1991; Shum et al.,
2001). Liposomes that are pH-sensitive have been reported to be especially useful for the
treatment of antisense mRNA (mRNA that is transcribed from a specially engineered
cloned gene so that the mRNA sequence is complementary to the normal RNA transcript)
in treatment of viral and inflammatory diseases and to combat cancer (Akhtar et al.,
2000; Fattal et al., 2004). Meers (2001) reviewed several studies reporting the production
of liposomes that would release their encapsulated content upon encountering specific
cellular enzymes. When liposomes reach the targeted cells via blood circulation, peptides
or lipid conjugates incorporated in the liposomal membranes may be cleaved. Liposomes
may then fuse with the cell membrane and release their content into cells. Reported uses
for this technology include anticancer treatments, inflammatory conditions such as cystic
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fibrosis and emphysema, and viral gene therapy (Meers, 2001). Hashida et al. (2001)
using cationic liposomes glycosylated with mannose residues demonstrated higher celltargeting efficiency for the potential treatment of conditions such as human
immunodeficiency virus (HIV) and Gaucher’s disease.

1.4.1.3.

Immuno-Liposomes (Antigen-Sensitive Liposomes): Some liposomes have

been designed to contain specific immunogens. These liposomes have been tested
extensively in the treatment of cancers and other diseases (Lofthouse, 2002; Storm et al.,
1997). Antibody-directed liposomes encapsulating non-active antitumor drugs and
bearing surface-bound enzymes had high efficacies as a chemotherapy treatment against
ovarian cancer. Upon fusion and release of contents, the bound enzyme cleaved a specific
portion of the drug to induce activity against the target cell (Storm et al., 1997). The
particular efficiency of antibody-tagged immuno-liposomes is based on the high antibody
specificity for a single antigen (especially for monoclonal antibodies), a well defined
chemistry, and greater biocompatibility when compared to peptides (Forssen and Willis,
1998). Nevertheless, their widespread use in drug delivery systems is still some years
away from being fully commercialized (Forssen and Willis, 1998).

1.4.1.4.

Oral and Skin-Based Applications of Liposomes: While a number of methods

exist to administer drugs to patients, special attention has been paid to methods of oral
ingestion and transdermal diffusion. Chen and Langer (1998) in a review of the status of
oral drug delivery systems claimed that liposomes, while not useful for ingestion due to
their breakdown in stomach and intestine, could be modified to improve stability during
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GI tract passage. Liposomes composed of crosslinked networks of modified lipids tested
on mice had significantly higher rates of survival after passage through the GI tract (Chen
and Langer, 1998).
In general, dermal and transdermal delivery of active compounds is difficult both
in the terms of the stability of the delivery vehicle and the therapeutic. While a number of
other medical and cosmetic applications exist for topically applied liposomes, their
efficacy is mediated by various factors such as the ability to penetrate the skin, their
activity on the skin surface and their deformability (Cevc et al., 1996). Nevertheless,
successful applications of liposomes for dermal and trans-dermal drug delivery have been
reported. Foldvari et al. (1999) reported a minimum of ~56% liposome encapsulation of
Interferon-α in the treatment of genital warts. Shi et al. (1999) reported development of a
non-invasive liposomal DNA vaccine that could be applied to the skin of mice. The latter
group concluded that this method is advantageous due to lack of need for trained
technicians and a reduced dependency on needle injections (Shi et al., 1999). Analgesic,
anti-inflammatory, anti-wrinkle, insulin, anticancer, and acne medications skin-based and
oral liposome delivery systems have also been tested with relatively high success (Cevc
et al., 1996).

1.4.1.5.

Liposomes and Gene Therapy: One of the most exciting medical applications

of liposomes relates to the ability to entrap and deliver genetic material. Key obstacles
that have to be overcome to ensure the continued functionality of entrapped genetic
materials include a lowering of the susceptibility of DNA and RNA to nucleases and the
design of liposomes, that while having a long shelf life, fuse upon recognition of the
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target cell (Chonn and Cullis, 1998). Studies utilizing DNA entrapped in SUVs that
allowed fusion to occur once the target cell was encountered demonstrated liposomes to
be an efficient tool in the treatment of cystic fibrosis, viral diseases, and some cancers
(Chen et al., 2000; Schreier and Sawyer, 1996). In order to increase the cellular uptake of
genetic material encapsulated within liposomes, researchers tagged liposomes with viral
envelope proteins that would recognize and attach to target cell membranes. The
subsequent liposome fusion with the target cell resulted in high therapeutic delivery to
the cell. Studies indicated a decreased toxicity to cells if cationic phospholipids were used
to construct liposomes which may improve treatment of more devastating diseases such
as HIV (Kunisawa et al., 2001).

1.5.

Non-Food Agricultural Applications of Liposomes

1.5.1. Introduction

In addition to the many medical and pharmaceutical applications of liposomes, the
use of liposomes in agriculture systems has been investigated. While the primary use of
liposomes in these studies has been as a model or control membrane system, some drug
and reagent delivery systems have been developed. Liposomal model membranes have
been used to study the transport of solutes across cellular membranes, elucidate the
mechanism of toxin and antimicrobial activity, study the mechanism of action in
pesticides, and deliver therapeutics substances to farm animals. This review will focus
primarily on the application of liposomes on plants as it is related to pesticide and toxin
attack and on veterinary applications. A schematic overview over the wide variety of
application of liposomes in agriculture is shown in Figure 1.4.
26

Liposomes

Food Industry
Applications

Non-Food Agricultural
Applications
Nutrient
Encapsulation &
Delivery

Plants

Trans-Membrane
Transport
Processes

Animal

Plant Stress Resistance

Plant Toxin &
Pesticide
Mechanisms

Functional
Component
Encapsulation

Toxin and
Pesticide
Mechanisms

Flavors

Proteins &
Enzymes

Antimicrobials

Figure 1.4: Representation of liposomal application in the agricultural industry.

1.5.1.1.

Toxin and Pesticide Attack on Liposomal Membrane Models: Ramalingam et

al. (1994) using liposomal model membranes, reported that ricin, a plant toxin containing
two polypeptide chains (A, B) connected by a disulfide linkage, can insert into
membranes with subsequent translocation. Theses researchers also observed that while
the intact toxin may translocate, it is the cleavage of the disulfide polypeptide-linker that
liberates the A-chain and gives rise to the toxicity (Ramalingam et al., 1994). Bertoluzza
et al. (1999) using Raman spectroscopy reported that prometryn, a herbicide derived from
1,3,5-triazine, inserted into PC and phosphatidic acid (PA) liposomes but did not disturb
the hydrophobic core of bilayers. Rather, prometryn accumulated near the glycerol
moiety to perturb the carbonyl linkages; however, as system pH was reduced to ~5.0,
prometryn insertion decreased, which resulted in a decreased capability of prometryn to
lower the bilayer phase transition temperature (Bertoluzza et al., 1999). Parathion, a
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common insecticide, was found to locally perturb dimyristoyl-PC (DMPC) liposomes at
parathion/lipid ratios as low as 1/200 via disordering of fatty acid acyl chains (Suwalsky
et al., 2001). Lee et al. (2001) reported the formation of a cation-permeable pore after
insertion of HrpZPsph from Pseudomonas syringae pv. phaesolicola, a bacterial
phytopathogen, on PC and PC/PE 8/2 liposomes. Authors speculated that the protein-pore
allowed delivery of virulence factors of the bacterium to its host while simultaneously
allowing pathogen nutrients to efflux from the plant cell (Lee et al., 2001).
Melittin, a bee venom, has shown to be extremely toxic due to its membrane lytic
capability at very low concentrations (1 melittin molecule per every 10,000 molecules of
phospholipid are sufficient to induce lysis) (Posch et al., 1983). Using temperature
scanning densiometry (TSD) to observe the specific volumes of samples in dilute systems
and their changes over a set temperature range, Posch et al. (1983) defined a biphasic
effect of melittin on liposomes. With DPPC liposomes, melittin at ratios below 1:1500
reduced the transition volume (the sample specific volume at the Tm) of lipids by ~25%,
eliminated lipid pre-transitions and increased the transition temperature from 41.5°C to
~48°C. At higher concentrations of melittin (1 mol%), the Tm decreased to ~31-32°C
from 41.5°C and the transition volume decreased to almost zero (Posch et al., 1983).
Authors concluded that the long range perturbation capability of melittin likely represents
one of the primary modes of action for the polypeptide together with its ability to
enhance fluctuations in the packing of phospholipids.
Pesticides, while targeted towards plant antagonists such as insects, often exhibit
activity towards higher organisms such as mammals, including humans. Since many
insecticides inhibit acetylcholine esterase in the nervous system, the potential for toxicity
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to humans from these compounds has led to studies of pesticide toxicity on species other
then the target organism. Dichlorodiphenyldichloroethylene (DDE), a metabolite of
dichlorodiphenyl-trichloroethane (DDT), was found to accumulate in PC liposomes. The
accumulation depended on temperature, concentration of DDT and presence of
cholesterol (Videira et al., 1995). DDE insertion into DMPC liposomes reached a
maximum at 37°C (partition coefficient=~1.1x104) and in the absence of cholesterol
(partition coefficient=~6.0x103). It was suggested that DDE preferentially targets
lipid/lipid and lipid/protein interactions near the hydrophobic core thereby reducing the
membrane cooperativity (Videira et al., 1995). González-Baró et al. (1997) reported on
the effects of fenitrothion, an organo-phosphate, on freshwater shrimp. Liposomes
formed from lipids extracted from shrimp microsomes were sonicated and exposed to
fluorescent probes in the presence of fenitrothion at varying concentrations and the
fluorescence anisotropy then recorded. Concentrations of insecticide as low as 10-6 M
were sufficient to stimulate an increase of polarization of probes. It was suggested that
fenitrothion activity was highest in the external region of the bilayer rather then within
the hydrophobic core (González-Baró et al., 1997).
Organotins, another class of pesticides, were found to have lipid-like properties
based on studies of their interactions with PC and PE liposomes (Chicano et al., 2002).
Thermotropic, nuclear magnetic resonance (NMR), and infrared (IR) spectroscopy
studies of two organotins applied to PE liposomes showed that organotins may attack PE
by lowering the transition temperature required to induce formation of an inverted
hexagonal (HII) phase. The phase transition temperature of PE liposome bilayers to HII
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conversion decreased by 20°C upon the addition of 0.5 molar % organotin (Chicano et
al., 2002).

1.5.1.2.

Veterinary Applications of Liposomes: While the majority of research to date

has focused on the use of liposomes to study various plant species, veterinary
applications for liposomes have also been reported. Longworth et al. (1994) first
confirmed previously formulated hypotheses that horses produced pulmonary
intravascular macrophages. Test horses were injected with PC/phosphatidylserine
(PS)/Cholesterol liposomes labeled with Indium (111In) and containing a copper
phthalocyanine dye (blue) at a concentration of 10 µM in saline buffer. The blood
pressure of both non-anesthetized and anesthetized horses injected with the liposomes
greatly increased (approx. twice that prior to injection) and retention of liposomes in the
lungs was high (~50%). Authors concluded that horses, contrary to previous expectations,
did produce pulmonary intravascular macrophages which may aid in mediating various
lung hemodynamic effects after encountering a phagocytizing endotoxin (Longworth et
al., 1994).
Similar to human pharmacokinetic and pharmaceutical studies, increased
efficiency of drug delivery following encapsulation have been reported for animals. For
example, the delivery efficiency of liposome-encapsulated chloroquine (anti-malaria)
administered to mice increased compared to non-encapsulated chloroquine (Kadir et al.,
1992). Prolonged monitoring of the drug revealed that the drug was still present in mice
15 days after intramuscular injection indicating a slow release of encapsulated antibiotic.
Seven days after the injection with 3.3 mg liposomal-encapsulated chloroquine, none of
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the test mice developed malaria after exposure to infected parasites. Fifteen days postliposome injection, 33% of the mice retained resistance to malaria (Kadir et al., 1992).
Cabanes et al. (1998) concluded that liposomes were not only effective in improving the
efficiency of the amount of drug delivery but were also very suitable for sustained drug
release in animal systems. Encapsulated gentamycin-oleate and gentamycin-sulfate
(PC/cholesterol) was slowly released from liposomes with little change in system
concentration over an eight-hour period post-injection and half-lives of liposomal
encapsulated antibiotics increased approximately three-fold over that of the aqueous
dispersions of antibiotics (Cabanes et al., 1998).

1.6.

Liposomes in the Food Industry

1.6.1. Introduction

The majority of micro-encapsulation techniques currently used in the food
industry are based on biopolymer matrices composed of sugars, starches, gums, proteins,
synthetics, dextrins, and alginates; nevertheless, liposomes have recently begun to gain in
importance. Based on results of numerous studies of liposomes for pharmaceutical and
medical uses (drug delivery, cancer treatments, etc.), food scientists have begun to utilize
liposomes for controlled delivery of functional components such as proteins and
enzymes, vitamins, and flavors in various food applications. The following discussion
will focus on the applications of liposomes in the food industry to date, reviewing
significant advancements and uses of liposomes for the preservation of both quality and
safety of various food products. Special attention has been given to dairy products, as the
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majority of applications of liposomes have been in the protection or enhancement of
these types of foods.

1.6.1.1.

Liposomes in Dairy Foods: Liposome uses for dairy products have been

studied for nearly two decades. Law and Wigmore (1982; 1983) reported that time and
cost to ripen some hard cheeses can be reduced with addition of proteinases to cheese
mixes prior to isolation of curds. Law and King (1985) found that the addition of MLVentrapped protease to cheese curd inhibited the rapid proteolysis of β-casein and resulted
in firmer cheeses after completion of fermentation while maintaining curd structure by
preventing enzymatic attack. Kirby et al. reported similar findings with freeze-thawed
small unilamellar vesicle (SUV) liposomes with respect to proteinase protection via
liposomes (1987). Researchers recorded that entrapped reporter dye (carboxyfluorescein)
was only slowly released from milk samples (<20% egg PC-encapsulated dye was
released over six months’ ripening), indicating that liposome entrapment could reduce
proteolysis-induced degradation of cheese curd structure during ripening. Liposomeentrapment of proteinase after a partial purification of the enzyme produced Saint-Paulin
style cheese with the same degree of ripeness as control samples that contained free
proteinase but with much shorter ripening times (Alkhalaf et al., 1988). Significant delay
in the onset of bitterness in liposome-treated cheeses versus liposome-free control cheese
samples was also observed. Analysis of experimental and control samples in cheese
ripening studies with encapsulated chymosin indicated that sensory and rheological
changes in samples during ripening were not due to the addition of liposome-entrapped
chymosin, indicating that liposome entrapment of proteinases does not negatively
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influence the organoleptic properties of the finished cheese (Picón et al., 1994; Picón et
al., 1997).
More recently the entrapment of lipases to improve the production of cheese has
been investigated. Addition of liposome-encapsulated lipases reduced the firmness of
Cheddar cheeses while increasing the cohesiveness and elasticity of samples (Kheadr et
al., 2002). An increase in the production of free fatty acids and a more desirable flavor
profile with the addition of moderate quantities (0.5 U/g) of lipase was observed.
Nevertheless, addition of encapsulated lipase at higher concentrations of enzyme (1.0
lipase U/g milk fat) led to the development of a soapy off-flavor after 60-90 days
ripening (Kheadr et al., 2002). Overall, addition of liposomes to cheese in order to
accelerate and improve the efficiency of the ripening process must be carefully controlled
so as not to negatively affect the overall quality of the final product. Liposome
composition is one key factor that manufacturers should consider in order to prevent
development of off-flavors and to ensure release of payloads in a predictable manner.
In addition to their ability to decrease processing time for cheese products,
liposomes have also been used to fortify dairy products with vitamins to increase their
nutritional quality as well as aid in digestion of constituents inherent to dairy products.
Banville et al. (2000) found significant differences in the recovery of vitamin D from
cheeses containing liposome-entrapped vitamin D (~62%) compared to commercially
prepared vitamin D (~43%) and vitamin D solubilized in cream (~40%) indicating that
liposomal encapsulation protected vitamins from degradation. Liposomes have also been
utilized in dairy products to induce the slow digestion of lactose to aid digestion of dairy
foods by the lactose intolerant. β-galactosidase entrapped in soy-PC/cholesterol (1/3)
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liposomes, stable at low pH conditions (pH=3.0 for 60 min at 37°C), retained enzymatic
activity after one month of refrigerated storage (5°C under nitrogen) (Matsuzaki et al.,
1989). In a similar study with liposome-entrapped β-galactosidase, activity was retained
over 20 days refrigerated storage at neutral pH. However, encapsulated enzyme activity
was significantly diminished with exposure to low pH conditions (pH=2.0-4.0),
suggesting the effectiveness of liposomes to stabilize the enzyme during storage but to
rapidly release entrapped contents upon encountering the high acid conditions of the
human stomach (Rao et al., 1995).

1.6.1.2.

Stabilization of Food Additives Against Degradation: Currently, liposome

applications focus primarily on dairy products. Nevertheless, new studies report
increasing uses for liposomes in other food applications. Lactoferrin, a glycoprotein
exerting bacteriostatic influences on cells through sequestering of iron, inhibited lipid
oxidation in corn oil emulsions and PC liposomes (Huang et al., 1999). The antioxidant
activity of free phosvitin exposed to PC liposomes was maximal at 40 µM (~80%
inhibition) (Lee et al., 2002). Antioxidant activity of liposome-entrapped phosvitin
exposed to a model meat system (pork muscle homogenate) was highest at 15 µM (~41%
inhibition of oxidation). Finally antioxidant activity was tested with ground pork exposed
to 0% and 2% salt and cooking to 80°C internal temperature. Entrapped phosvitin was
most effective in inhibiting oxidation in unsalted, uncooked samples and least effective in
inhibiting inhibition in salted, cooked samples (Lee et al., 2002).
PC liposomes supplemented with stearic acid and α-tocopherol effectively
protected entrapped α-amylase against pepsin attack, cold temperature storage, and
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extreme pH conditions (Hsieh et al., 2002). In kinetic studies of free and PC-entrapped
glucose oxidase, the reaction Km for entrapped enzyme versus free enzyme increased
(Rodriguez-Nogales, 2004). A decrease in Vmax (factor=0.35) for liposome-entrapped
enzyme was also observed. The entrapment of enzyme afforded greater proteolysis
resistance and thermal stability (Rodriguez-Nogales, 2004). Collectively, these results
indicated that liposome entrapment of enzyme restricts access of entrapped enzyme to
substrate but that liposomes can shield enzymes from environmental stresses. Entrapment
of immunoglobulin Y (IgY) in PC:cholesterol (1:1) liposomes provided maximal
shielding of IgY from acid (1.8, 2.8) and pepsin attack (Chang et al., 2001). These
researchers concluded that liposome entrapment represented a powerful potential method
for the oral delivery of immunoglobulins.
Liposomes may stabilize and protect vitamins in food systems other than dairy
products. Kirby et al. (1991) reported that the antioxidant activity of ascorbic acid
(vitamin C) encapsulated in PC liposomes increased compared to free vitamin C
solutions. Liposome-encapsulated ascorbic acid retained >50% activity after 50 days
refrigerated storage while free ascorbic acid lost all activity after 19 days. Addition of
cholesterol to PC liposomes at 1:1 further increased vitamin C activity compared to PC
liposomes containing no cholesterol. Approximately 65% vitamin C was retained in PCcholesterol (1:1) liposomes after 40 days at 4°C compared to approximately 10% in
cholesterol free liposomes (Kirby, 1991). Degradation of liposome-entrapped and free
vitamin A (retinol) was measured as a function of system temperature (Lee et al., 2002).
Rates of light- or heat-induced degradation of retinol decreased upon encapsulation of
vitamin regardless of light source (ambient or UV) or temperature compared with free
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retinol. The addition of vitamin E (α-tocopherol) further decreased the degradation of
retinol entrapped in liposomes (Lee et al., 2002). These studies point to the potential for
liposomes to aid in the protection of bioactivity of nutrients against degradation in foods
as well as the potential for fortification of foods with liposome-entrapped vitamins to
increase the overall health benefit of the food product.

1.7.

Properties and Functionality of the Antimicrobial Nisin

1.7.1. Properties of Nisin

1.7.1.1.

Physico-Chemical Properties of Nisin: The antimicrobial nisin, named so

because it is classified as a group N inhibitory substance, is a 3.4 kDa posttranslationally-modified polypeptide produced by the bacterium Lactococcus lactis
subsp. lactis. The primary structure of nisin was first reported by Gross and Morell
(1971). The polypeptide is amphipathic by nature, resulting from the inclusion of several
hydrophobic amino acids including isoleucine, alanine, valine, and glycine. Nevertheless,
it also contains a high percentage of polar amino acids; the presence of multiple cationic
residues (e.g., lysine) induce a cationic charge on the peptide residing mainly at the Cterminus (Epand and Vogel, 1999; Twomey et al., 2002). A hinge region that functions
during nisin’s insertion into the target membrane has also been described, located
between residues 20-22 (Breukink and de Kruijff, 1999). There are five thioether bridges
that exist in the native bacteriocin, giving the polypeptide high stability to both acid and
heating (Delves-Broughton, 1990). It is most soluble in acidic conditions and least
soluble in mild alkalinity to extreme basic conditions (Liu and Hansen, 1990). Two
variants of nisin have been reported, nisin A and Z; the variants are highly homologous,
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differing by only one residue at position 31 (Epand and Vogel, 1999). Nisin Z exchanges
the histidine found in nisin A for an asparagines at position 27; these variants have been
reported to demonstrate no difference in their antimicrobial activity against identical
strains (Breukink and de Kruijff, 1999).

1.7.1.2.

Synthesis of Nisin: Siegers et al. (1996) demonstrated the genes NisB and

NisC form membrane-associated proteins which interact with the peptide after its initial
synthesis to induce the post-translational modifications observed in its structure (Fig.
1.5). Immuno-precipitation experiments and mutagenesis studies were shown to
demonstrate the existence of a nisin synthesis and modification operon consisting of 11
genes, encoding precursors and functioning to complete the modifications of the
prepeptide after its translation (Siegers and Entian, 1995; Siegers et al., 1996). It has been
demonstrated that not only are these genes necessary for the production of the bacteriocin
but also for the immunity of the L. lactis microbe to the bacteriocin which it produces
(Dodd et al., 1992; Klein and Entian, 1994; Siegers and Entian, 1995).

Figure 1.5: Simplified structure of nisin A. (Breukink and de Kruijff, 1999).
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1.7.1.3.

Mechanism of Action Models for Nisin: Nisin possesses a cationic charge

which functions via attractive electrostatic interactions with anionic lipids on the outer
membrane of the bacterium to bring the bacteriocin into intimate contact with the cell
(Breukink et al., 2000; Breukink et al., 1997). In fact, it has been reported by several
researchers that the presence of anionic lipids is generally a necessity for nisin to interact
with the bacterial membrane (Breukink and de Kruijff, 1999; El Jastimi and Lafleur,
1997; Martin et al., 1996). Nevertheless, nisin can interact with lipids that do not bear an
overall charge, such as the zwitterionic phosphatidylcholine (PC) (El-Jastimi et al.,
1999). Nisin-induced changes in membranes formed from non-charged lipids are
reportedly evidenced in rearrangement of lipid around the insertion site of the
bacteriocin, resulting in changes in the morphology of the membrane and its lipids (ElJastimi et al., 1999).
While nisin binds intimately with anionic lipids in the bacterial membrane, these
lipids are not the final target of the bacteriocin. Rather, a peptidoglycan precursor termed
Lipid II was theorized and later discovered to modulate the activity of nisin in intact
bacterial cell membranes (Linnett and Strominger, 1973; Reisinger et al., 1980). It is
speculated that this precursor is one explanation for the generally increased sensitivity of
Gram-positive microbes to the bacteriocin over Gram-negative bacteria. Others have
reported that an increased content of anionic lipid in Gram-positive membranes and the
presence of an outer membrane in Gram-negatives as contributing factors towards
observed differences in nisin resistance (Branen and Davidson, 2004; Crandall and
Montville, 1998; Demel et al., 1996). Lipid II is membrane bound and composed of 11
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polyisoprene residues bound to a molecule of MurNAc(pentapeptide)-GlcNAc via a
pyrophosphate linker (Breukink and de Kruijff, 1999). It has a high affinity for the
bacteriocin, as evidenced by reports stating that nisin was lethal in nanomolar
concentrations for cells, whereas micromolar concentrations of the lantibiotic were
required for model membranes composed of lipids similar to those of the bacterial
membrane but without Lipid II (Brotz et al., 1998). It has been speculated that the sugar
components of Lipid II are key to nisin recognition of the molecule and binding and that
it is the N-terminus of nisin that interacts more strongly with Lipid II (Breukink et al.,
2003; Breukink et al., 1999; Brotz et al., 1998). It has also been reported that bacterial
resistance to nisin is not Lipid II concentration-dependent (Kramer et al., 2004).
Nisin induces pores in the membrane following its insertion and interaction with
the membrane and Lipid II. Yet, how exactly this is done is still a matter of some debate;
multiple models have been described detailing the activity of the bacteriocin and its
preferred structure and orientation within the membrane. As was stated above, the Cterminus of nisin is especially important for the initial binding and insertion of the
bacteriocin into the membrane of the organism; electrostatic interactions play a key role
in the attraction of the cationic peptide to anionic surface lipids, thus giving rise to an
initial binding of the molecule to the outer membrane of the Gram-positive. However,
once the initial binding has occurred, it is believed that nisin’s amphiphilic properties aid
it in inserting the hydrophobic N-terminus deep into the membrane (Breukink et al.,
1998; Martin et al., 1996). The presence of a hinge in the middle of the bacteriocin
allows for the peptide to maintain an overall parallel orientation within the membrane
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while simultaneously allowing the N-terminal region to bury deep within the bilayer
(Breukink et al., 1998).
Porulation of the bacterial membrane has been reported to be a cooperative
process involving multiple monomers of nisin with the eventual formation of aggregates
around a single pore (Breukink and de Kruijff, 1999). It is also believed that the pore is
anion-selective (Breukink et al., 1997). Studies have reported that nisin maintains its
overall parallel orientation to the membrane, although that is disputed by several studies
which demonstrate pore formation by leakage of fluorescent reporters following
incubation of vesicles with nisin. It is thus possible that either the peptide can translocate
across the membrane or that the pore is of a transient nature (Breukink et al., 2000;
Breukink et al., 1998). Nisin is known to dissipate the membrane electrical potential of
cells, although it has been reported that the potential is not an absolute necessity for nisin
activity (Bruno et al., 1992; Driessen et al., 1995).

1.8.

Liposome Encapsulation of Food Antimicrobials
To date, only a small number of studies have been published investigating the

efficiency of antimicrobials encapsulated in liposomes for selected food applications.
Nevertheless, given the numerous reports of successful entrapment of a variety of
compounds, it should not be surprising that liposomes can be employed for the
entrapment of food-grade polypeptide antimicrobials such as nisin. Liposomes, as
mentioned earlier, are aqueous dispersions of phospholipids in which lipids
spontaneously associate and align so as to minimize the exposure of hydrophobic fatty
acid tails to the aqueous buffer. Thus, compounds of interest that are hydrophilic or
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amphipathic, such as polypeptides, make excellent candidates for encapsulation in
liposomes. Indeed, much of the work completed in the fields of pharmaceuticals and drug
delivery have sought to optimize the encapsulation and utility of compounds that are
chemically very similar to nisin.
Thapon and Brule (1986) reported the use of liposomes to encapsulate lysozyme
and/or nisin in an effort to prevent the spoilage of various cheeses. Degnan and
Luchansky (1992) reported anti-listerial effects of the bacteriocin pediocin AcH in beef
tallow and muscle slurries using PC liposomes. Bacteriocin activity generally improved
following encapsulation compared to non-encapsulated pediocin (~28% increase in
activity of encapsulated versus free bacteriocin). Authors reported that pediocin AcH
activity was degraded very rapidly when unencapsulated bacteriocin was added to
slurries or tallow, likely a function of cross-reactions with food component leading to loss
of activity (Degnan and Luchansky, 1992).
Benech et al. (2002b) encapsulated nisin Z (an asparagine-containing variant of
nisin) in hydrogenated PC liposomes (1 mg nisin Z/ml buffer) and added liposomes or
unencapsulated nisin Z to a cheese milk solution at a final concentration of 300 IU/g
cheese. Listeria innocua counts decreased by 3.0 log units over a six-month ripening
period with minimal observed differences in cheese composition between free and
encapsulated nisin cheeses (Benech et al., 2002b). Nisin Z activity at the end of the sixmonth ripening period was reported to be 90% of the initial activity, with a final
concentration of L. innocua below 10 CFU/g cheese.
Figure 1.6 demonstrates the differences in liposome-encapsulated antimicrobial
versus free nisin in cheese samples with respect to maintenance of antimicrobial activity.
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Figure 1.6: Nisin activity in ripened cheeses containing either free nisin produced in
Situ or liposome-entrapped nisin. Figure reproduced from Benech et al. (2002b).

Benech et al. (2002a), again using hydrogenated PC liposomes to encapsulate nisin Z,
reported similar activity retention for nisin Z after a six-month cheddar cheese ripening
period. L. innocua counts decreased below a limit of detection in a selective plating assay
by the end of the ripening period for cheeses containing encapsulated nisin Z. In both
studies, authors claimed that starter cultures for cheese production must be chosen
carefully so as to delay the acidification of the product in an effort to maximize the
potential for nisin activity (Benech et al., 2002a; Benech et al., 2002b).
Laridi et al. (2003) investigated the encapsulation of nisin Z in liposomes
composed of various commercially prepared proliposomes: hydrogenated PC, soybean
PC, charged phospholipids (unspecified), and various other soy-based unsaturated
phospholipids. These authors investigated the effects of fatty acid compositions, system
pH, cholesterol content, and nisin Z content on the encapsulation efficiency (EE) of
prepared liposomes. Hydrogenated PC liposomes were found to be optimal (34.6% EE)
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for the encapsulation of nisin Z versus other unsaturated phospholipids (11.6% EE) or
phospholipid mixtures (26% EE). Increasing cholesterol concentration in liposomes from
0% to 20% led to a decrease in nisin Z encapsulation (e.g., ~25% EE at 0% cholesterol to
~15% EE at 20% cholesterol for hydrogenated PC liposomes). An increase in pH from
3.6 to 6.6 resulted in reduction in EE for hydrogenated liposomes (~25% EE at pH=3.6 to
~14% at pH=6.6), while liposomes containing higher percentages of unsaturated fatty
acids did not display large fluctuation in EE (~12% EE at pH=3.6 to ~9% EE at pH=6.6)
(Laridi et al., 2003). Interestingly, nisin loading of vesicles resulted in significant
reductions in vesicle diameter as measured by dynamic light scattering from a mean
diameter of 1741 nm to ~740 nm (Laridi et al., 2003). Finally, it was reported that nisin-Z
encapsulated liposomes in milk were able to withstand the cheese manufacture
temperature cycle without statistically significant losses of entrapped antimicrobial
(Laridi et al., 2003).
Were et al. (2003) successfully encapsulated nisin and lysozyme in liposomes
containing three different phospholipids. Liposomes containing PC, PC/cholesterol
(70/30), and PC/PG/cholesterol (50/20/30) were reported to encapsulate nisin Z and
calcein, a fluorescent reporter, with >50% efficiency regardless of liposome composition.
Encapsulation efficiency for the antimicrobial protein lysozyme was ~60% for all
liposome preparations. Antimicrobial-induced leakage of fluorescent reporter was low
(<40% release) in all liposomes except PC liposomes containing a high concentration of
nisin (375 µM) (~70% release) (Were et al., 2003). Interestingly, PC/cholesterol
liposomes showed little leakage of contents, presumably due to the inclusion of 30%
cholesterol (El-Jastimi and Lafleur, 1999). Authors concluded that while leakage was
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high in PC liposomes loaded with nisin Z, the encapsulation of antimicrobials constitutes
a potentially powerful method of pathogen control in food products (Were et al., 2003).
Were et al. (2004), in studies investigating antimicrobial activity of liposomeencapsulated nisin against L. monocytogenes, reported > 2 logs inhibition of L.
monocytogenes strains with encapsulated nisin. Liposome-encapsulated lysozyme was
also inhibitory to L. monocytogenes strains, though to a lesser degree.
With respect to entrapment of food antimicrobials for delivery in food systems,
dairy foods have been the predominant food matrix of choice for the testing of liposome
entrapment of antimicrobials and their functionality in food. Fluid milk and ripened
cheeses in particular make useful experimental model foods as liposomes can be easily
incorporated and distributed homogeneously throughout the entire sample. In contrast,
fruit and vegetable products are not able to incorporate liposomes to an appreciable
amount without substantial processing; the same is true for muscle foods. Fluid milk and
cheeses contain substantial levels of proteins and lipids, two major food constituents
known to interfere with antimicrobial activity of nisin. Dairy foods contain a high level of
monovalent and divalent cations, also known to protect bacteria against the activity of
antimicrobials. Hence, if activity is observed, then entrapment is likely to be responsible
for the protection of the antimicrobial activity rather then some other factor. Liposomes
have been demonstrated to be capable of sequestering their payload from food
components, as evidenced by high entrapment efficiencies and kinetically slow release of
entrapped contents over time (Benech et al., 2002b; Were et al., 2003). Finally, liposomal
vesicles possess the potential to behave in a manner similar to a bacterium with respect to
the localizing of a cell in one phase or another of an emulsion product. Hence, if a
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bacterium preferentially locates at the fat/water interface in fluid milk, it is likely that a
liposomal vesicle should locate itself at the interface as well, thus bringing the
antimicrobial into close physical proximity of the bacterium.
Research to date has demonstrated the excellent potential for liposomes to serve
as a model system for cell membranes and to deliver a wide variety of quality-enhancing
compounds to biological systems. Use of liposomes in the pharmaceutical industry has
led to the successful treatment of a wide variety of diseases. Methods to finely tune the
composition of liposomes have allowed manufacturers to target specific organs within the
human body, reducing the degree of side effects experienced with non-targeted drugs. In
the area of food science, the utility and functionality of liposomes for encapsulation of
food ingredients and preservatives is an area of research still largely unexplored. Initial
experimentation has dealt with the entrapment of additives, nutrients, and now
antimicrobials; the next frontier in terms of liposome entrapment research will likely
focus on flavor and aroma delivery. Liposomes are often formulated from lipids of
natural sources (e.g., soy, egg); hence, overcoming regulatory hurdles should be less
difficult and newly developed carrier systems might be quickly implemented. In order to
extend the degree of utilization of liposomes, future research should focus on the
production of liposomes from non-purified polar lipid sources to reduce the cost of raw
materials and to develop suitable models that can predict the rate of release of entrapped
compounds. The use of food-grade solvents for the solubilization, storage, and mixing of
lipids for the purpose of liposome formulation should also be explored, as currently the
use of food-grade solvents for lipids is limited with respect to encapsulates. The goal is to
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demonstrate the true potential for liposome entrapped antimicrobial to improve the
quality and safety of a wide variety of food products.
In closing, the following chapters in this thesis will discuss both the physicochemical and antimicrobial properties of nisin-loaded liposomes formed from both
naturally-occurring and synthetic phospholipids. A wide range of analytical chemistry
and microbiological techniques are employed for the description of the properties of
liposome suspensions with respect to their structure, responses to changes in
environment, and antimicrobial efficiency against the foodborne pathogens Listeria
monocytogenes and Escherichia coli O157:H7.

46

References
1.

Akhtar S., Hughes M.D., Khan A., Bibby M., Hussain M., Nawaz Q., Double J.,
and Sayyed P. 2000. The delivery of antisense therapeutics. Adv. Drug Del. Rev.
44: 3-21.

2.

Alkhalaf W., Piard J.-C., El Soda M., Gripon J.-C., Desmazeaud M., and Vassal
L. 1988. Liposomes as proteinase carriers for the accelerated ripening of SaintPaulin type cheese. J. Food Sci. 53: 1674-1679.

3.

Allen T.M., and Cleland L.G. 1980. Serum-induced leakage of liposome contents.
Biochim. Biophys. Acta. 597: 418-426.

4.

Allen T.M., Sapra P., Moase E., Moreira J., and Iden D. 2002. Adventures in
targeting. J. Liposome Res. 12: 5-12.

5.

Bangham A.D., Hill M.W., and Miller N.G.A. 1974. Methods in Membrane
Biology. Korn E.D. New York, NY, Plenum Press. 1: 1-68.

6.

Bangham A.D., Hill M.W., and Miller N.G.A. 1974. Preparation and use of
liposomes as models of biological membranes. Methods in Membrane Biology.
Korn E.D. New York, NY, Plenum Press. 1: 1-68.

7.

Banville C., Vuillemard J.-C., and Lacroix C. 2000. Comparison of different
methods for fortifying Cheddar cheese with vitamin D. Int. Dairy J. 10: 375-382.

8.

Barenholz Y., Gibbes D., Litman B.J., Goll J., Thompson T.E., and Carlson F.D.
1977. A simple method for the preparation of homogenous phospholipid vesicles.
Biochemistry. 16: 2806-2810.

9.

Barnadas-Rodríguez R., and Sabés M. 2001. Factors involved in the production of
liposomes with a high-pressure homogenizer. Int. J. Pharm. 213: 175-186.

10.

Barnadas-Rodríguez R., and Xamani M.S.I. 2003. Liposomes prepared by high
pressure homogenizers. Meth. Enzymol. 367: 28-45.

11.

Bendas G. 2001. Immunoliposomes - A promising approach to targeting cancer
therapy. Biodrugs. 15: 215-224.

12.

Benech R.-O., Kheadr E.E., Lacroix C., and Fliss I. 2002a. Antibacterial activities
of nisin Z encapsulated in liposomes or produced in situ by mixed culture during
cheddar cheese ripening. Appl. Environ. Microbiol. 68: 5607-5619.

13.

Benech R.-O., Kheadr E.E., Laridi R., Lacroix C., and Fliss I. 2002b. Inhibition of
Listeria innocua in cheddar cheese by addition of nisin Z in liposomes or by in
situ production in mixed culture. Appl. Environ. Microbiol. 68: 3683-3690.
47

14.

Bertoluzza A., Bonora S., Fini G., and Morelli M.A. 1999. Effects of the
herbicide prometryn on the physicochemical properties of artificial model
membranes. Pestic. Sci. 55: 147-153.

15.

Biltonen R.L., and Lichtenberg D. 1993. The use of differential scanning
calorimetry as a tool to characterize liposome preparations. Chem. Phys. Lipids.
64: 129-142.

16.

Boguslavsky V., Hruby V.J., O'Brien D.F., Misicka A., and Lipkowski A.W.
2003. Effect of peptide conformation on membrane permeability. J Pept Res. 61:
287-297.

17.

Brandl M., Drechsler M., Bachmann D., Tardi C., Schmidtgen M., and Bauer K.H. 1998. Preparation and characterization of semi-solid phospholipid dispersions
and dilutions thereof. Int. J. Pharm. 170: 187-199.

18.

Branen J.K., and Davidson P.M. 2004. Enhancement of nisin, lysozyme, and
monolaurin antimicrobial activities by ethylenediaminetetraacetic acid and
lactoferrin. Int. J. Food Microbiol. 90: 63-74.

19.

Breukink E., and de Kruijff B. 1999. The lantibiotic nisin, a special case or not?
Biochim. Biophys. Acta. 1462: 223-234.

20.

Breukink E., Ganz P., de Kruijff B., and Seelig J. 2000. Binding of nisin Z to
bilayer vesicles as determined with isotherm titration calorimetry. Biochemistry.
39: 10247-10254.

21.

Breukink E., van Heusden H.E., Vollmerhaus P.J., Swiezewska E., Brunner L.,
Walker S., Heck A.J., and de Kruijff B. 2003. Lipid II is an intrinsic component
of the pore induced by nisin in bacterial membranes. J. Biol. Chem. 278: 19898903.

22.

Breukink E., van Kraaij C., Demel R.A., Siezen R.J., Kuipers O.P., and de Kruijff
B. 1997. The C-terminal region of nisin is responsible for the initial interaction of
nisin with the target membrane. Biochemistry. 36: 6968-6976.

23.

Breukink E., van Kraaij C., van Dalen A., Demel R.A., Siezen R.J., de Kruijff B.,
and Kuipers O.P. 1998. The orientation of nisin in membranes. Biochemistry. 37:
8153.

24.

Breukink E., Wiedemann I., van Kraaij C., Kuipers O.P., Sahl H., and de Kruijff
B. 1999. Use of the cell wall precursor lipid II by a pore-forming peptide
antibiotic. Science. 286: 2361-4.

25.

Brotz H., Josten M., Wiedemann I., Schneider U., Gotz F., Bierbaum G., and Sahl
H.G. 1998. Role of lipid-bound peptidoglycan precursors in the formation of
pores by nisin, epidermin and other lantibiotics. Mol. Microbiol. 30: 317-27.
48

26.

Bruno M.E., Kaiser A., and Montville T.J. 1992. Depletion of proton motive force
by nisin in Listeria monocytogenes cells. Appl. Environ. Microbiol. 58: 2255-9.

27.

Cabanes A., Reig F., Garcia-Anton J.M., and Arboix M. 1998. Evaluation of free
and liposome-encapsulated gentamycin for intramuscular sustained release in
rabbits. Res. Vet. Sci. 64: 213-217.

28.

Caffrey M., and Hogan J. 1992. LIPIDAT: a database of lipid phase transition
temperatures and enthalpy changes. DMPC data subset analysis. Chem. Phys.
Lipids. 61: 1-109.

29.

Campbell R.B., Balasubramanian S.V., and Straubinger R.M. 2001a. Influence of
cationic lipids on the stability and membrane properties of paclitaxel-containing
liposomes. J. Pharm. Sci. 90: 1091-1105.

30.

Campbell R.B., Fukumura D., Brown E.B., Mazzola L.M., Izumi Y., Jain R.K.,
Torchilin V.P., and Munn L.L. 2002. Cationic charge determines the distribution
of liposomes between the vascular and extravascular compartments of tumors.
Cancer Res. 62: 6831-6836.

31.

Cevc G., Blume G., Schatzlein A., Gebauer D., and Paul A. 1996. The skin: a
pathway for systemic treatment with patches and lipid-based agent carriers. Adv.
Drug Del. Rev. 18: 349-378.

32.

Chang H.-M., Lee Y.-C., Chen C.C., and Tu Y.-Y. 2001. Microencapsulation
protects immunoglobulin in yolk (IgY) specific against Helicobacter pylori. J.
Food Sci. 67: 15-20.

33.

Chen D., Cole D.L., and Srivatsa G.S. 2000. Determination of free and
encapsulated oligonucleotides in liposomes formulated drug product. J.
Pharmacol. Biomed. Anal. 22: 791-801.

34.

Chen H., and Langer R. 1998. Oral particulate delivery: status and future trends.
Adv. Drug Del. Rev. 34: 339-350.

35.

Chicano J.J., Ortiz A., Teruel J.A., and Aranada F.J. 2002. Organotin compounds
promote the formation of non-lamellar phases in phosphatidylethanolamine
membranes. Biochim. Biophys. Acta. 1558: 70-81.

36.

Chonn A., and Cullis P.R. 1998. Recent advances in liposome technologies and
their applications for systemic gene delivery. Adv. Drug Del. Rev. 30: 73-83.

37.

Connor J., and Huang L. 1985. Efficient cytoplasmic delivery of a fluorescent dye
by pH-sensitive immunoliposomes. J. Cell Biol. 101: 582-589.

49

38.

Crandall A.D., and Montville T.J. 1998. Nisin resistance in Listeria
monocytogenes ATCC 700302 is a complex phenotype. Appl. Environ.
Microbiol. 64: 231-237.

39.

Degnan A.J., and Luchansky J.B. 1992. Influence of beef tallow and muscle on
the antilisterial activity of pediocin AcH and liposome-encapsulated pediocin
AcH. J. Food Prot. 55: 552-554.

40.

Delves-Broughton J. 1990. Nisin and its uses as a food preservative. Food
Technol. 44: 110-117.

41.

Demel R.A., Peelen T., Siezen R.J., De Kruijff B., and Kuipers O.P. 1996. Nisin
Z, mutant nisin Z and lacticin 481 interactions with anionic lipids correlate with
antimicrobial activity. A monolayer study. Eur. J. Biochem. 235: 267-74.

42.

Dodd H.M., Horn N., Hao Z., and Gasson M.J. 1992. A lactococcal expression
system for engineered nisins. Appl. Environ. Microbiol. 58: 3683-93.

43.

Driessen A.J.M., van den Hooven H.W., Kuiper W., van de Kamp M., Sahl H.-G.,
Konings R.N.H., and Konings W.N. 1995. Mechanistic studies of lantibioticinduced permeabilization of phospholipid vesicles. Biochemistry. 34: 1606-1614.

44.

El-Aneed A. 2004. An overview of current delivery systems in cancer gene
therapy. J. Cont. Rel. 94: 1-14.

45.

El-Jastimi R., Edwards K., and Lafleur M. 1999. Characterization of permeability
and morphological perturbations induced by nisin on phosphatidylcholine
membranes. Biophys. J. 77: 842-852.

46.

El-Jastimi R., and Lafleur M. 1999. Nisin promotes the formation of non-lamellar
inverted phases in unsaturated phosphatidylethanolamines. Biochim. Biophys.
Acta. 1418: 97-105.

47.

El Jastimi R., and Lafleur M. 1997. Structural characterization of free and
membrane-bound nisin by infrared spectroscopy. Biochim. Biophys. Acta. 1324:
151-158.

48.

Epand R.M., and Vogel H.J. 1999. Diversity of antimicrobial peptides and their
mechanisms of action. Biochim. Biophys. Acta. 1462: 11-28.

49.

Fattal E., Couvreur P., and Dubernet C. 2004. "Smart" delivery of antisense
oligonucleotides by anionic pH-sensitive liposomes. Adv. Drug Del. Rev. 56:
931-946.

50.

Foldvari M., Baca-Estrada M.E., He Z.H., Hu J.P., Attah-Poku S., and King M.
1999. Dermal and transdermal delivery of protein pharmaceuticals: lipid-based
delivery systems for interferon-a. 30: 129-137.
50

51.

Forssen E., and Willis M. 1998. Ligand-targeted liposomes. Adv. Drug Del. Rev.
29: 249-271.

52.

Gerasimov O.V., Boomer J.A., Qualls M.M., and Thompson D.H. 1999.
Cytosolic drug delivery using pH- and light-sensitive liposomes. Adv. Drug Del.
Rev. 38: 317-338.

53.

Gibbs B.F., Kermasha S., Alli I., and Mulligan C.N. 1999. Encapsulation in the
food industry: a review. Int. J. Food Sci. Nutr. 50: 213-224.

54.

González-Baró M.R., Garda H., and Pollero R. 1997. Effect of fenitrothion on
hepatopancreas microsomal membrane fluidity in Macrobrachium borelli. Pestic.
Biochem. Physiol. 58: 133-143.

55.

Gregoriadis G., Bacon A., Caparrós-Wanderley W., and McCormack B. 2003.
Plasmid DNA vaccines: entrapment into liposomes by dehydration-rehydration.
Meth. Enzymol. 367: 70-80.

56.

Gross E., and Morell J.L. 1971. The structure of nisin. J. Am. Chem. Soc. 93:
4634-4635.

57.

Hafez I.M., and Cullis P.R. 2001. Roles of lipid polymorphism in intracellular
delivery. Adv. Drug Del. Rev. 47: 139-148.

58.

Hashida M., Nishikawa M., Yamashita F., and Takakura Y. 2001. Cell-specific
delivery of genes with glycosylated carriers. Adv. Drug Del. Rev. 52: 187-196.

59.

Hayashi H., Kono K., and Takagishi T. 1996. Temperature-controlled release
property of phospholipid vesicles bearing a thermo-sensitive polymer. Biochim.
Biophys. Acta. 1280: 127-134.

60.

Heurtault B., Saulnier P., Pech B., Benoit J.P., and Proust J.E. 2003. Interfacial
stability of lipid nanocapsules. Colloid Surf. B. 30: 225-235.

61.

Hope M.J., Bally M.B., Mayer L.D., Janoff A.S., and Cullis P.R. 1986.
Generation of multilamellar and unilamellar phospholipid vesicles. Chem. Phys.
Lipids. 40: 89-107.

62.

Hope M.J., Bally M.B., Webb G., and Cullis P.R. 1985. Production of large
unilamellar vesicles by a rapid extrusion procedure. Characterization of size
distribution, trapped volume and ability to maintain a membrane potential.
Biochim. Biophys. Acta. 812: 55-65.

63.

Hsieh Y.-F., Chen T.-L., Wang Y.-T., Chang J.-H., and Chang H.-M. 2002.
Properties of liposomes prepared with various lipids. J. Food Sci. 67: 2808-2813.

51

64.

Huang S.-W., Saute-Gracia M.T., Frankel E.N., and German J.B. 1999. Effect of
Lactoferrin on oxidative stability of corn oil emulsions and liposomes. J. Agric.
Food Chem. 47: 1356-1361.

65.

Jung B.H., Chung S.J., and Shim C.K. 2002. Proliposomes as prolonged
intranasal drug delivery systems. Stp. Pharma. Sci. 12: 33-38.

66.

Kadir F., Eling W.M.C., Crommelin D.J.A., and Zuidema J. 1992. Kinetics and
prophylactic efficiency of increasing dosages of liposome-encapsulated
chloroquine after intramuscular injection into mice. J. Cont. Rel. 20: 47-54.

67.

Kaneda Y. 2000. Virosomes: evolution of the liposome as a targeted drug delivery
system. Adv. Drug Del. Rev. 43: 197-205.

68.

Kheadr E.E., Vuillemard J.-C., and El-Deeb S.A. 2002. Acceleration of Cheddar
cheese lipolysis by using liposome-entrapped lipases. J. Food Sci. 67: 485-492.

69.

Kirby C.J. 1991. Microencapsulation and controlled delivery of food ingredients.
Food Sci. Technol. 5: 74-78.

70.

Kirby C.J., Brooker B.E., and Law B.A. 1987. Accelerated ripening of cheese
using liposome-encapsulated enzyme. Int. J. Food Sci. Technol. 22: 355-375.

71.

Kirby C.J., and Gregoriadis G. 1984. Dehydration-rehydration vesicles-a simple
method for high-yield drug entrapment in liposomes. Biotechnology. 2: 979-984.

72.

Kirby C.J., Whittle C.J., Rigby N., Coxon D.T., and Law B.A. 1991. Stabilization
of ascorbic acid by microencapsulation in liposomes. Int. J. Food Sci. Technol.
26: 437-449.

73.

Kitano H., Akatsuka Y., and Ise N. 1991. pH-responsive liposomes which contain
amphiphiles prepared by using lipophilic radical initiator. Macromolecules. 24:
42-46.

74.

Klein C., and Entian K.D. 1994. Genes involved in self-protection against the
lantibiotic subtilin produced by Bacillus subtilis ATCC 6633. 60: 2793-801.

75.

Koynova R. 1997. Liquid crystalline phase metastability of
phosphatidylglycerols. Chem. Phys. Lipids. 89: 67-73.

76.

Koynova R., and Caffrey M. 1994a. Phases and phase transitions of the
glycoglycerolipids. Chem. Phys. Lipids. 69: 181-207.

77.

Koynova R., and Caffrey M. 1994b. Phases and phase transitions of the hydrated
phosphatidylethanolamines. Chem. Phys. Lipids. 69: 1-34.

52

78.

Koynova R., and Caffrey M. 1995. Phases and phase transitions of the
sphingolipids. Biochim. Biophys. Acta. 1255: 213-236.

79.

Koynova R., and Caffrey M. 1998. Phases and phase transitions of the
phosphatidylcholines. Biochim. Biophys. Acta. 1376: 91-145.

80.

Kramer N.E., Smid E.J., Kok J., De Kruijff B., Kuipers O.P., and Breukink E.
2004. Resistance of Gram-positive bacteria to nisin is not determined by Lipid II
levels. FEMS Microbiol. Lett. 239: 157-161.

81.

Kunisawa J., Nakagawa S., and Mayumi T. 2001. Pharmacotherapy by
intracellular delivery of drugs using fusogenic liposomes: application to vaccine
development. Adv. Drug Del. Rev. 52: 177-186.

82.

Lamprecht A., Ubrich N., Hombreiro Perez M., Lehr C.-M., Hoffman M., and
Maincent P. 1999. Biodegradable monodispersed nanoparticles prepared by
pressure homogenization-emulsification. Int. J. Pharm. 184: 97-105.

83.

Laridi R., Kheadr E.E., Benech R.-O., Vuillemard J.C., Lacroix C., and Fliss I.
2003. Liposome encapsulated nisin Z: optimization, stability and release during
milk fermentation. Int. Dairy J. 13: 325-336.

84.

Lasch J., Weissig V., and Brandl M. 2003. Preparation of liposomes. Liposomes:
A Practical Approach. Torchilin V.P. and Weissig V. New York, NY, Oxford
University Press: 3.

85.

Lasch J., Weissig V., and Brandl M. 2003. Preparation of Liposomes. Liposomes:
A Practical Approach. Torchilin V.P. and Weissig V. New York, NY, Oxford
University Press: 3-30.

86.

Lasic D.D. 1990. On the thermodynamic stability of liposomes. J. Colloid
Interface Sci. 140: 302-304.

87.

Lasic D.D. 1998. Novel applications of liposomes. Trends Biotechnol. 16: 307321.

88.

Law B.A., and King J.S. 1985. Use of liposomes for proteinase addition to
Cheddar cheese. J. Dairy Res. 52: 183-188.

89.

Law B.A., and Wigmore A.S. 1982. Accelerated cheese ripening with food grade
proteinases. J. Dairy Res. 49: 137-146.

90.

Law B.A., and Wigmore A.S. 1983. Accelerated ripening of Cheddar cheese with
a commercial proteinase and intracellular enzymes from starter streptococci. J.
Dairy Res. 50: 519-525.

53

91.

Lee J., Klusener B., Tsiamis G., Stevens C., Neyt C., Tampanaki A.P.,
Panopoulos N.J., Noller J., Weiler E.W., Cornelis G.R., Mansfield J.W., and
Nurnberger T. 2001. HrpZPsph from the plant pathogen Pseudomonas syringae pv.
Phaesolicola binds to lipid bilayers and forms an ion-conducting pore in vitro.
Proc. Nat. Acad. Sci. 98: 289-294.

92.

Lee S.-C., Yuk H.-G., Lee D.-H., Lee K.-E., Ludescher Y.-I., and Ludescher R.D.
2002. Stabilization of retinol through incorporation into liposomes. J. Biochem.
Mol. Biol. 35: 358-363.

93.

Lee S.K., Han J.H., and Decker E.A. 2002. Antioxidant activity of phosvitin in
phosphatidylcholine liposomes and meat model systems. J. Food Sci. 67: 37-41.

94.

Linnett P.E., and Strominger J.L. 1973. Additional antibiotic inhibitors of
peptidoglycan synthesis. Antimicrob. Agents Chemother. 4: 231-236.

95.

Liu W., and Hansen J.N. 1990. Some chemical and physical properties of nisin, a
small-protein antibiotic produced by Lactococcus lactis. Appl. Environ.
Microbiol. 56: 2551-2558.

96.

Lofthouse S. 2002. Immunological aspects of controlled antigen delivery. Adv.
Drug Del. Rev. 54: 863-870.

97.

Longworth K.E., Jarvis K.A., Tyler W.S., Steffey E.P., and Staub N.C. 1994.
Pulmonary intravascular macrophages in horses and ponies. Am. J. Vet. Res. 55:
382-388.

98.

Makino K., Yamada T., Kimura M., Oka T., Ohshima H., and Kondo T. 1991.
Temperature-induced and ionic strength-induced conformational changes in the
lipid head group region of liposomes as suggested by zeta-potential data. Biophys.
Chem. 41: 175.

99.

Marelja S., and Wolfe J. 1979. Properties of bilayer membranes in the phase
transition or phase separation region. Biochim. Biophys. Acta. 557: 24-31.

100.

Martin I., Ruysschaert J.-M., Sanders D., and Giffard C.J. 1996. Interaction of the
lantibiotic nisin with membranes revealed by fluorescence quenching of an
introduced tryptophan. Eur. J. Biochem. 239: 156-164.

101.

Mason J.T., Huang C., and Biltonen R.L. 1983. Effect of liposomal size on the
calorimetric behavior of mixed-chain phosphatidylcholine bilayer dispersions.
Biochemistry. 22: 2013-8.

102.

Matsuzaki M., McCafferty F., and Karel M. 1989. The effect of cholesterol
content of phospholipid vesicles on the encapsulation and acid resistance of Bgalactosidase from E. coli. Int. J. Food Sci. Technol. 24: 451-460.
54

103.

Meers P. 2001. Enzyme-activated targeting of liposomes. Adv. Drug Del. Rev.
53: 265-272.

104.

Milsmann M.H.W., Schwendener R.A., and Weder H.-G. 1978. The preparation
of large single bilayer liposomes by a fast and controlled dialysis. Biochim.
Biophys. Acta. 512: 147-155.

105.

New R.R.C. 1990a. Introduction. Liposomes: A Practical Approach. New R.R.C.
New York, NY, Oxford University Press: 1-32.

106.

New R.R.C. 1990b. Preparation of liposomes. Liposomes: A Practical Approach.
New R.R.C. New York, NY, Oxford University Press: 33-104.

107.

Olson F., Hunt C.A., Szoka F.C., Vail W.J., and Papahadjopoulos D. 1979.
Preparation of liposomes of defined size distribution by extrusion through
polycarbonate membranes. Biochim. Biophys. Acta. 557: 9-23.

108.

Papahadjopoulos D., and Watkins J.C. 1967. Phospholipid model membranes. II.
Permeability properties of hydrated liquid crystals. Biochim. Biophys. Acta. 135:
639-652.

109.

Parente R.A., and Lentz B.R. 1984. Phase behavior of large unilamellar vesicles
composed of synthetic phospholipids. Biochemistry. 23: 2353-2362.

110.

Payne N.I., Browning I., and Hynes C.A. 1986. Characterization of proliposomes.
J. Pharmacol. Sci. 75: 330-333.

111.

Payne N.I., Timmins P., Ambrose C.V., Ward M.D., and Ridgway F. 1986.
Proliposomes: a novel solution to an old problem. J. Pharmacol. Sci. 75: 325-329.

112.

Picón A., Gaya P., Medina M., and Nunez M. 1994. The effect of liposome
encapsulation of chymosin derived from fermentation on Manchego cheese
ripening. J. Dairy Sci. 77: 16-23.

113.

Picón A., Gaya P., Medina M., and Nunez M. 1997. Proteninases encapsulated in
stimulated release liposomes for cheese ripening. Biotechnol. Lett. 19: 345-348.

114.

Posch M., Rakusch U., Mollay C., and Laggner P. 1983. Cooperative effects in
the interaction between melittin and phosphatidylcholine model membranes. J.
Biol. Chem. 258: 1761-1766.

115.

Qiu R., and MacDonald R.C. 1994. A metastable state of high surface activity
produced by sonication of phospholipids. Biochim. Biophys. Acta. 1191: 343353.

55

116.

Ramalingam T.S., Das P.K., and Podder S.K. 1994. Ricin-membrane interactions:
membrane penetration depth by fluorescence quenching and resonance energy
transfer. Biochemistry. 33: 12247-12254.

117.

Rao D.R., Chawan C.B., and Veeramachaneni R. 1995. Liposomal encapsulation
of B-galactosidase: comparison of two methods of encapsulation and in vitro
lactose digestibility. J. Food Biochem. 18: 239-251.

118.

Reineccius G.A. 1995. Liposomes for controlled release in the food industry.
Encapsulation and Controlled Release of Food Ingredients. S.J. Risch a.G.A.R.
Washington, D.C., American Chemical Society. 590: 113-131.

119.

Reisinger P., Seidel H., Tschesche H., and Hammes W.P. 1980. The effect of
nisin on murein synthesis. Arch. Microbiol. 127: 187-193.

120.

Rodriguez-Nogales J.M. 2004. Kinetic behavior and stability of glucose oxidase
entrapped in liposomes. J. Chem. Toxicol. Biotechnol. 79: 72-78.

121.

Schreier H., and Sawyer S.M. 1996. Liposomal DNA vectors for cystic fibrosis
gene therapy. Current applications, limitations, and future directions. Adv. Drug
Del. Rev. 19: 73-87.

122.

Schubert R. 2003. Liposome preparation by detergent removal. Meth. Enzymol.
367: 46-69.

123.

Sharma A., and Sharma U.S. 1997. Liposomes in drug delivery: progress and
limitations. Int. J. Pharm. 154: 123-140.

124.

Shi Z., Curiel D.T., and Tang D.-C. 1999. DNA-based non-invasive vaccination
onto the skin. 17: 2136-2141.

125.

Shum P., Kim J.M., and Thompson D.H. 2001. Phototriggering of liposomal drug
delivery systems. Adv. Drug Del. Rev. 53: 273-284.

126.

Siegers K., and Entian K.D. 1995. Genes involved in immunity to the lantibiotic
nisin produced by Lactococcus lactis 6F3. Appl. Environ. Microbiol. 61: 1082-9.

127.

Siegers K., Heinzmann S., and Entian K.D. 1996. Biosynthesis of lantibiotic
nisin. J. Biol. Chem. 271: 12294-12301.

128.

Storm G., Vingerhoeds M.H., Crommelin D.J.A., and Haisma H.J. 1997.
Immunoliposomes bearing enzymes (immuno-enzymosomes) for site-specific
activation of anticancer prodrugs. Adv. Drug Del. Rev. 24: 225-231.

129.

Suwalsky M., Ramos P., Villena F., Cardenas H., Norris B., Cuevas F., and
Sotomayer C.P. 2001. The organophosphorous insecticide parathion changes
properties of natural and model membranes. Pestic. Biochem. Physiol. 70: 74-85.
56

130.

Szoka F.C., and Papahadjopoulos D. 1978. Procedure for preparation of
liposomes with large internal aqueous space and high capture by reverse-phase
evaporation. Proc. Natl. Acad. Sci. 75: 4194-4198.

131.

Thapon J.L., and Brule G. 1986. Effets du pH et de la forme ionize sur l'affinit
lysozymes-caseines. Le Lait. 66: 19-30.

132.

Twomey D., Ross R.P., Ryan M., Meaney B., and Hill C. 2002. Lantibiotics
produced by lactic acid bacteria: structure, function and applications. Antonie Van
Leeuwenhoek. 82: 165-185.

133.

Vemuri S., and Rhodes C.T. 1995. Preparation and characterization of liposomes
as therapeutic delivery systems: a review. Pharma. Acta Helv. 70: 95-111.

134.

Videira R.A., Antunes-Madeira M.D.C., Custodio J.B.A., and Madeira V.M.C.
1995. Partition of DDE in synthetic and native membranes determined by
ultraviolet derivative spectroscopy. Biochim. Biophys. Acta. 1238: 22-28.

135.

Were L.M., Bruce B., Davidson P.M., and Weiss J. 2004. Encapsulation of nisin
and lysozyme in liposomes enhances efficiency against Listeria monocytogenes.
J. Food Prot. 67: 922-927.

136.

Were L.M., Bruce B.D., Davidson P.M., and Weiss J. 2003. Size, stability, and
entrapment efficiency of phospholipid nanocapsules containing polypeptide
antimicrobials. J. Agric. Food Chem. 51: 8073-8079.

137.

Wilschut J., and Hoekstra D. 1986. Membrane fusion: Lipid vesicles as a model
system. Chem. Phys. Lipids. 40: 145-166.

138.

Winterhalter M., and Lasic D.D. 1993. Liposome stability and formation:
Experimental parameters and theories on the size distribution. Chem. Phys.
Lipids. 64: 35-43.

57

2. Ultrasonic Spectroscopy and Differential Scanning
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Reproduced with permission from the American Chemical Society from Taylor, T.M.,
P.M. Davidson, B.D. Bruce, and J. Weiss. 2005. Ultrasonic spectroscopy and differential
scanning calorimetry of liposomal-encapsulated nisin. J Agric Food Chem. 53: 87228278.”

2.1.

Abstract
The thermal stability of phosphatidylcholine (PC) liposomes (colloidal

dispersions of bilayer-forming polar lipids in aqueous solvents) in the presence and
absence of the antimicrobial polypeptide nisin, was evaluated using differential scanning
calorimetry (DSC) and low-intensity ultrasonic spectroscopy (US). PC liposome mixtures
with varying acyl chain lengths (C16:0- and C18:0), were formed in buffer with or
without entrapped nisin. Gel-to-liquid crystalline phase transition temperatures (TM) of
liposomes determined from DSC thermograms were in excellent agreement with those
determined by ultrasonic velocity and attenuation coefficient measurements recorded at 5
MHz. Dipalmitoylphosphatidylcholine (DPPC) TM measured by DSC was ~41.3°C and
~40.7°C when measured by ultrasonic spectroscopy. TM of distearoylphosphatidylcholine
(DSPC) and DPPC/DSPC 1:1 liposomes was 54.3°C and 54.9°C, and ~44.8°C and
~47.3°C when measured by DSC and US, respectively. Thermotropic stability generally
increased upon addition of nisin. Analysis of the step-wise decrease in ultrasonic velocity
with temperature indicated increased compressibility corresponding to a loss of structure
upon heating.
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2.2.

Introduction
Liposomes, spherical bilayer vesicles formed by dispersion of polar lipids in

aqueous solvents, have been widely studied for their ability to act as drug delivery
vehicles by shielding reactive or sensitive compounds prior to release (Chrai et al., 2002;
Juliano, 1981; LaVan et al., 2003; Redziniak, 2003). Liposome entrapment has been
shown to stabilize encapsulated bioactive materials against a range of environmental and
chemical changes, including enzymatic and chemical modification, as well as protecting
against extreme pH, temperature, and high ion concentrations. Liposomes have been
especially useful to researchers in studies of physiological processes as models of
biological membranes in both eukaryotes and prokaryotes. Industrial applications include
encapsulation of pharmaceuticals and therapeutics, cosmetics, anti-cancer and gene
therapy drugs. In the food industry, liposomes have been used to deliver food flavors and
nutrients (Gibbs et al., 1999; Kheadr et al., 2002). More recently, liposomes have been
investigated for their ability to incorporate food antimicrobials, such as the polypeptide
antimicrobial nisin, that could aid in the protection of food products against growth of
spoilage and pathogenic microorganisms (Benech et al., 2002a; Benech et al., 2002b;
Were et al., 2004; Were et al., 2003).
The functional properties of liposomes depend on their size, composition and
stability in food systems (New, 1990a; New, 1990b). Liposomes are typically spherical in
shape and may consist of single or multiple bilayers composed from amphiphilic
molecules such as polar lipids (Hope et al., 1986; Shah et al., 2001). Their size can vary
widely, anywhere from ~40-50 nm up to ~1-3 µm, depending on the molecular properties
of the lipid molecules, environmental conditions and method of formulation (Duzgunes,
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2003; Gregoriadis et al., 2003; Lamprecht et al., 1999; Mui et al., 2003; Schubert, 2003;
Van Winden, 2003). Of particular importance for food applications is their ability to
withstand thermal stresses that may be encountered during processing, packaging or
storage. While a large number of analytical techniques have been used to characterize the
structural and functional properties of liposomes and investigate their responses to
various stimulants and stressors, differential scanning calorimetry (DSC) has proven to be
one of the most powerful methods to analyze macroscopic physicochemical and
thermodynamic properties of liposomes (Biltonen and Lichtenberg, 1993; Finegold et al.,
1985; Finegold and Singer, 1984; Koynova and Caffrey, 1998). The technique has been
widely used to describe liposomes of all types and has led to the creation of common
databases such as LIPIDAT that contain comprehensive information on lipid
mesomorphic and polymorphic transitions and miscibility (Caffrey and Hogan, 1992;
Koynova and Caffrey, 1994a; Koynova and Caffrey, 1994b; Koynova and Caffrey,
1995).
Ultrasonic spectroscopy (US) has been introduced as a new analytical technique
to characterize dispersed systems such as emulsions of interest to food scientists. While
there exist published reports on the use of the technology to measure the properties of
some food systems, it is not widely utilized by food scientists (Gekko and Noguchi, 1979;
McClements et al., 1993). Low-intensity ultrasonic waves that propagate through a
system containing dispersed particles are scattered, diffracted and refracted (Buckin and
Smyth, 1999). As a consequence, ultrasonic velocity and attenuation changes depending
on composition, physical state, microstructure and molecular relaxation phenomena.
Further, ultrasonic spectroscopy is capable of detecting temperature dependent phase
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transitions similar to information obtained in a differential scanning calorimeter because
the ultrasonic velocity and attenuation of a material in the solid state differs from that in
the liquid state (Lin and Thomas, 2003; Schrader et al., 2002). McClements et al. studied
the ultrasonic attenuation and velocity of hexadecane-in-water emulsions (1993). Authors
reported distinct changes in compressibility of the lipid droplets when the temperature
was increased from 0-25°C and calculated a phase transition temperature TM of 18°C
(McClements et al., 1993). Ultrasonic spectroscopy has been utilized to determine
properties of liposomes composed of phospholipids with varying degrees of unsaturation
in the acyl chains and with varying sterol content (Hianik et al., 1998). Authors reported
that ultrasonic velocity increased with increased number of double bonds in the acyl
chains and sterol content, and was likely a function of the packing of the polar lipids
within the vesicle (Hianik et al., 1998).
In this study, we investigated the thermal stability of liposomes formed from
synthetic phospholipids containing either aqueous buffer or a low concentration of nisin
using both differential scanning calorimetry and high-sensitivity ultrasonic spectroscopy.
The two analytical methods were compared for accuracy and sensitivity in determining
the gel-liquid crystalline phase transition temperature (TM) of liposomes. Finally, the
influence of entrapment of nisin on the phase transition temperature of liposomes was
examined. Possible explanations of observed changes in thermodynamic properties of
liposomes upon entrapment of nisin are offered.
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2.3.

Materials and Methods

2.3.1. Phospholipids and Antimicrobial

Dipalmitoylphosphatidylcholine (DPPC) and distearoylphosphatidylcholine
(DSPC) were purchased from Avanti Polar Lipids (Alabaster, AL, USA) in chloroform
and stored at -20°C until used. Nisin (CAS 1414-45-5; 2.5% w/w in sodium chloride and
denatured milk solids) was obtained from Sigma-Aldrich (St. Louis, MO, USA) and
stored in a desiccator at 5°C until used.

2.3.2. Liposome Formation

Multi-lamellar vesicle (MLV) liposomes of DPPC, DSPC and a 1:1 mixture of
DSPC and DPPC were formed according to the method of Pinnaduwage and Bruce
(1996). Lipids dispersed in chloroform were dried under N2 to disperse lipids over the
walls of glass reaction tubes. In the case of DSPC-DPPC liposomes, the two chloroformdispersed phospholipids were mixed at a 1:1 ratio, vigorously shaken to ensure a
homogeneous mix of the two species and then dried under N2. Following chloroform
evaporation, phospholipids were rehydrated in 0.1X PBS buffer (0.017M KH2PO4,
0.05M Na2HPO4, 1.5M NaCl at pH=7.4) (Biowhittaker, Rockland, ME, USA) to a
concentration of 3 mg/ml and mixed vigorously by vortexing to suspend lipids in the
aqueous buffer. For liposomes containing antimicrobial, nisin was solubilized in 0.1X
PBS buffer at 1 mg/ml which was used to rehydrate the phospholipids to obtain a final
nisin concentration of 0.25 mg/ml. Following MLV formation, liposomes were frozen in
liquid nitrogen for ~10 sec, gently thawed in water (25°C) for ~10 sec, and 70°C water
for 15 sec.
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The process was repeated four times. Liposomes were held at 70°C for one hour
to guarantee that phospholipids were above their respective gel-liquid crystalline phase
transition temperature (TM). Liposomes were finally sonicated for 20 minutes in reaction
tubes using an ultrasonic water bath according to the method of Were et al. (2003).

2.3.3. Differential Scanning Calorimetry

Thermal analysis of liposomes was performed using a Micro-Differential
Scanning Calorimeter (VP-DSC, MicroCal, Northampton, MA, USA). Liposomes and
0.1X PBS were degassed with stirring under vacuum at 25°C for 20 minutes using a
Thermovac (MicroCal) to prevent bubble formation or attachment of bubbles to the wall
of the measurement cell during the temperature scans. DSC reference and sample cells
were loaded with ~0.5 ml of reference buffer (0.1X PBS; Biowhittaker) and liposome
suspension, respectively. Samples were equilibrated to 25°C for 10 min. and then heated
from 25°C to 75°C at a heating rate of 0.5°C/min. All samples scans were repeated a
minimum of six times. Upon completion of scans, the DSC sample cell was thoroughly
cleaned using 80 ml 1% Dawn Ultra Concentrated detergent (Procter & Gamble,
Cincinnati, OH, USA) (warmed) and 60 ml absolute ethanol (Sigma Chemical Co, St.
Louis, MO); 100 ml volumes of Millipore water were used before, between, and after
both the detergent and ethanol to rinse the cell. The reference cell was cleaned with 100
ml of Millipore water only.
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2.3.4. Ultrasonic Spectroscopy

Ultrasonic spectroscopy analysis of MLVs was carried out using a high resolution
ultrasonic spectrometer (HR-US 102, Ultrasonic Scientific, Dublin, Ireland). Liposomes
and 0.1X PBS were degassed with stirring under vacuum at 25°C for 20 min and 1 ml of
sample and reference buffer (0.1X PBS; Biowhittaker) were loaded into the sample and
reference cell. Temperature of both sample and reference was equilibrated to 25°C for 10
min. After equilibration, ultrasonic peak profiles were determined to select an optimum
resonance frequency at 5 MHz for subsequent ultrasonic velocity and attenuation
measurements. Samples were then heated from 25° to 75°C using a heating rate of
0.3°C/min and the ultrasonic velocity and attenuation recorded. All ultrasonic
spectroscopy experiments were run in duplicate. Upon completion of scans, sample and
reference cells were thoroughly cleaned using 1% Dawn solution (Procter & Gamble), 1
N HCl (Sigma-Alrich), followed by extensive rinsing with HPLC-grade water (Fisher
Scientific, Fairlawn, NJ, USA).

2.3.5. Data Analysis

PeakFit v. 4.1.2 (Seasolve Software Inc., Framingham, MA, USA) was used to
determine phase transitions from the peaks of plots of the ultrasonic attenuation (α) as a
function of temperature and the peaks of plots of the temperature derivative of the
ultrasonic velocity (dv12/dT) versus temperature. Statistically significant differences in
phase transition temperatures were determined with Student’s t-test (p<0.05) using SAS
v. 8.0 (SAS Institute, Cary, NC).
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2.4.

Results
Figures 2.1 shows the heat capacity (cp) of the sample liposomes as a function of

temperature both without (Fig. 2.1A) and with entrapped antimicrobial (Fig. 2.1B). DPPC
MLVs demonstrated a phase transition of 41.2°C; the addition of 1 mg/ml nisin increased
the TM to 41.3°C (Table 2.1). For DSPC, the phase transition observed with the
differential scanning calorimeter was 54.3°C and did not change upon inclusion of nisin
(54.3°C). In the case of the DSPC-DPPC liposomes with no entrapped antimicrobial had
a phase transition at 44.8°C but this shifted to 46.5°C when nisin was encapsulated in the
liposomes (Table 2.1, Fig. 2.1).
Figure 2.2 shows the ultrasonic attenuation coefficient (α) as a function of
temperature measured at a frequency of 5 MHz for liposomes with and without entrapped
nisin. As the temperature increased, the baseline of the ultrasonic attenuation generally
decreased. During the transition of the lipids from the gel to the liquid crystalline form,
the attenuation almost tripled to reach a maximum at the midpoint temperature of the
transition. Calculated phase transition temperatures of MLVs of DPPC, DSPC, and
DPPC-DSPC without entrapped nisin were 40.6°C, 54.6°C, and 47.4°C, respectively
(Table 2.1, Fig. 2.2A). For liposomes with entrapped antimicrobial, attenuation analysis
revealed a slight increase in TM of vesicles with DPPC, DSPC, and DPPC-DSPC of
41.8°C, 55.2°C, and 48.1°C, respectively (Fig. 2.2B).
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A

B
Figure 2.1: Heat capacity (cp) in kcal/mol °C as a function of temperature of DPPC,
DSPC and DPPC:DSPC 1:1 liposomes (A) without nisin and (B) containing 0.025
mg/ml nisin. Plots represent duplicate replications. Scan rate: 0.5 °C/min; sample
volume: 0.5 ml; reference buffer: 0.1X PBS (0.5 ml); liposomes composed of 3.0
mg/ml phos-pholipid. DPPC: dipalmitoylphophatidylcholine; DSPC:
distearoylphosphatidylcholine.
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Table 2.1. Comparative analysis of phase transition temperatures TM of liposomes
(3.0 mg/ml) with or without entrapped nisin (1 mg/ml) calculated from results of
differential scanning calorimetry and ultrasonic spectroscopy.
Without Nisin4

With Nisin4

Method1
DPPC2

DSPC3

DPPCDSPC

DPPC

DSPC

DPPCDSPC

DSC

41.22a

54.33d

44.79g

41.34j

54.32m

46.54p

US-α

38.99b

54.28e

44.63h

40.71k

54.36n

46.25q

US-∆v121

40.64c

54.58f

47.44i

41.80l

55.15o

48.07r

1

Abbreviations: DSC: Differential Scanning Calorimetry, US-α: Ultrasonic Attenuation, US-∆v12:
Ultrasonic Velocity.
2
DPPC: dipalmitoylphophatidylcholine.
3
DSPC: distearoylphosphatidylcholine.
4
Values are means of duplicate replications. Values with differing superscript letters across rows, but not
columns, are statistically different (p<0.05).
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A

B

Figure 2.2. Ultrasonic attenuation coefficient α in Npm-1 measured at 5 MHz as a
function of temperature of DPPC, DSPC and DPPC:DSPC 1:1 liposomes (A)
without nisin and (B) containing 0.025 mg/ml nisin. Plots represent duplicate
replications. Scan rate: 0.3 °C/min; sample volume: 0.5 ml; reference buffer: 0.1X
PBS (0.5 ml); Liposomes composed of 3.0 mg/ml phospholipid. DPPC:
dipalmitoylphophatidylcholine; DSPC: distearoylphosphatidylcholine.

Figure 2.3 shows the temperature dependence of the ultrasonic velocity increment
(i.e., the velocity measured in the samples minus the velocity measured in a reference cell
containing 0.1X PBS buffer). The ultrasonic velocity increment generally decreased with
increasing temperature. Prior to the phase transition and after the phase transition, the
decrease in velocity with temperature was nearly linear, however the slope prior to the
transition was larger than the slope after the transition. During the transition of all lipids
regardless of whether nisin was present or absent, the temperature dependent ultrasonic
velocity decrease had an approximately sigmoidal shape (Fig. 2.3). Phase transitions
temperatures were 39.0°C; 54.3°C and 44.6°C for DSPC, DPPC and DPPC-DSPC
vesicles without nisin, respectively (Table 2.1).
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A

B

Figure 2.3: Ultrasonic velocity differential ∆v1-2 in ms-1 between sample and
reference cell measured at 5 MHz as a function of temperature of DPPC, DSPC and
DPPC:DSPC 1:1 liposomes (A) without nisin (B) containing 0.025 mg/ml nisin. Plots
represent duplicate replications. Scan rate: 0.3 °C/min; sample volume: 0.5 ml;
reference buffer: 0.1X PBS (0.5 ml); liposomes composed of 3.0 mg/ml phospholipid.
DPPC: dipalmitoylphophatidylcholine; DSPC: distearoylphosphatidylcholine.

Liposomes composed of DPPC with entrapped nisin had a TM of 40.7°C while liposomes
composed of DSPC and DPPC-DSPC 1:1 with entrapped nisin had a TM equal to 54.4°C
and 44.3°C, respectively.

2.5.

Discussion
This study demonstrates the utility of ultrasonic spectroscopy for the analysis of

phase transitions induced by temperature in the presence and absence of entrapped
antimicrobial polypeptides such as nisin. Statistical analysis of TM values for the different
analytical methods indicated excellent agreement between the ultrasonic velocity and
differential scanning calorimetry measurements (Table 2.1). With the exception of the
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DPPC-nisin liposomes, transition temperatures obtained with the two methods were not
statistically different. However, transition temperatures obtained from ultrasonic
attenuation measurements with exception of DSPC-nisin samples, were consistently
higher and statistically different in comparison to the other two methods (p<0.05).
Ultrasonic spectroscopy has been shown to be capable of detecting phase
transition in a variety of dispersed systems with high accuracy. For example,
McClements et al. demonstrated that ultrasonic attenuation and velocity measurements
can be used to follow the crystallization and melting of lipids in emulsion droplets (1993)
based on the fact that ultrasonic attenuation and velocity of solid and liquid phases differ
greatly. The ultrasonic velocity is particularly sensitive to phase transitions that involve
formation of crystalline or quasi-crystalline structures because these phase changes are
accompanied by large changes in adiabatic compressibility (Povey, 1998).
Generally, propagation of ultrasonic waves through a system that contains
dispersed particles gives rise to reflected compression, thermal and shear waves as well
as transmitted compression, thermal and shear waves in the dispersed particle. The
overall attenuation (α) by ultrasound in a sample can be divided into a molecular
relaxation component (αMR) and a scattering component (αs):

α = α MR + α S

(1)

Since the scattering contribution of the overall attenuation primarily depends on
size and concentration of dispersed particles, it is the molecular relaxation component
that is most sensitive to phase changes. Assuming a single relaxation mechanism, the
attenuation due to molecular relaxation can be described as:
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α MR =

AT

1 f + (2πτ )
2

2

+ Bf

2

(2)

Where f is the frequency and τ is a characteristic relaxation time. A and B are system
specific constants. A for example depends on the number of groups involved in the
relaxation process and the “strength” of the relaxation process while B is the attenuation
due to classical adsorption mechanisms (viscous and thermal conductivity losses) (Bryant
and McClements, 1999). The ultrasonic energy “feeds” into the transition between the
two states and as a result, the attenuation greatly increases during a phase transition and
decreases after the system has reached a stable state.
Thus at a constant angular frequency the measurement will be highly sensitive to
changes in compressibility and densities of the dispersed phase fraction. In the case of
liposomes, both are altered as the polar lipids transitions from the gel to the fluid phase.
Harkness and White (1979) found that because of the changes in density and
compressibility, the ultrasonic attenuation of LUV (large unilamellar vesicle) suspensions
greatly increased in the vicinity of the TM while the ultrasonic velocity decreased. Morse
et al., in an ultrasonic study of the role of deuterium chain substitution in the phase
transition of DPPC-DPPG LUVs, pointed out that ultrasonic attenuation studies were
much more specific than DSC studies, i.e., depending on the frequency of the ultrasonic
wave, the interaction of ultrasound occurred primarily with the hydrophobic side chains
and the measurements were sensitive to localized structural reorganizations of small
domains of molecules (Morse et al., 1999). This may explain some of the observed
differences between TM’s determined from ultrasonic attenuation versus transition
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temperatures from DSC and ultrasonic velocity measurements. Clearly, more
measurements at different ultrasonic frequencies are required to clarify this point.
For DPPC, all three analytical methods reported a lower TM than the average
value of 41.3°C reported by Koynova and Caffrey in their review of records from
LIPIDAT (1998). The TM,DSC of 41.2°C and TM,∆v12 of 39.0°C were ca. 0.2% and 6.3%
lower, respectively. In the case of DSPC, all methods showed very good agreement (<
0.3°C difference) with previously reported data listed in LIPIDAT (Koynova and
Caffrey, 1998). Liposomes consisting of a 1:1 ratio of DPPC and DSPC both without and
with entrapped nisin had single phase transitions of 44.79°C and 46.54°C as measured by
DSC, respectively. The presence of single peaks rather then two individual peaks indicate
a strong competitive interaction between the two phospholipid species, a phenomenon
that also was noted by other authors (Anyarambhatla and Needham, 1999; Kim et al.,
1990; Mason et al., 1983). Because these two particular PC species undergo phase
transitions that are approximately 13°C apart, it is unlikely that the single peak transition
represents an unresolved or overlapping two peak transition. Rather, it may be the result
of miscibility of both phospholipids in both solid (gel) and liquid (liquid crystal) phases.
Thus, the system consists of liposomes with bilayers that are composed of a mixture of
the two lipids instead of a mixture of single species liposomes.
The increase in TM with the entrapment of nisin in all liposomes led us to
conclude that nisin at low concentrations acts to stabilize PC vesicles. Generally, this is in
agreement with low rates of leakage of nisin from liposomes that was reported earlier and
is in contrast to the inclusion of more complex antimicrobial polypeptides, such as
lysozyme, that were found to permeabilize the bilayer structure resulting in a gradual loss
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of the encapsulated material (Were et al., 2003). Currently, measurement of surface
charge of nisin-free and nisin-containing liposomes is underway in our laboratories to
gain a better understanding of the specific interaction of nisin with vesicles composed of
DPPC, DSPC or DPPC:DSPC.
DSC analysis of DPPC with nisin reported a TM of 41.34°C, representing an
increase in TM of 0.14°C, possibly due to stabilization of liposomes as a consequence of
the nisin insertion (Table 2.1). This small upshift in TM and consequent stabilization was
also observed with DSPC and DSPC-DPPC 1:1 liposomes, although to a lesser extent
(Table 2.1). Wiener et al. (1983) observed similar increases in TM of DPPC-DPPG 1:1
liposomes containing a matrix protein of vesicular stomatitis virus, potentially a result of
association of the protein with liposomes restricting the mobility of lipid acyl chains
thereby increasing the thermal energy requirements for lipid chain expansion. While
antimicrobials like nisin typically function to permeabilize and/or cause pore formation in
cytoplasmic membranes of their target microorganisms, their insertion at low
concentrations may result in increases in membrane stability through the stabilization of
inner-layer concave inverted lipids (Pantev et al., 2003; Tytler et al., 1993).
Membrane lipid-polypeptide interactions may also help explain the specific
inability of nisin to destabilize PC liposomes. Lohner et al. (1997) in DSC analysis of
human defensin HNP-2, demonstrated that the polypeptide interacted primarily with
bacterial mimetic membranes composed of phosphatidylglycerol (PG). On the other
hand, erythrocyte-mimetic PC membranes were not thermotropically altered by HNP-2
(Lohner et al., 1997). Nisin is an antimicrobial that is bacterially-synthesized as a defense
mechanism against competing microflora. Its cationic nature and interaction with the
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bacterial cell wall peptidoglycan-associated receptor lipid II and anionic membrane lipids
such as PG provides nisin with greater specificity to attack prokaryotic rather then
eukaryotic species where PC permeates membranes (Breukink et al., 2003; Brotz et al.,
1998; El-Jastimi et al., 1999). While some have reported differing effects of nisin and
other lytic peptides on model membranes as a function of phospholipid composition, we
have been unsuccessful in our searches throughout the literature to locate other studies
that have reported either similar or contradictory findings using DSC analysis to study the
effects of nisin entrapment on thermotropic properties of phospholipids (Breukink et al.,
2000; El-Jastimi and Lafleur, 1997). Hence, these findings lead us to conclude that the
peptide nisin can act to stabilize PC-based liposomes at low peptide concentration that is
observable via an increase in the TM.

2.6.

Conclusion
This study relates the measurement of TM’s of liposomes composed of the

synthetic phospholipids DSPC and DPPC, both with and without encapsulated nisin via
DSC and low-intensity US analysis. Our results indicate excellent agreement between
DSC, a widely accepted method for measurement of liposomal thermotropic properties,
and US. Our results suggest that US measurements represent a viable alternative to the
measurement of TM’s of dispersions of polar lipids by DSC. In addition, attenuation
measurements as a function of frequency may yield additional insights into the structure
of liposomes that cannot be obtained by DSC. Upon incorporation of nisin into liposomes
via encapsulation, the observed increases in sample TM lead us to conclude that nisin may
act to stabilize liposomes at very low concentrations via a possible lowering of curvature
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stresses. Further, the interaction of nisin with those lipids not commonly found in
prokaryotic membranes (e.g., phosphatidylcholine) is likely to produce an alternate effect
than that of permeabilization, in this case a stabilizing effect. Finally, companies planning
to incorporate polypeptide-based antimicrobials in polar lipid dispersions for use in food
products need to carefully evaluate the effect of the encapsulated material on the thermal
stability of the dispersion i.e., stabilization versus permeabilization.
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3. Characterization of Antimicrobial-Bearing Liposomes by
Zeta-Potential, Vesicle Size, and Encapsulation Efficiency

81

3.1.

Abstract

Liposome entrapment may improve activity of protein or polypeptide antimicrobials
against a variety of microorganisms. In this study, ability of liposomes to withstand
exposure to environmental and chemical stresses typically encountered in foods and
food processing operations were tested. Liposomes consisting of distearoylphosphatidycholine (PC) and distearoyl-phosphatidylglycerol (PG), with 0, 5 or 10
g/ml of the antimicrobial peptide nisin entrapped, were exposed to elevated
temperatures (25 - 75°C) and a range of pH (5.5 - 11.0). Ability of liposomes to
maintain integrity was assessed by measuring the encapsulation efficiency (EE),

-

potential, and particle size distribution of liposomes. PC, PC/PG 8/2, and PC/PG 6/4
(mol fraction) liposomes retained between ~70 - 90% EE despite exposure to elevated
temperature and alkaline or acidic pH. Particle size of liposomes averaged between
100-240 nm depending on liposome preparation. Liposomal surface charge depended
primarily on phospholipid composition and changed little with inclusion of nisin.
Surface charge was not affected by temperature for PC and PC/PG 8/2 but decreased
for PC/PG 6:4 liposomes. Our results suggest that liposomes containing nisin may be
suitable for use as antimicrobial-active ingredients in low or high pH foods subjected
to moderate heat treatments.
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3.2.

Introduction
Liposomes, spherical bilayer vesicles formed by dispersion of polar lipids in

aqueous solvents, have been widely studied for their ability to act as drug delivery
vehicles by shielding reactive or sensitive compounds prior to release (Chrai et al., 2002;
Juliano, 1981). Liposome entrapment may stabilize encapsulated bioactive materials
against a range of environmental and chemical stresses, including presence of enzymes or
reactive chemicals, and exposure to extreme pH, temperature, and high ion
concentrations (Allen and Cleland, 1980; Makino et al., 1991; Taira et al., 2004). The
functional properties of liposomes depend on their size, composition and stability in food
systems (New, 1990a; New, 1990b). Liposomes are typically spherical in shape and may
consist of single or multiple bilayers composed of polar lipids (Shah et al., 2001). Their
size can vary widely, from ~40-50 nm to as much as ~1-3 µm, depending on the
molecular properties of the lipid molecules, environmental conditions and method of
production (Lasch et al., 2003). Of importance for application in foods is their ability to
withstand various stresses that may be encountered during processing, packaging or
storage (Taylor et al., 2005). Although traditionally used as model systems for biological
membranes to study physiological processes in both eukaryotes and prokaryotes,
liposomes are increasingly used in industrial applications including encapsulation of
pharmaceuticals and therapeutics, cosmetics, anti-cancer and gene therapy drugs. In the
food industry, liposomes have been used to deliver food flavors and nutrients (Gibbs et
al., 1999). More recently, liposomes have been investigated for their ability to
incorporate bioactive compounds to formulate novel functional foods and as carriers of
food antimicrobials that might aid in the protection of food products against growth of
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spoilage and pathogenic microorganisms (Benech et al., 2002a; Benech et al., 2002b;
Were et al., 2004; Were et al., 2003). We previously demonstrated in our laboratories the
successful production and high antimicrobial efficacies of liposomes containing two food
antimicrobials, nisin and lysozyme against strains of L. monocytogenes and E. coli (Were
et al., 2004; Were et al., 2003).
Antimicrobial polypeptides such as nisin and lysozyme are known to be inhibitory
towards the growth of Gram-positive pathogens such as Listeria monocytogenes,
Staphylococcus aureus, and Bacillus spp. (Jay et al., 2005; Johnson and Larson, 2005).
Nisin is not inhibitory towards Gram-negative pathogens if used without additives but its
spectrum of activity can be broadened by combining the polypeptide with chelators such
as EDTA or polyphosphates (Boland et al., 2004; Branen and Davidson, 2004).
Nevertheless, loss of antimicrobial activity has been reported when nisin was directly
added to foods. Jung et al. (1992) found significant loss of nisin activity in milk due to
interactions with milk fat globules. Apparently, nisin preferentially adsorbed at the milk
fat droplet surface in order to maximize interaction of the hydrophobic side chains with
lipid phase molecules. Divalent cations associated with bacterial cell wall surfaces have
been shown to induce electrostatic repulsion preventing the cationic polypeptide nisin
from interacting with the bacterial pathogens, thus reducing its activity (Thomas and
Delves-Broughton, 2005). Further, thermal processing of foods may lead to structural
changes in polypeptide and protein antimicrobials and decrease their activity. For
example, exposure to pasteurization temperatures can inactivate as much as 40% of nisin
in a food product and lysozyme is generally completely inactivated above 75°C (Johnson
and Larson, 2005).
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Storage above refrigeration temperatures may decrease nisin activity as well (DelvesBroughton, 1990; Delves-Broughton and Gasson, 1994). Finally, nisin has shown to be
less efficacious in solid food systems than in semi-solid or liquid foods which has been
attributed to the difficulty of maintaining a homogeneous distribution of the antimicrobial
throughout the solid food matrix (Delves-Broughton, 1990). Encapsulation of nisin may
therefore offer a potential solution to overcome some of these stability issues resulting on
antimicrobial formulations that are better suited for use in foods and can withstand a
range of processing conditions.
The objectives of this study were to formulate liposomes bearing the
antimicrobial polypeptide nisin and determine the integrity of liposomes exposed to
environmental stresses (pH 5-11, temperature < 75ºC). Integrity of liposomes was
evaluated by determining the liposomal encapsulation efficiency using a fluorescent
tracer dye (calcein). Additionally, liposome surface charge and size changes as a function
of nisin entrapment at two concentrations were evaluated as indicators of vesicle stability
to the antimicrobial polypeptide.

3.3.

Materials and Methods

3.3.1. Phospholipids and Antimicrobial

Distearoyl-phosphatidylcholine (PC) was purchased in chloroform from Avanti
Polar Lipids (Alabaster, AL, USA). Distearoyl-phosphatidylglycerol (PG) was purchased
in powdered form from Matreya Biochemicals LLC (Pleasant Gap, PA, USA). PG was
solubilized in a 4:1 chloroform: methanol mixture (Fisher, Fair Lawn, NJ) prior to mixing
with PC. All lipids were stored at -20°C until ready for use. Nisin (CAS 1414-45-5; 2.5%
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w/w in sodium chloride and denatured milk solids) was obtained from Sigma-Aldrich (St.
Louis, MO, USA) and stored in a desiccator at 5°C until used.

3.3.2. Liposome Preparation

Small unilamellar vesicles (SUVs) were prepared using the method of
Pinnaduwage and Bruce (1996) with modification. Liposome samples were prepared
from PC, PC:PG (8:2 mol%), or PC:PG (6:4 mol%). The lipids were first dispersed in
chloroform or chloroform:methanol (4:1) and dried under N2 to form a lipid film on the
wall of glass reaction tubes. Samples were desiccated overnight under vacuum to remove
solvents. Lipid films were rehydrated with 0.1X phosphate buffered saline (0.1X PBS)
(0.017M KH2PO4, 0.05M Na2HPO4, 1.5M NaCl at pH=7.4) (Biowhittaker, Rockland,
ME, USA) to a lipid concentration of 10 mM. For nisin-containing liposomes, nisin was
dissolved in 20 mM HCl (Sigma) to obtain an acidic stock solution with a nisin
concentration of 500 µg/ml. The nisin stock solution was immersed in boiling water for 5
minutes to denature extraneous protein (Tramer and Fowler, 1964), passed through a 0.22
µm cellulose acetate (low-protein binding) membrane (Corning Inc., Corning, NY, USA)
and diluted with 0.1X PBS to levels of 5.0 µg/ml and 10.0 µg/ml for rehydration of lipid
films. To allow for the determination of the encapsulation efficiency, the fluorescent
tracer calcein was solubilized in 0.1X PBS at a concentration of 50 mM and used to
rehydrate lipid samples prior to SUV formation. Following rehydration, vesicles were
frozen in liquid nitrogen for ~10 sec, gently thawed in water (25°C) for ~10 sec, and
immersed in 70°C water for 15 seconds. The thermal cycling was repeated four times.
Liposomes were held at 60°C for one hour to ensure that phospholipids were above their
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respective gel-liquid crystalline phase transition temperature (TM) prior to extrusion to
achieve size reduction of vesicles. Crude vesicle preparations were loaded into a
Liposofast Basic handheld extruder (Avestin, Ottawa, Canada) and extruded sequentially
through polycarbonate membranes (Avestin). Membranes were arranged in layers of
three with liposomes being passed first 11 times through a 400 – 200 - 400 nm membrane
stack followed by 11 passes through a 100 – 50 - 100 nm membrane stack. The extrusion
was carried out at 60°C to maintain vesicles above their respective TMs. Calceincontaining liposomes were subjected to size-exclusion chromatography to remove any
unentrapped fluorophores from the liposomal preparation by passing them over a BioGel
A0.5 M agarose (200-400 mesh) column (BioRad, Hercules, CA, USA) using a 0.1X
PBS buffer as carrier. Liposomes were eluted in the void volume. All samples were
stored at 5°C until ready for use. Liposomes were assayed within 72h of production.

3.3.3. Encapsulation Efficiency

Liposome vesicles were diluted to 100 µM in 2 ml of 0.1X PBS buffer, capped in
film, and incubated in glass tubes at the desired temperatures (25-60°C) in a Lauda RM-6
circulating water bath (Eppendorf, Westbury, NY, USA). Samples were incubated for 2
hours prior to measurement. For pH-dependent entrapment experiments, 20 µl of
liposomes was added to 10 µl 1 M pH-adjusted 3-Cyclohexylamino-propanesulfonic
Acid (CAPS) (CAS 1135-40-6) or 2-N-Morpholino-Ethanesulfonic Acid (MES) (CAS
4432-31-9) buffers (Sigma) and brought to 2 ml total volume. Samples were incubated 1
hour prior to measurement.
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Fluorescence of incubated samples was scanned from 500-550 nm with an
excitation of 495 nm and a maximum emission of ~515 nm in an LS-50B fluorescence
spectrophotometer (Perkin Elmer, Wellesley, MA, USA). Peaks were determined and
reported as inherent fluorescence (F0). 20 µl of 10% Triton X-100 (Sigma) solution was
added to the cuvette and allowed to stand for ~1 minute to induce rupturing of liposomes
and record the fluorescence of the released tracer (FT). FT is assumed to correspond to a
100% release of entrapped compounds. Detergent was added carefully so as to avoid the
introduction of gas bubbles; samples were gently inverted 8-10 times to allow thorough
mixing of detergent and liposomes. Encapsulation efficiency was calculated as:
⎛ ⎛F
EE = 100 × ⎜⎜1 − ⎜⎜ 0
⎝ ⎝ FT

⎞⎞
⎟⎟ ⎟
⎟
⎠⎠

(1)

3.3.4. Zeta-Potential Measurement

The ζ-potential of liposomal preparations was determined by placing 1 ml
samples in a disposable cuvette. The cuvette was inserted into the measurement chamber
of a particle electrophoresis instrument (Zetasizer Nanoseries ZS, Malvern Instruments,
Worcestershire, UK), and equilibrated to 25°C in the Peltier-controlled cuvette holder for
five min. prior. The ζ-potential was then determined by measuring the direction and
velocity that the liposomes moved by the applied electric field. The Smoluchowsky
mathematical model was used by the software to convert the electrophoretic mobility
measurements into ζ -potential values. To account for any effects on zeta-potential from
the buffer, which contained some negative charge in the form of Cl- ion, the buffer was
subjected to analysis in identical fashion to the liposomes. Immediately following

88

recording the ζ25C, the instrument sample cell was heated to 75°C and the sample again
equilibrated for 5 min and the ζ-potential recorded.

3.3.5. Particle Size

The particle size of liposomes was determined using a dynamic light scattering
technique (Zetasizer Nanoseries ZS, Malvern Instruments, Worcestershire, UK). One ml
samples were placed in disposable polystyrene cuvettes, inserted into the measurement
chamber and allowed to equilibrate to 25°C for five min. The Peltier-controlled
measurement chamber was then heated from 25°C to 75°C in increments of 5°C and the
particle size distribution measured at each temperature. The Sauter mean diameter (d32)
of the samples was determined from the particle size distribution as:
d 32

∑d
=
∑d

3
i
2
i

Ni
Ni

(2)

3.3.6. Statistical Analysis

All experiments were carried out in triplicate with like means being averaged.
Student’s t-test was used to determine statistically significant differences with a
confidence interval (CI) of 95%. Statistical analysis was carried out using Statistical
Analysis Software (SAS) v. 9.1 (SAS Institute, Cary, NC, USA).

3.4.

Results

3.4.1. Encapsulation Efficiency

Three liposome mixtures were prepared from PC, and PC containing 20 or 40%
PG with calcein entrapped in the aqueous core of the liposome. Entrapment efficiency of
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liposomes containing the fluorophore calcein exposed to different temperatures (25-60°C;
Fig. 3.1A) and pH (5.5-11.5 at 25°C, Fig. 3.1B) was measured. Liposomes containing 20
or 40% PG in addition to PC entrapped a high percent of dye (~89% and ~83%,
respectively) at room temperature. Entrapment efficiency did not change significantly for
PC/PG liposomes between 25 and 60°C. PC liposomes entrapped less calcein (~72%)
than PC/PG formulations and slightly decreased in EE as temperature increased from 25
to 60°C (Fig. 3.1A). Due to limitations of the instrument, determination of EE at
temperatures higher then 60°C was not possible. Liposome EE did not appear to be
significantly influenced by pH at room temperature. EE was approximately 89-91%, 7883% and 72-78% for PC/PG 6/4, PC/PG 8:2 and PC, respectively at pH = 5.5 - 11.5 (Fig.
3.1B).
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Figure 3.1: Calcein entrapment within liposomes as influenced by incubation (A)
temperature and (B) pH. Values represent means of duplicate replications; bars
represent standard deviations of sample means. Temperature-exposed samples were
equilibrated at indicated temperatures for 2 hr prior to fluorescence measurement;
pH-exposed samples were incubated at 25°C for 1 hr prior to fluorescence
measurement. PC: distearoyl-phosphatidylcholine; PG: distearoylphosphatidylglycerol.
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3.4.2. Zeta-Potential

ζ-potential distributions of liposomal preparations with and without nisin at pH
7.4 exposed to 25-75 °C were measured in triplicate and mean ζ-potentials calculated
from the distributions (Table 3.1). Phospholipid composition predominantly influenced
surface charge of liposomes. While PC vesicles had a ζ-potential of -8.30 mV, the
incorporation of nisin in PC vesicles resulted in a decrease of the surface charge. For
example, ζ-potentials of PC vesicles containing 5 and 10 µg/ml nisin were -7.61 and 6.89 mV at 25°C, respectively (Table 3.1). ζ-potential decreased with increasing
concentrations of the anionic phospholipid PG in the liposomal preparations to -52.28
and -72.60 mV for nisin-free liposomes containing 20 and 40 mol% PG at 25°C (Table
3.1). Likewise, surface charge of vesicles incorporating 40% PG, but not 20%, decreased
with the entrapment of nisin (Table 3.1). For PC/PG 6/4 liposomes, surface charge at
25°C was -60.44 and -58.81 mV with 5 and 10 µg/ml entrapped nisin, respectively (Table
3.1). PC/PG 8/2 vesicles, on the other hand, maintained their ζ-potential at ~-53 mV,
regardless of nisin content (Table 3.1). Increasing the sample temperature to 75°C did
not result in statistically significant changes in liposome charge for PC/PG 8/2 vesicles,
regardless of nisin level. Statistically significant differences in ζ-potential of PC/PG 6/4
liposomes were observed in vesicles following increases in temperature and addition of
nisin, but not for nisin-free liposomes (Table 3.1). For example, the mean ζ-potential of
PC/PG 6/4 liposomes containing 5 and 10 µg/ml nisin at 25°C increased from -60.44 mV
to -70.18 mV and from -58.81 mV to -70.11 mV upon heating (Table 3.1).
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Table 3.1. Mean zeta potential (mV) of liposomes composed of PC (distearoylphosphatidylcholine) and PG (distearoyl-phosphatidylglycerol) at two temperatures
(25°C, 75°C) containing 0, 5.0 and 10.0 µg/ml nisin.
PCa
Nisin (µg/ml)
0.0
5.0
10.0
a

25°C
-8.30 (0.11)
-7.61 (0.37)
-6.89 (0.03)

75°C
-9.74 (0.05)
-6.59 (0.53)
-8.55 (0.49)

PC/PG 8/2a
25°C
75°C
-52.28 (2.91) -54.72 (3.71)
-54.93 (4.83) -57.93 (5.97)
-52.64 (4.01) -57.82 (3.24)

PC/PG 6/4a
25°C
75°C
-72.60 (3.66) -72.51 (3.58)
-60.44 (5.61) -70.18 (2.52)
-58.81 (3.04) -70.11 (5.24)

Values represent means of triplicate replications with one standard deviation in
parentheses.

3.4.3. Mean liposomal size (d32) and size distribution
Particle size distribution as a function of temperature was measured for PC,
PC/PG 8/2 and PC/PG 6/4 lipsomes with 0, 5 and 10 µg/ml nisin and mean particle sizes
(d32; equation 2) were calculated (Fig. 3.2). Except in the case of PC vesicles, nisin
loading (5 and 10 µg/ml) led to an overall decrease in vesicle diameter (Fig. 3.2). For
PC/PG 8/2 and PC/PG 6/4 liposomes, particle sizes decreased with increasing nisin
concentration (Fig. 3.2). With respect to PC vesicles containing 5 and 10 µg/ml nisin, d32
values increased significantly as compared to empty PC vesicles when liposomes were
heated to 50°C (Fig. 3.2). In the cases of PC/PG 8/2 and 6/4 vesicles, the particle size did
not statistically change with temperature, regardless of whether vesicles were nisinloaded or empty (Fig. 3.2). Figure 3.3 shows a comparison of the entire particle size
distributions of PC, PC/PG 8/2 and PC/PG 6/4 liposomes containing 10 µg/ml nisin as a
function of temperature in the form of a contour plot. The volume fraction of the particle
size distribution is shown as contour lines in the plot. Particle size distributions of PG
liposomes broadened and mean particle size increased between 40 and 60C while particle
size distributions remained unchanged for PC/PG 8/2 and PC/PG 6/4 liposomes.
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Figure 3.2: D32 change in liposome size as a function of antimicrobial entrapment
and high-temperature exposure. Values represent averages of triplicate replications;
bars represent standard deviations of means. Liposomes were tested at 10 mM with
nisin encapsulated at 5.0 (Nis5) and 10.0 µg/ml (Nis10).
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Figure 3.3: Contour Plot of (A) PC Nis10, (B) PC/PG 8/2 Nis10 and (C) PC/PG 6/4
Nis10 liposomal size distribution as a function of temperature. Curves represent
means of triplicate replications and depict the percentage of sample with a given size
(nm). Samples were allowed to equilibrate to temperature for 5 min. prior to
measurement. Nisin was encapsulated at 10.0 µg/ml (Nis 10).
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On the other hand, particle size of was influenced by phsopholipid composition of
the preparations (Fig. 3.2). PC, PC/PG 8/2, and PC/PG 6/4 vesicles (empty) had d32
values at 25°C of 103.1+2.0, 181.7+8.2, and 132.1+2.8 nm, respectively. Upon inclusion
of 5 µg/ml nisin, particle sizes at 25°C were 310.1+104.9, 187.4+13.3, and 122.7+6.2 nm
for PC, PC/PG 8/2, and PC/PG 6/4 vesicles, respectively (Fig. 3.2). In the case of 10
µg/ml nisin encapsulation, vesicle diameters for PC/PG 6/4 liposomes were statistically
different compared to nisin-free PC/PG 6/4 liposomes (Fig. 3.2). Interestingly, while
PC/PG vesicles decreased in vesicle size with the inclusion of nisin, pure PC vesicles
containing nisin increased in vesicle diameter (Fig. 3.2). PC vesicles containing 10
µg/ml nisin had an average diameter of 242.7+44.9 nm, more then double the size of
nisin-free PC liposomes (Fig. 3.2).

3.5.

Discussion
Results of entrapment efficiency and ζ-potential measurements as a function of

temperature correlate well with data reported elsewhere (Hsieh et al., 2002; Kitano et al.,
1991). The high entrapment efficiency of PG-containing liposomes with respect to
temperature exposure has been reported previously (Findlay and Barton, 1978; Zhang et
al., 1997). In general, instability of liposomes has been attributed to collisions and
eventual merging of liposomal membranes of two or more liposomes (Taylor et al.,
2005). This process is thermodynamically driven due to the tendency of the system to
decrease the energetically unfavorable curvature of the bilayer membrane in spherical
liposomes. Collisions may be due to random (Brownian) movement of vesicles in
solution or due to superimposed convection. Similar to emulsions, the probability of
95

collisions of liposomes depends on the colloidal interactions between the particles
(McClements, 2005). Increasing the repulsive interactions may reduce the frequency of
collision while increasing the temperature can increase the probability for collisions.
Thus liposomes composed of charged polar lipids carrying higher electrical charges such
as PC/PG 8/2 and PC/PG 6/4 liposomes with a ζ-potential of -52.28 mV and 72.60
respectively, can be expected to be more stable than liposomes composed of neutral polar
lipids. With respect to PC liposomes, a surface charge of ~-8.3 mV is in agreement with
values reported for other PC vesicles (Huang et al., 2005; Makino et al., 1991; Willumeit
et al., 2005).
Straubinger et al. (1985) demonstrated that liposomes composed of 100% PC
were pH insensitive and change of pH did not trigger release of encapsulated compounds.
Lee et al. (2002) determined that incorporation efficiency of retinol in PC liposomes was
99.25% at pH 3.0 and 97.45% at pH 11.0, a statistically insignificant difference.
Similarly, our data confirms that release of entrapped reporter did not vary with pH (Fig.
3.1); negatively charged liposomes produced in this study did not exhibit significant
differences in entrapment efficiencies as the pH was adjusted from 5.5 to 11.5. In
contrast, inclusion of phosphatidylethanolamine (PE) has shown to yield liposomes that
released constituents from their aqueous core under mild acidic conditions (pH<6). In
general, liposomes can be expected to retain the encapsulated material if the
phospholipids used to formulate the liposomes maintain their charge regardless of the
specific pH of systems in which they are applied. Consequently, knowledge of the pKa
values of the involved phospholipids of which liposomes are composed is critical.
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ζ-potential measurements indicated that introduction of nisin in PC and PC/PG
8/2 liposomes effected net surface charge of liposomes as compared with surface charge
of nisin-free liposomes (Table 3.1). Addition of nisin has been reported to perturb PC
membranes, increasing fluidity and altering the overall bilayer structure (El Jastimi et al.,
1999; Willumeit et al., 2005). Model membrane studies have shown that nisin has a high
specificity for anionic phospholipids, which is in fact part of the basis for its
antimicrobial activity (El Jastimi et al., 1999; Gao et al., 1991; Van Kraau et al., 1997).
Nisin is a member of a class of small antimicrobial polypeptides known as lantibiotics
that are thought to self-assemble in the bacterial membrane to form pores that prevent
bacteria from maintaining homeostasis (Driessen et al., 1995). While nisin creates pores
in membranes that contain high levels of anionic lipids these pores are transient in nature
with nisin possibly translocating entirely across the membrane bilayer following
porulation (Breukink and de Kruijff, 1999; El Jastimi et al., 1999). In PC/PG 6/4
liposomes, more nisin may have been present in the liposomal membrane or might have
translocated during incubation because of the higher content of the anionic phospholipids
PG. Accordingly, ζ-potentials decrease at 25°C as nisin is incorporated at higher levels
(Table 3.1). Nisin-induced pores or leakage from vesicles has been reported previously
and given that 100% EE has not been reported here, it is not unlikely that the cationic
peptide neutralized charge of PG lipids on the outer surface of the membrane (Were et
al., 2003).
An increase in temperature to <70ºC of liposomes containing nisin did not
significantly affect the surface charge of liposomes. Similarly, Makino et al. reported that
surface charge of DSPC liposomes remained unchanged as temperature was increased
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from 20 to 55°C (1991). However, at >70°C, PC liposomes had increased
electronegativity, regardless of nisin encapsulation levels (Table 3.1, Fig. 3.1). Possibly,
nisin/PC interactions and structural rearrangement of nisin within the liposome may have
been altered as the lipids underwent their main gel-liquid crystalline phase transition,
known to occur at ~54°C (Taylor et al., 2005). Heating of vesicles can increase the
Brownian motion of lipids in vesicles and potentially induced rearrangement of lipid
headgroups increasingly exposing the phosphatidyl groups of liposomes to the
environment. Alternatively, heating of nisin could have decreased its solubility and
stability. Liu and Hansen (1990) reported almost complete insolubility of nisin at 25°C at
pH 7.0; others have reported that heating of nisin to temperatures approximating ultrahigh temperature processing (UHT) can result in as much as 40% loss of nisin activity
(Thomas and Delves-Broughton, 2005).
PC vesicles, upon inclusion of 5 and 10 µg/ml nisin, displayed increases in their
size around the phase transition temperature of the polar lipid. The phase transition
temperature of DSPC, the lipid used in this study, occurs around 54°C. In the presence of
nisin, the change from gel to liquid crystalline appears to have a destabilizing effect on
the vesicles. The increases of liposome diameter according to the DLS assay suggests
changes in the liposome structure and morphology, a phenomenon recorded elsewhere
(El Jastimi et al., 1999). Breukink et al. (2000) demonstrated via calorimetric
experiments that nisin has low penetration power for membranes formed from PC versus
membranes formed from PC and PG, and that nisin/PC interactions are primarily
hydrophobic in nature. El-Jastimi et al. reported the formation of large aggregates of
nisin and liposomes following heating of liposomes past their phase transition
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temperatures (1999). Wiener et al. (1983) demonstrated increases in vesicle diameter
following loading with matrix protein of stomatitis virus. As previously mentioned
heating of nisin can also lead to decreases in solubility which may also contribute to the
observed size changes of PC liposomes.
Particle size distributions of PG-containing liposomes did not significantly change
when samples were heated from 25 to 75°C, even when nisin was entrapped (Figs. 3.23.3). Overall, in the absence of nisin, PG-containing vesicles were of greater size then PC
liposomes, a phenomenon reported previously by Were et al. (2003). While the lipids
used in this study were identical in their acyl chain length and degrees of saturation,
differences in headgroup chemistry may contribute to these differences. Despite similar
molecular weights (PC=790.15 g/mol; PG=801.06 g/mol), charge differences and steric
hindrances from headgroups could force PG-containing liposomes to increase their
diameter so as to reduce charge repulsion and allow for optimal headgroup packing. This
difference in size stability of PC liposomes versus those with PG incorporated is not
thought to be a function of the zwitterion not being able to maintain stability due to
charge repulsion at the surface, as the lipid has only a small electronegative surface
charge at neutral pH (Table 3.1). Interestingly, with inclusion of nisin, the diameters of
PG-containing liposomes decreased while size of pure PC liposomes increased compared
to their nisin-free counterparts (Fig. 3.2). Laridi et al. (2003) reported substantial size
reductions in liposomal preparations following nisin incorporation. Mean diameters of
liposomes containing PC and other charged lipids decreased from ~1741 nm to ~740 nm
upon entrapment of 100 µg/ml nisin (Laridi et al., 2003). Other authors have speculated
that the size decrease is due to nisin’s ability to reorganize the liposome via electrostatic
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and hydrophobic interactions (Bayerl and Bloom, 1990; El Jastimi et al., 1999; Fenske
and Cullis, 1993).
Nisin-containing PC/PG bilayers may be able to attain a more optimal packing,
via charge neutralization of anionic lipids by the cationic peptide and a realignment of the
phospholipids including the formation of vesicles with decreased curvature stress, which
could explain the reductions in diameters (Bonev et al., 2000; El Jastimi et al., 1999).
The interaction between the polar lipids and nisin ultimately depends on the composition
of the bilayer and thus the ratio of the two lipids in the liposomes and contribute to the
observed differences in PC/PG 8/2 and PC/PG 6/4 vesicle size reductions (Bonev et al.,
2000; Breukink and de Kruijff, 1999; El-Jastimi and Lafleur, 1997; El-Jastimi and
Lafleur, 1999; El Jastimi et al., 1999). Neveretheless, a more in-depth elucidation of
membrane composition and structural arrangement of phospholipids and nisin within the
membrane using fluorescence or neutron scattering will be required to quantify these
changes (El Jastimi et al., 1999).

3.6.

Conclusions
Results presented in this study indicate that liposomes may be good candidates for

the entrapment of bioactive compounds such as antimicrobials polypeptides. However,
data presented here also show that formulation plays a critical role in terms of liposome
diameter/size and surface charge of liposomes that in turn may impact the functionality of
these particles in complex food systems. An in-depth understanding of the overall
structure of liposomes will be needed to enable food processors to use these encapsulated
compounds to control growth of foodborne pathogens in foods. We are encouraged by the
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fact that liposomes formulated with PC and PG appear to be relatively stable to
pasteurization protocols although exposure to temperatures above 75°C has yet to be
tested. It should be noted though that we did not yet test whether nisin maintained its
antimicrobial property after exposure to the elevated temperatures. The relatively high pH
stability of liposomes demonstrates one of the main advantages of this encapsulation
system, namely that they could be formulated such that the internal pH is different from
that of the surrounding continuous phase using appropriate polyelectrolytes (Driessen et
al., 1995; Gao et al., 1991). Thus pH-sensitive compounds such as nisin may be
particularly suited to be encapsulated in liposomal carrier systems. Finally, as liposomes
are generally formed from lipids that are naturally-occurring in various food staples,
allergenicity and product labeling concerns can be expected to be minimal. In terms of
encapsulation of food antimicrobials, data existing relating the bacteriostatic and
bacteriolytic capability of liposomes with entrapped antimicrobials is still limited. Studies
ongoing in our laboratory are currently focused on assessing the in vitro inhibitory effect
of liposome encapsulation of antimicrobials, as well as the inhibitory potential of
liposome-entrapped antimicrobials within various food matrices.
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4. Listeria monocytogenes Inhibition by Liposome-Entrapped
Antimicrobial as Measured by Agar Well Diffusion Assay
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4.1.

Abstract
Listeria monocytogenes, a Gram-positive non-sporulating rod-shaped psychro-

troph, is an important foodborne pathogen that is known to contaminate ready-to-eat
(RTE) foods. One method for inhibiting the growth of or inactivating L. monocytogenes
in RTE foods is to use antimicrobial food preservatives. Encapsulation tools that could
effectively protect antimicrobials from food components and food processing measures
would constitute a significant advancement in the preservation of RTE foods. Liposomes
represent such a technology; recent application in the preservation of cheese has spurred
research into their utility in other food matrices. In order to determine the feasibility of
encapsulated antimicrobial for the control of L. monocytogenes growth in a model
system, nisin was entrapped in phospholipid liposomes at varying concentrations.
Liposomes were formed using high-pressure extrusion in order to reduce liposome size,
homogenize liposome suspensions, and entrap antimicrobial. Nisin was entrapped at 5
and 10 µg/ml and then added in a well diffusion assay to determine the inhibitory effect
on L. monocytogenes Scott A or 310. L. monocytogenes inhibition was observed to be
slightly dependent upon dose, but greatly dependent upon phospholipid constituents of
liposomes. Data indicated slow liposome release of antimicrobial as compared to
surfactant-induced quick release of nisin, and that liposome encapsulation represents a
potentially useful technology for inhibition of L. monocytogenes.
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4.2.

Introduction
Despite a zero-tolerance policy and implementation of HACCP programs

designed to eliminate their presence, pathogens such as Listeria monocytogenes continue
to persist as a significant threats to the safety of the U.S. food supply. L. monocytogenes
is recognized to be of special importance with respect to the contamination of ready-toeat (RTE) foods such as pasteurized dairy products and meat emulsions (e.g. frankfurters)
(Johnson et al., 1990; Lovett et al., 1987). One method for inhibiting or inactivating this
microorganism in RTE foods is the addition of antimicrobial food preservatives.
However, there is much variability of antimicrobials against various foodborne pathogens
and often high amounts of compounds are necessary to overcome cross-reaction with
food components resulting in a loss of activity. The latter has encouraged investigation
into alternative means of delivering antimicrobials to bacterial contaminants to achieve
inhibition as lower concentrations of antimicrobials. Encapsulation tools that could
effectively protect antimicrobials from food components, necessary processing measures,
and effectively deliver their antimicrobials would constitute a significant advancement in
the preservation of RTE foods.
Liposomes may represent one such technology; while they have been used for
decades in the delivery of pharmaceuticals, recent application in the preservation of
cheese via encapsulation of antimicrobial has spurred research into their utility in other
food matrices (Benech et al., 2002a; Benech et al., 2002b; Degnan et al., 1993; Degnan
and Luchansky, 1992; Laridi et al., 2003). Liposomes represent colloidal dispersions of
lipids in aqueous buffers and are often formulated from a single species of lipid or from
multiple phospholipids. Liposomes can range in size from ~40-50 nm to 1-2 μm,
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depending on their formulation method and also their intended use (Barenholz et al.,
1977; Mason et al., 1983).
In studies testing the effectiveness of liposome-entrapped antimicrobials (nisin,
lysozyme) against the foodborne pathogen Listeria monocytogenes, researchers reported
inhibition L. monocytogenes Scott A and 310 after incubation with phosphatidylcholine
(PC), phosphatidylglycerol (PG), and cholesterol containing-liposomes with entrapped
nisin (3.3 mg/ml) (Were et al., 2003). Cholesterol was included in some liposomes as it is
known to increase liposome fluidity while increasing resistance to leakage and
permeabilization (Vemuri and Rhodes, 1995). Were et al. (2004) reported decreases in
log10 CFU/ml of 0.5->2.6 and 0.7->3.7 in broth cultures of L. monocytogenes Scott A and
310, respectively, for 10 mM PC, PC/Ch 7/3, and PC/PG/Ch 5/2/3 (mol fraction)
liposomes with entrapped nisin.
The objective of this study was to determine the feasibility of encapsulating nisin
in phospholipid liposomes and determine if the encapsulated antimicrobial retained
activity against L. monocytogenes using a nisin assay system (Fowler et al., 1975; Tramer
and Fowler, 1964).

4.3.

Materials and Methods

4.3.1. Cultures and Growth Media
Listeria monocytogenes Scott A and 310 cultures were transferred daily in tryptic
soy broth plus 0.6% yeast extract (TSB-YE) (Becton Dickinson, Franklin Lakes, NJ).
Cultures were incubated aerobically at 32°C and periodically streaked on to tryptic soy
agar plus 0.6% yeast extract (TSA-YE) or tryptic soy agar (TSA) (Becton Dickinson)
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plates to confirm culture purity; plates were incubated aerobically at 32°C for 24 h before
inspecting for colony morphology.

4.3.2. Phospholipids and Antimicrobial
Distearoylphosphatidylcholine (PC) and distearoylphosphatidylglycerol (PG)
were purchased from Avanti Polar Lipids (Alabaster, AL) in chloroform and stored at 20°C until used. Powdered nisin (2.5% w/w in milk solids) was obtained from Sigma (St.
Louis, MO) and stored in a desiccator at 5°C until used. Nisin stock solution was
prepared according to the methods described by Fowler et al. (1975) and Wolf and
Gibbons (1996). Briefly, nisin was added at 0.5 g/50 ml in 20 mM sterile HCl (Fisher
Scientific, Fairlawn, NJ) to give a final concentration of 250 μg nisin/ml. The solution
was mixed and then boiled for five minutes to stabilize the solution and protect against
growth of nisin-resistant microbes. The stock solution was able to be stored refrigerated
(4°C) for up to six days. Working solutions of nisin were made fresh daily in 0.1X PBS
to concentrations of 5.0 and 10.0 µg/ml.

4.3.3. Liposome Formation
Multi-lamellar vesicle (MLV) liposomes were formed according to the method of
Pinnaduwage and Bruce (1996) with modification. Lipid-containing chloroform was
dried down under N2 to disperse lipids over the walls of glass reaction tubes. PC/PG 8/2
and 6/4 (mol fraction) liposomes were formed by combining solvated phospholipids prior
to chloroform evaporation followed by vigorous vortexing to ensure homogeneity of the
two species. Following chloroform evaporation, phospholipids were rehydrated in 0.1X
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PBS (0.017M KH2PO4, 0.05M Na2HPO4, 1.5M NaCl at pH=7.4) (Biowhittaker,
Rockland, ME) to a concentration of 10 mM and vortexed vigorously to suspend lipids in
the aqueous buffer. For liposomes containing antimicrobial, nisin was solubilized in 20
mM HCl according to the method of Tramer and Fowler (1964) at a concentration of 5 or
10 µg/ml (actual nisin) immediately prior to rehydration of liposomes. Following MLV
formation, liposomes were frozen in liquid nitrogen for ~10 sec, gently thawed in
ambient (25°C) water for ~10 sec, and 70°C water for 15 sec. The process was repeated
four times. Liposomes were then loaded into a handheld extruder (Liposofast Basic,
Avestin, Ottawa, Canada), and extruded sequentially through polycarbonate membranes
of 400, 200, 100, and 50 nm (pore diameter) to reduce MLVs to small unilamellar
vesicles (SUVs) and increase encapsulation of antimicrobial. All extrusions were carried
out at 65°C to maintain lipids in a liquid-crystalline phase so as to facilitate their
extrusion. Liposomes were then separated from unencapsulated nisin by size exclusion
chromatography on an A0.5 (200-400 mesh) agarose column with liposomes eluting off
the column directly after the void volume (BioRad, Hercules, CA). Liposome fractions
collected, pooled, and then stored at refrigeration temperatures until ready for use;
liposomes were used with 72 h of production.

4.3.4. Agar Diffusion Assay Plates
An agar diffusion assay similar to assays described by other researchers was
employed for the assay of encapsulated nisin inhibition of target pathogen strains (Fowler
et al., 1975; Pongtharangkul and Demirci, 2004; Rogers and Montville, 1991; Tramer and
Fowler, 1964; Wolf and Gibbons, 1996). Diffusion agar was prepared according to the
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method of Tramer and Fowler (1964) with modifications made by Wolf and Gibbons
(1996), except that no surfactant was added to the media in order to protect against
immediate breakdown of liposomes upon loading into test wells. Plates were poured at 20
ml/plate after seeding with ~107 CFU/ml Listeria cells (confirmed via enumeration on
TSA-YE) and then refrigerated for 1 hr prior to boring of wells with a sterile glass
transfer pipet. Bored agar was removed and wells were filled with 50 µl of sample
(control solution, free antimicrobial, or liposome encapsulated nisin) and then incubated
at 32°C. Control wells were filled with 0.1X PBS (Biowhittaker), 0.2% Triton X-100
(Sigma), or liposomes with no encapsulated antimicrobials. Plates were observed for
zones of clearing at 0 (baseline control) 12, 24, and 48 hr. Zones were measured using a
caliper to determine the zone of inhibition surrounding the well. All experiments were
completed in triplicate statistically significant differences were analyzed with Student’s ttest (P<0.05) (SAS v. 9.1, SAS Institute, Cary, NC). For the determination of theoretical
limits of inhibition based on complete liposome rupture, plates were prepared as
described above but with an additional 10 µl of 0.2% Triton X100 solution.

4.3.5. Inhibition Limit Determination
The experimental maximum inhibition of L. monocytogenes Scott A and 310 by
liposome-encapsulated nisin as a function of time was determined experimentally via
inclusion of 10 µl of 1% Triton X100 (Sigma) with liposomes prior to incubation. The
surfactant-lysed liposomes caused release of the entire amount of entrapped nisin to the
cells, thus achieving the theoretical experimental limit of inhibition. Percent potential
inhibition was calculated mathematically as [(Radius inhibition zone of Treatment
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X/Radius inhibition zone of Treatment X+0.2%Triton)*100%] where Treatment X is a
liposome with either 5 or 10 µg/ml antimicrobial at either 0, 12, 24, or 48 hr incubation.

4.4.

Results
The inhibition of L. monocytogenes Scott A and 310 by free and liposome-

entrapped antimicrobial is shown in Figures 4.1-4.2, respectively. Significant inhibition
of L. monocytogenes strains Scott A and 310 by free nisin occurred for both strains, but
there was no inhibition by the 0.2% Triton X100 solution (Data not shown). Liposomes
prepared without nisin did not demonstrate any discernable inhibition of the Grampositive pathogens (Figs. 4.1-4.2). Furthermore, target strains did not show significant
differences in sensitivity to the free or liposomal nisin as determined by agar-diffusion
assay (Figs. 4.1-4.2).
Figures 4.1-4.2 indicate that no significant change in the diameters of the
inhibition zones of free or liposomal nisin occurred between 24 and 48 hr of incubation.
Nevertheless, though no inhibition was observed with PC liposomes with encapsulated
nisin, significant inhibition of both strains was observed when PC-encapsulated nisin
liposomes were ruptured with surfactant (0.2% Triton X-100) (Figs. 4.1-4.2). Unlike free
nisin, the inclusion of 5 or 10 μg/ml nisin into PC liposomes did not produce a dosedependent response against L. monocytogenes Scott A or 310. Conversely, PC/PG 8/2
and PC/PG 6/4 liposomes exerted significant inhibition upon target strains (Fig. 4.1-4.2).
Surfactant-induced lysis of PG-containing liposomes resulted in significant increases in
pathogen inhibition after 48 hr incubation (Figs. 4.1-4.2).
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Figure 4.1: Inhibition of L. monocytogenes Scott A by (A) unencapsulated, (B)
liposomal nisin, and (C) surfactant-lyzed liposome-entrapped nisin. Symbols
represent means of three replications; error bars indicate standard deviations of
sample means.
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Figure 4.2: Inhibition of L. monocytogenes 310 by (A) unencapsulated, (B) liposomal
nisin, and (C) surfactant-lyzed liposome-entrapped nisin. Symbols represent means
of three replications; error bars indicate standard deviations of sample means.
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Figure 4.3 demonstrates the differences in inhibition of target L. monocytogenes
as a function of liposome formulation and vesicle rupture via surfactant after 24 hr
incubation. For each liposome preparation/target strain combination, increased inhibition
was observed, albeit statistically insignificant, following surfactant-induced lysis as
compared to surfactant-free liposomes (p<0.05) (Fig. 4.3).

4.5.

Discussion
Results confirm data reported by findings of other researchers with respect to L.

monocytogenes sensitivity to comparable levels of nisin (Branen and Davidson, 2004).
That inhibition zones were not significantly different for either of the two levels of
entrapped nisin can be viewed as a positive attribute of the delivery vehicle in that lower
concentrations of nisin may be effective at inhibiting the growth of pathogens. The
entrapment of nisin in PC effectively prevented action of the peptide against the
pathogens; no inhibition zone was observed, even after 48 hr (Figs. 4.1; 4.2). Unlike
lipids such as phosphatidylethanolamine, PC is not a fusogenic phospholipid in
physiological conditions. Hence, vesicles formed exclusively from this lipid would be
very stable against mixing with lipids found in the bacterial membrane (El Jastimi et al.,
1999; El Jastimi and Lafleur, 1999). Additionally, nisin is known not to interact strongly
with PC lipids, due primarily to an inability of the cationic bacteriocin to engage in
attractive electrostatic interactions with the zwitterionic phospholipid (El Jastimi and
Lafleur, 1999). This phenomenon of nisin inactivity using liposomes formed from PC
was observed with both strains of the target pathogen and thus was not considered to be a
function of inherent antimicrobial resistance or sensitivity by one strain over another.
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Figure 4.3: Inhibition of L. monocytogenes (A) Scott A and (B) 310 via
free and liposomal nisin (10 µg/ml). Bars represent means of triplicate
replications with error bars indicating sample standard deviation. PC:
phosphatidylcholine; PG: phosphatidylglycerol; Tri: 0.2% Triton
X100®. Samples were incubated for 24 hr at 32°C.
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Liposomes containing the anionic lipid PG proved to be effective at inhibiting the
pathogen via release of entrapped antimicrobial. PC/PG 8/2 and PC/PG 6/4 liposomes
demonstrated nearly equivalent inhibition of both Listeria strains over 48 hr (Figs. 4.14.2). Surfactant-induced lysis of liposomes further increased the inhibition observed in
experimental wells, but differences in strain sensitivity were not observed. As mentioned
earlier, nisin is cationic and does not interact favorably with non-charged lipids. It does,
however, interact very favorably with PG to form membrane-spanning pores and to
destabilize the membrane (El-Jastimi and Lafleur, 1999). Increasing the molar% of PG in
liposomes from 20% to 40% did not dramatically increase the extent of inhibition
observed. We do not believe this to be a function of decreased entrapment of nisin in
PC/PG 6/4 vesicles versus PC/PG 8/2 vesicles as increases in inhibition following Triton
X100 addition were not statistically different between PC/PG 8/2 and 6/4 liposomes after
48 hr (Figs. 4.1-4.2).
Finally, increases in inhibition of pathogens by liposomes lysed with surfactant
versus liposomes not ruptured with surfactant indicate effective entrapment of
antimicrobial within liposomes. Figure 4.3 depicts differences in inhibition zone diameter
as a function of liposome formulation and surfactant-induced release of antimicrobial.
Dramatic increases in inhibition are evident for both strains and for all three lipsome
formulations following Triton X100 addition to experimental wells. In fact, differences
between non-lysed liposomes and liposomes formulated identically but ruptured via
surfactant were significant for all liposome formulations (P<0.05). The most dramatic
differences were observed for PC vesicles tested against L. monocytogenes 310, followed
by PC vesicles tested against L. monocytogenes Scott A. As mentioned previously, PC
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vesicles are stable against fusion and do not interact to a great extent with nisin; they
have been reported previously to be excellent choice for liposomal entrapment of
antimicrobials such as nisin and lysozyme (El-Jastimi et al., 1999; Were et al., 2003).

4.6.

Conclusions
Liposomes represent a potentially useful new technology for the inhibition of

Gram-positive foodborne pathogens by antimicrobial polypeptides such as nisin. Results
suggest addition of encapsulated antimicrobials increases the inhibitory effectiveness
compared to non-encapsulated antimicrobials by allowing for a slower, longer-lasting
release of antimicrobial. Nonetheless, the formulation of encapsulates is an important
factor in determining the efficacy of vesicles in achieving inhibition of target pathogens.
Liposomes containing the anionic lipid PG were significantly more effective at inhibiting
target L. monocytogenes strains than liposomes formulated from PC lipids.
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5. Enhanced Listeria monocytogenes and Escherichia coli
O157:H7 in vitro Inhibition by Liposome-Encapsulated
Antimicrobial and Chelator
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5.1.

Abstract
Encapsulation technologies that effectively reduce antimicrobial interaction with

food components or protect antimicrobial compounds from food processing measures
have potential to improve microbiological safety of ready-to-eat (RTE) foods. Recent
application of liposomes for the preservation of cheese has spurred research into their
utility in other food matrices. To ascertain the feasibility of encapsulated antimicrobial
for the control of Listeria monocytogenes and Escherichia coli O157:H7 growth in a
model system, nisin (5.0 and 10.0 µg/ml) and the chelator ethylene diaminetetraacetic
acid (EDTA) were entrapped in phospholipid liposomes. While phosphatidylcholine (PC)
liposomes did not produce significant inhibition of target pathogens,
PC/phosphatidylglycerol (PG) 8/2 and 6/4 (mol%) produced significant inhibition of
pathogens. Near complete inhibition of E. coli O157:H7 with liposomal antimicrobials at
concentrations below those reported necessary for unencapsulated antimicrobial and
chelator suggest that liposomes may represent a powerful technology for the
encapsulation of antimicrobials and the control of foodborne pathogens.
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5.2.

Introduction
Despite zero-tolerance policies and implementation of HACCP programs

designed to control their presence, Listeria monocytogenes and Escherichia coli O157:H7
continue to persist as threats to the safety of the U.S. food supply. Therefore, advances in
preservation technologies that aid in the inhibition or elimination of these pathogens
following processing are needed to protect consumers of RTE foods. However, the
variability of effectiveness of antimicrobials against some foodborne pathogens, as well
as the high concentrations necessary to cause inhibition due to interactions with food
components, has encouraged investigation into means of targeting antimicrobials to
bacterial contaminants.
Encapsulation technologies that could effectively shield antimicrobials from
interfering food components and protect them from processing measures, while at the
same time effectively delivering their contents would represent a significant advancement
in the preservation of RTE foods. Liposomes may represent one such technology; while
they have been used for decades in the delivery of pharmaceuticals, recent application in
the preservation of cheese via encapsulation of antimicrobial has spurred research into
their utility in other food matrices (Benech et al., 2002b; Benech et al., 2002a; Degnan et
al., 1993; Degnan and Luchansky, 1992; Laridi et al., 2003). Liposomes are colloidal
dispersions of lipids in aqueous buffers and are often formulated from single or multiple
phospholipids. Liposomes can range in size from ~40-50 nm to 1-2 μm, depending on
their formulation method and intended use (Barenholz et al., 1977; Mason et al., 1983).
In studies testing the effectiveness of liposome-entrapped antimicrobials (nisin,
lysozyme), researchers reported inhibition of two L. monocytogenes strains with
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phosphatidylcholine (PC), phosphatidylglycerol (PG), and cholesterol (Ch) containingliposomes with entrapped nisin (3.3 mg/ml) (Were et al., 2003). Were et al. (2004)
reported optical density (OD630) decreases in broth cultures of L. monocytogenes Scott A
and 310 using 10 mM PC, PC/Ch 7/3 (mol%), and PC/PG/Ch 5/2/3 (mol%) liposomes
with entrapped nisin.
Multiple studies have reported the synergistic effects of combining antimicrobials
such as nisin or lysozyme with chelators such as EDTA or lactoferrin against gram
negative pathogens like E. coli O157:H7 (Boziaris and Adams, 1999; Branen and
Davidson, 2004; Cutter et al., 2001). The ability of chelators like EDTA to destabilize the
outer membrane of gram negative bacteria by sequestering cations such as Ca+2 and Mg+2
is believed to lead to greater access of the antimicrobial to the membrane and thereby
increased inhibitory effects (Branen and Davidson, 2004).
The objective of this study was to determine the feasibility of encapsulating nisin
and EDTA in phospholipid vesicles for the inhibition of the foodborne bacterial
pathogens L. monocytogenes and E. coli O157:H7 in a model system.

5.3.

Materials and Methods

5.3.1. Cultures and Growth Media
L. monocytogenes Scott A (clinical isolate) and 310 (goat-cheese associated
outbreak isolate) cultures were transferred daily in tryptic soy broth plus 0.6% yeast
extract (TSB-YE) (Becton Dickinson, Franklin Lakes, NJ, USA). E. coli O157:H7 932
(hard salami isolate) and American Type Culture Collection (ATCC) 43895 (Manassas,
VA, USA) (ground beef-associated outbreak isolate) cultures were transferred daily in
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tryptic soy broth (TSB) (Becton Dickinson). Cultures were obtained from the University
of Tennessee Food Science and Technology culture collection. Cultures were incubated
aerobically at 32°C and periodically streaked on to tryptic soy agar plus 0.6% yeast
extract (TSA-YE) or tryptic soy agar (TSA) (Becton Dickinson) plates to confirm culture
purity; plates were incubated aerobically at 32°C for 24 h before inspecting for colony
morphology.

5.3.2. Phospholipids, Antimicrobial, and Chelator
Distearoylphosphatidylcholine (PC) and distearoylphosphatidylglycerol (PG)
were purchased from Avanti Polar Lipids (Alabaster, AL, USA) in chloroform and stored
at -20°C until used. Powdered nisin was obtained from Sigma (St. Louis, MO, USA) and
stored in a desiccator at 5°C until used. Nisin stock solution was made according to
previously reported methods (Wolf and Gibbons, 1996). Ethylenediamine tetraacetic
Acid (EDTA) (Fisher) was dissolved with gentle heating in distilled water and filtered
through a 0.22 µm cellulose acetate filter (Corning Instruments, Corning, NY, USA) and
stored at 5°C. Nisin was diluted appropriately in 0.1X phosphate buffered saline (PBS)
(0.017M KH2PO4, 0.05M Na2HPO4, 1.5M NaCl at pH=7.4) (Biowhittaker, Rockland,
ME, USA) and encapsulated at 5.0 and 10.0 µg/ml. EDTA was co-encapsulated with
antimicrobial at 300 µg/ml. In order to determine the theoretical limit of inhibition of
liposomal antimicrobials, 10 µl of a solution of the surfactant Triton X100® (Sigma) was
added to give a final well concentration of 0.2% to rupture liposomes.
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5.3.3. Liposome Formation
Multi-lamellar vesicles (MLVs) were formed according to previously reported
methods with modification (Pinnaduwage and Bruce, 1996). Lipid-containing chloroform
was dried down under N2 to disperse lipids over the walls of glass reaction tubes. PC/PG
8/2 and 6/4 (mol%) liposomes were formed by combining solvated phospholipids prior to
chloroform evaporation followed by vigorous vortexing to ensure homogeneity of the
two species. Following chloroform evaporation and overnight desiccation, phospholipids
were rehydrated in antimicrobial-containing 0.1X PBS to a final concentration of 10 mM
and vortexed vigorously to suspend lipids in the aqueous buffer. Liposomes were chilled
in liquid nitrogen for ~10 sec, gently thawed in 25°C water for ~10 sec, and warmed in
70°C water for 15 sec; the process was repeated four times. Liposomes were then loaded
into a handheld extruder (Liposofast Basic, Avestin, Ottawa, Canada), and extruded
sequentially through polycarbonate membranes of 400, 200, 100, and 50 nm (pore
diameter) to reduce MLVs to small unilamellar vesicles (SUVs) and increase
encapsulation of antimicrobial. All extrusions were carried out at 65°C to maintain lipids
in a liquid-crystalline phase so as to facilitate their extrusion. Liposomes were then
separated from unencapsulated nisin by size exclusion chromatography on an A0.5 (200400 mesh) agarose column with liposomes eluting off the column directly after the void
volume (BioRad, Hercules, CA, USA). Liposome fractions collected, pooled, and then
stored at refrigeration temperatures until ready for use; liposomes were used with 72 h of
production.
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5.3.4. Microbroth Dilution Assay
A checkerboard assay was employed for the detection of inhibitory effects of
liposome-encapsulated antimicrobial against L. monocytogenes and E. coli O157:H7 as
well as detection of differences in inhibition between free and liposome-encapsulated
antimicrobial. Micro-titer plates (Becton Dickinson) were loaded with 100 µl of doublestrength brain heart infusion (2x BHI), 50 µl of treatment solution (appropriate controls,
naked, or 2.5 mM liposome-encapsulated antimicrobial with or without 10 µl surfactant
as appropriate), and 50 µl of L. monocytogenes or E. coli O157:H7 cocktail diluted to
final concentration ~250 CFU/ml. Optical density was read at 630 nm with an ELx 800
Universal Microplate Reader (BioTek Instruments, Winooski, VT, USA). Plates were
covered and incubated aerobically at 32°C in between readings at 0, 2, 4, 6, 12, 24, and
48 hr.

5.3.5. Surfactant-Induced Lysis of Liposomal Antimicrobial and Chelator
In order to confirm that antimicrobial and chelator were in fact encapsulated in
liposomes, 10 µl of a solution of the surfactant Triton X100® (to a final concentration of
0.2%; Sigma) was added to experimental wells that were prepared identically to wells
containing only pathogens and antimicrobial-containing liposomes. The percent
difference in growth of L. monocytogenes or E. coli O157:H7, as measured by optical
density, after 48 hr of liposome-treatment and that of samples treated with liposomes
ruptured with 0.2% surfactant is expressed mathematically in equation 1.

128

[(OD630nm, 48hr Liposome Sample/OD630nm, 48hr PBS Control)-(OD630nm, 48hr Liposome
Sample+Surfactant/OD630nm, 48hr PBS Control)]*100%
Equation 1.

5.3.6. Statistical Analysis
All experimental treatments were tested in duplicate and averages were
calculated for treatments at each time point. Statistically significant differences were
calculated and analyzed using Student’s t-test with p<0.05 indicating statistical
differences (SAS v.9.1, SAS Institute, Cary, NC, USA).

5.4.

Results

5.4.1. Growth of Pathogens by Free Antimicrobial and Chelator
Growth of L. monocytogenes and E. coli O157:H7 cocktails exposed to nisin and
EDTA combinations (free and liposomal) are shown in Figures 5.1 and 5.2, respectively.
Cells exposed to unencapsulated nisin at 5.0 and 10.0 μg/ml and combinations of nisin
and EDTA were strongly inhibitory to L. monocytogenes cells compared to the PBS
control (Fig. 5.1A). In the presence of 10.0 µg/ml nisin and 300 µg/ml EDTA
(Nis10EDTA), L. monocytogenes achieved a final OD of 0.13, significantly less than that
of the PBS control (OD = 1.02) (Fig. 5.1A). In the case of E. coli O157:H7, with the
exception of EDTA alone, nisin and nisin plus EDTA extended the lag phase of E. coli
O157:H7 (Fig. 5.2A). Only the combinations of nisin and EDTA were effective at
significantly inhibiting growth of E. coli O157:H7 throughout the 48 hr incubation
period.
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Figure 5.1: Listeria monocytogenes inhibition via (A) unencapsulated, (B) PC, (C)
PC/PG 8/2, and (D) PC/PG 6/4 liposome-encapsulated nisin and EDTA. Data points
indicate means of duplicate replications with each replicate containing three
identical samples; error bars indicate standard deviations of like samples. Optical
density readings were taken at 630 nm after given incubation times at 32°C.
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Figure 5.1: Continued.
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Figure 5.2: E. coli O157:H7 inhibition via (A) unencapsulated, (B) PC, (C) PC/PG
8/2, and (D) PC/PG 6/4 liposome-encapsulated nisin and EDTA. Data points indicate
means of duplicate replications with each replicate containing three identical
samples; error bars indicate standard deviations of like samples. Optical density
readings were taken at 630 nm after given incubation times at 32°C.
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Figure 5.2: Continued.
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PC (Fig. 5.1B), and PC/PG 6/4 (Fig. 5.1D) liposomes containing nisin 5.0 or 10.0 µg/ml
(with or without EDTA) were nearly equivalent in inhibition to the unencapsulated nisin
plus EDTA and slightly greater than inhibition by PC/PG 8/2 (Fig. 5.1C) liposomes.
Similarly, at 12 h, E. coli O157:H7 was inhibited less by PC/PG 8/2 (Fig. 5.2C) than PC
(Fig. 5.2B) and PC/PG 6/4 (Fig. 5.2D).
Experiments to confirm liposome-encapsulation of antimicrobial and chelator
demonstrated that inhibitory effects observed were not due in whole to unentrapped nisin
and EDTA (Figs. 5.3-5.4). Liposome entrapment and subsequent pathogen inhibition
were dependent on both lipid formulation and inherent resistance. Surfactant-induced
lysis of liposomes increased the inhibition of L. monocytogenes strains via complete
release of entrapped nisin and EDTA (Fig. 5.3). PC liposomes with 5.0 and 10.0 µg/ml
nisin demonstrated the slowest apparent release of antimicrobial. PC vesicles containing
5.0 µg/ml and EDTA achieved only ~66% of their potential inhibitory capability based
upon theoretical limits determined from the identically prepared surfactant-ruptured
liposomes (Fig. 5.3). With respect to E. coli O157:H7 cells, PC liposomes with nisin at
5.0 and 10.0 µg/ml again demonstrated an extended release of entrapped nisin (Fig. 5.4).
Wells treated with PG-containing liposomes appeared to release their contents very
efficiently and thus exhibit nearly all of their potential inhibitory power against the
Gram-negative pathogen strains, with increases in inhibition upon surfactant lysis of
liposomes not exceeding ~20% (Fig. 5.4).
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Figure 5.3: Increases in Listeria monocytogenes inhibition by surfactant-induced
rupture of liposomes. Bars depict the percent difference in inhibition of L.
monocytogenes by non-surfactant treated liposomes minus surfactant-ruptured
liposome samples. PC: phosphatidylcholine; PG: phosphatidylglycerol; Tri: 0.2%
Triton X100®; Nis5: 5 µg/ml nisin; Nis10: µg/ml nisin.
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Figure 5.4: Increases in E. coli O157:H7 inhibition by surfactant-induced rupture of
liposomes. Bars depict the percent difference in inhibition of L. monocytogenes by
non-surfactant treated liposomes minus surfactant-ruptured liposome samples. PC:
phosphatidylcholine; PG: phosphatidylglycerol; Tri: 0.2% Triton X100®; Nis5: 5
µg/ml nisin; Nis10: µg/ml nisin.
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5.5.

Discussion
While not all differences between unentrapped and liposomal antimicrobial and

chelator-induced inhibition were statistically significant, data clearly demonstrate the
potential for liposome encapsulated antimicrobials to inhibit the growth of foodborne
pathogens (Figs. 1-2). Furthermore, data indicate that liposomes are efficient
encapsulating agents for the antimicrobials tested in this study, as evidenced by the
increases in inhibition following surfactant-induced lysis of liposome vesicles (Figs. 3-4).
PC liposomes demonstrated the highest apparent entrapment efficiency (EE) of
antimicrobial as compared to liposomes containing the anionic lipid PG (Figs. 3-4).
These results mirror observations made by others who reported liposome entrapment of
nisin was highest in PC liposomes as opposed to liposomes composed of PC, PG, and the
sterol cholesterol (Were et al., 2003). Were et al. (2004), in studies tested against L.
monocytogenes, demonstrated significant differences in pathogen inhibition between
unencapsulated and entrapped nisin. This study supports conclusions made by these and
other researchers that liposome entrapment of compounds such as nisin or EDTA can
increase their effective shelf-life by slow steady release of contents (Benech et al., 2002b;
Benech et al., 2002a).
Although L. monocytogenes Scott A and 310 cultures used in this study were not
inhibited from growth over the entire course of experimentation by the free or liposome
entrapped nisin, substantial inhibition of pathogens versus the positive controls was
observed. The co-encapsulation of antimicrobial and chelator greatly increased the
inhibitory potential of liposomes. Application of antimicrobials in combination with
compounds such as chelators has been demonstrated by several to be inhibitory towards
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pathogens, both Gram-positive and Gram-negative (Boziaris and Adams, 1999; Branen
and Davidson, 2004; Cutter et al., 2001).
Inhibition of E. coli O157:H7 cells by free and liposomal antimicrobial varied
greatly, but maximum inhibition was observed in liposomes co-encapsulating nisin and
EDTA. This was not completely unexpected as nisin is not known to be effective against
Gram-negative pathogens, especially at lower concentrations, as Gram-negative
pathogens possess a lipopolysaccharide (LPS) outer membrane that shields them from
many molecules including nisin (Abee et al., 1995). E. coli O157:H7 cells exposed to
free nisin, EDTA, or a combination thereof, were not completely inhibited no matter the
concentrations of antimicrobial or chelator (Fig. 2). Nevertheless, the combination of
nisin with chelator did produce significant inhibition versus the control, presumably due
to the ability of the chelator to sequester cations from the bacterial membrane where they
have been proposed to add stability by electrostatic interactions favorable to the
bacterium (Boziaris and Adams, 1999; Gill and Holley, 2000; Gill and Holley, 2003).
PC/PG 6/4 liposomes consistently released nearly all the nisin and EDTA within
48 hr while other liposomes with a smaller fraction of PG or PC released their contents
more slowly. Breukink and de Kruijff (1999) reported that nisin interacts much more
strongly with PG then with PC lipids, but only at concentrations of ~40 mol% or above of
PG. Hence, it is likely that nisin in PC/PG 6/4 liposomes effectively effluxed from
vesicles via porulation of vesicles. It is possible that liposome entrapment of
antimicrobials such as nisin might be able to effectively provide both short- and longterm inhibition of target pathogens, thereby adding to the effective safety and shelflife of
some food products.
137

5.6.

Conclusions
Data presented here demonstrate that liposome carriers for antimicrobials such as

nisin, and sequestrants such as EDTA, can act as slow, long-lasting inhibitors of both
Gram-positive and Gram-negative pathogens. A careful balance of lipid components is
required in order to maintain stable entrapment while simultaneously ensuring predictable
release of contents. Current and future studies in our lab are focused on the application of
this technology to food matrices in order to ascertain the antimicrobial potential of
liposomes as carriers of antimicrobials, as well as detect possible undesirable interactions
of food components with liposomes that might limit antimicrobial capabilities.
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6. Liposome-Encapsulated Antimicrobial Effectively Inhibits
Listeria monocytogenes But Not Escherichia coli O157:H7 in
Skim, Lowfat, and Whole Milk
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6.1.

Abstract
Liposome encapsulation is one technology that is gaining interest in the food

industry for the delivery of naturally-occurring antimicrobials to control pathogens in
foods. Currently, understanding of liposome encapsulation and its efficacy for the
delivery of antimicrobials in foods is limited. The objective of this study was to evaluate
the inhibitory activity of liposome-entrapped nisin and the chelator EDTA in sterile milk
of varying fat levels against the foodborne pathogens L. monocytogenes and E. coli
O157:H7. Liposomal nisin was inhibitory to L. monocytogenes strains, and effects were
equivalent, regardless of milkfat level. Increases in L. monocytogenes counts were ~0.51.0 log10 CFU/ml over the 48 hr incubation, regardless of milkfat content or liposome
formulation. No differences in sensitivity to the liposomal or free nisin between L.
monocytogenes strains were observed. Conversely, growth of E. coli O157:H7 was
unimpeded by liposome-encapsulated antimicrobial. The encapsulation of nisin and
EDTA in liposomes abolished the antimicrobial effect of nisin against both Grampositive and Gram-negative strains. It is evident that co-encapsulation of antimicrobial
and chelator does not automatically result in significant increases in nisin’s spectrum of
activity.
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6.2.

Introduction
Listeria monocytogenes and Escherichia coli O157:H7, despite implementation of

HACCP programs designed to eliminate their presence, persist as significant threats to
the safety of the U.S. food supply. L. monocytogenes, a Gram-positive non-sporulating
rod-shaped psychrotroph, is recognized to be of special importance with respect to the
contamination of ready-to-eat (RTE) foods such as pasteurized dairy products and meat
emulsions (e.g. frankfurters) (Delves-Broughton et al., 1996). The existence of a bovine
reservoir for E. coli O157:H7 has been established and consequently the microbiological
safety of beef and dairy products are of concern (Chapman et al., 1993; Hancock et al.,
1994). Therefore, technologies that might aid in the protection of foods against
contamination after processing should be studied in order to attempt to control the growth
of these pathogens.
The antimicrobial polypeptide, nisin, has long been known to be effective at
inhibiting the growth of several Gram-positive foodborne pathogens, including species of
Staphylococcus, Clostridium, Listeria, and Bacillus (Delves-Broughton et al., 1996).
Nevertheless, the activity of nisin against Gram-negative bacteria such as E. coli is
limited, presumably due to a decreased peptidoglycan content as well as the presence of
the lipopolysaccharide (LPS) outer membrane that effectively shields the organism from
the antimicrobial (Boland et al., 2004; Boziaris and Adams, 2001). Some studies have
been published describing increased inhibitory potential of nisin against some Gramnegatives when combined with a membrane-destabilizing compound; examples include
monolaurin, ethylenediamine tetraacetic acid (EDTA), and other chelators (Boland et al.,
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2003; Branen and Davidson, 2004; Mansour and Milliere, 2001; Stevens et al., 1992;
Stevens et al., 1991; Stevens et al., 1992).
One method for inhibiting or inactivating foodborne pathogens is the addition of
antimicrobial food preservatives. However, there is much variability of antimicrobials
against various foodborne pathogens and often high amounts of compounds are necessary
to overcome cross-reaction with food components that result in a loss of activity. This has
encouraged investigation into alternative means for delivering antimicrobials to bacterial
contaminants to achieve inhibition at lower concentrations. Encapsulation tools that could
effectively protect antimicrobials from food components, necessary processing measures,
and effectively deliver their antimicrobials would constitute a significant advancement in
the preservation of foods (Degnan et al., 1993; Were et al., 2003). Liposomes, colloidal
dispersions of phospholipids in the form of unilamellar or multi-lamellar bilayers, may
represent one such technology (Taylor et al., 1990; Taylor et al., 2005). Liposomes are
often formulated from one or multiple species of phospholipid, and may range in
diameter from ~40-50 nm to 1-2 μm depending on their formulation method and also
their intended use (Taylor et al., 2005).
In studies testing the effectiveness of liposome-entrapped antimicrobial
polypeptides (nisin, lysozyme) against L. monocytogenes, Were et al. (2004) reported
log10 CFU/ml decreases in broth ranging from 0.5 to >2.6 for L. monocytogenes Scott A
and 0.7 to >3.7 for L. monocytogenes 310 using liposomes containing PC, PC/Ch 7/3, and
PC/PG/Ch 5/2/3 (mol fraction) liposomes with entrapped nisin. Benech et al. (2002b)
reported log reductions of ~ 3 logs of L. innocua upon mixing with nisin-containing
liposomes; after six months of storage less then 10 CFU/g cheese were reported (Benech
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et al., 2002a; Benech et al., 2002b). Laridi et al. (2003) demonstrated that liposomal
release of entrapped nisin was lowest in milk products during 4°C storage versus
phosphate buffered saline (PBS) and whey concentrate, indicating the potential for longterm inhibition of pathogens.
The objective of this study was to determine the feasibility of encapsulating nisin
and the chelator EDTA in small unilamellar vesicles (SUVs) composed of one or two
species of lipids. These liposomes were then evaluated for their antimicrobial efficacy
against the bacterial pathogens L. monocytogenes and E. coli O157:H7 in a model milk
system of varying fat contents.

6.3.

Materials and Methods

6.3.1. Cultures and Growth Conditions
All experimental microorganisms were obtained from the University of Tennessee
Food Science and Technology Department culture collection. L. monocytogenes strains
Scott A (LM SA) and 310 (LM 310) were incubated aerobically in tryptic soy broth plus
0.6% yeast extract (TSB-YE, Becton Dickinson and Co., Franklin Lakes, NJ, USA) at
32°C; cells were transferred daily and grown 24 hr without agitation. E. coli O157:H7
American Type Culture Collection (ATCC) strain 43895 (EC 95) and 932 (EC 932) were
grown aerobically without agitation at 35°C in TSB (Becton Dickinson) for 24 hr prior to
experimentation. All cells were transferred from brain heart infusion agar slants (BHIA)
(Becton Dickinson) and transferred at least twice prior to experimentation in order to
fully resuscitate refrigerated cells. Culture purity of L. monocytogenes and E. coli strains
were determined via streaking on Modified Oxford’s media (MOX) (Becton Dickinson)
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and Sorbitol MacKonkey agar (SMAC) (Becton Dickinson), respectively. All plates were
inverted and incubated aerobically at 35°C for 24 hr prior to examination.

6.3.2. Preparation of Antimicrobial and Chelator
Nisin (CAS# 1414-45-5) was obtained from Sigma-Aldrich Co. (St. Louis, MO,
USA) (2.5% w/w nisin in milk proteins; 106 IU/g) and solubilized in 20 mM HCl (Fisher
Scientific, Hampton, NH, USA) at a concentration of 0.01 g/ml (10,000 IU/ml). The
stock solution was then boiled at 100°C for ~4 min and immediately placed at 5°C; stock
solution was stable for up to seven days (Wolf and Gibbons, 1996). Working solutions of
nisin (50 IU/ml final concentration) were made fresh daily in 0.1X phosphate buffered
saline (PBS) (0.017M KH2PO4, 0.05M Na2HPO4, 1.5M NaCl at pH=7.4) (Biowhittaker,
Rockland, ME, USA). Disodium-EDTA (CAS# 60-00-4) (Sigma) was mixed in distilled
water at a concentration of 30.0 mg/ml and then pH-adjusted to ~pH=10.0 with 1 N
NaOH (Fisher Scientific) with constant stirring in order to fully solubilize the chelator.
Following complete solubilization, the stock solution was then pH-adjusted to ~pH=8.0
using 1 N HCl (Fisher Scientific). The stock solution was filtered through a 0.22 µm
cellulose acetate filter (Corning Incorporated, Corning, NY, USA) and stored at 5°C prior
to use. Working solutions of EDTA were made up to achieve a final concentration of 300
µg/ml EDTA (free or encapsulated).

6.3.3. Lipids and Liposome Preparation
Phosphatidylcholine (PC) (egg-source) and phosphatidylglycerol (PG) (eggsource) were purchased from Avanti Polar Lipids (Alabaster, AL, USA) solubilized in
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chloroform and stored at -20°C until ready for use. Three liposome preparations were
formulated for experimentation: PC, PC:PG 8:2, and PC:PG 6:4 (mol%). To formulate
liposomes, appropriate volumes of solubilized PC and PG lipids were added to
chloroform-rinsed glass reaction tubes to achieve a final liposome concentration of 60
mM. Following mixing of lipids, solvent was evaporated under N2 with gentle heating,
yielding a homogenous film of dried lipid around the walls of the reaction tube. After
solvent removal, tubes were vacuum desiccated overnight to ensure complete solvent
removal as well as prohibit atmospheric moisture from degrading lipids. Following
desiccation, tubes were removed and lipids rehydrated with 1 ml of antimicrobial-free
buffer (control) or antimicrobial-containing buffer and vortexed violently to remove lipid
films and induce the formation of large mutilamellar vesicles (MLVs). Samples were
then subject to four cycles of freeze-thaw processing. Liposomes were immersed in 0°C
water, tepid water, and 70°C for ~10 sec each in order to induce lipids to cross their main
phase transition temperature (TM), thus increasing the packing order of lipids upon refreezing (Bangham et al., 1974). Samples were then placed in 70°C for 30 min to fully
heat the liposome sample past the TM prior to SUV formation.
In order to form a homogenous population of SUVs for use in experimentation, a
LiposoFast Basic benchtop extruder (Avestin, Ottawa, Canada) was used to rupture large
vesicles, allowing spontaneous formation of smaller vesicles and increased antimicrobial
entrapment. MLVs were loaded into the extruder and passed 11 times each through stacks
of 400nm-200nm-400nm and 100nm-50nm-100nm polycarbonate membranes; the
extruder was immersed in 70°C water to facilitate extrusion. Following extrusion, nonencapsulated antimicrobial was removed via size-exclusion chromatography by passing
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over a BioGel A0.5 M agarose (200-400 mesh) column (BioRad, Hercules, CA, USA)
using a 0.1X PBS buffer as carrier. Liposomes were eluted in the void volume. Finally,
antimicrobial-bearing liposomes were filtered through a 0.20 µm HT Tuffryn low
protein-binding membrane (Pall Corporation, East Hills, NY, USA). Liposomes were
stored overnight at 25°C prior to experimentation to allow formation of large unilamellar
vesicles (LUVs) at the expense of very small vesicles, thus allowing relaxation of
curvature stress on liposomes, a destabilizing physico-chemical property of SUVs.

6.3.4. Bacterial Inhibition Assay
The inhibition of both L. monocytogenes and E. coli O157:H7 via liposomeentrapped antimicrobial and antimicrobial plus chelator in milk of varying fat levels was
conducted in similar fashion to that of Gaysinsky et al. (2005). Ultra-high-temperature
(UHT) processed skim, 1% lowfat, and whole milk (Parmalat, Farmland Dairies, LLC,
Wallington, NJ, USA) was used in the assays. Figure 6.1 shows the basic inhibition assay
flow diagram. To 8 ml of sterile milk was added 1 ml of the pathogenic strain of interest
to a final concentration of ~log10 4 CFU/ml and 1 ml of experimental liposomes, diluted
to achieve a final concentration of 2 mM. Immediately following addition of bacteria and
vesicles, milk samples were mixed by vortexing for 5 sec and placed at 25°C for the
duration of the experiment. This temperature was selected to simulate product abuse
conditions. At designated time points (0, 1, 3, 6, 12, 24, and 48 hr) sub-samples were
removed, serially diluted in 0.1% peptone water (Fisher Scientific) and plated on either
tryptic soy agar plus 0.6% yeast extract (TSA-YE; Becton Dickinson) ( LM SA and LM
310) or TSA (Becton Dickinson) (EC 95 and EC 932).
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8 ml Milk: Whole, 1%, or Skim
1 ml Inoculum (log
4/ml)

1 ml Liposomes:
PC, PC/PG 8/2,
PC/PG 6/4 (2 mM)
Nisin: 50 IU/ml
EDTA: 300 ug/ml
Control: replace with
1 ml 0.1% Peptone

Incubate (25°C): 0, 1, 3, 6, 12, 24, 48 hr

Plate; incubate 24 hr @ 32°C (LM) or
35°C (EC)

Enumerate Survivors

Figure 6.1: Flow diagram of bacterial inhibition assay. Cells were serially diluted
and enumerated on plates after incubation at 48 hr at 32°C (LM SA, 310; TSA-YE)
or 35°C (EC 95, 932; TSA).
Plates were allowed solidify and incubated aerobically; plates for LM and EC cultures
were incubated at 32°C and 35°C, respectively, for 48 hr prior to enumeration.

6.3.5. Statistical analysis
All experiments were run in duplicate; means and standard deviations were
calculated from like samples. Statistically significant differences were calculated via
Student’s t-test (P<0.05) using Statistical Analysis Software v. 9.1 (SAS) (SAS Institute,
Cary, NC, USA).
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6.4.

Results

6.4.1. Inhibition of L. monocytogenes in Milk By Free and Liposome-Entrapped
Nisin
Listeria monocytogenes Scott A (LM SA) and L. monocytogenes 310 (LM 310)
cells grown in the presence of liposomes without entrapped antimicrobial achieved final
cell densities of ~8 log10 CFU/ml after 48 hr at 25°C, regardless of milkfat concentration
(Fig. 6.2). In the presence of unencapsulated nisin, an initial decrease in pathogen
population was observed within 3 hr of incubation for both LM SA and LM 310 treated
cells (Fig. 6.2). However, after 6 hr, cells exposed to unencapsulated nisin began to
demonstrate evidence of recovery; Listeria populations in all milk types were able to
recover and grow to high levels (~log10 7-7.5 CFU/ml) after 48 hr incubation (Fig. 6.2).
Conversely, liposomal nisin was able to significantly inhibit both strains of L.
monocytogenes for the 48 hr incubation period; this bacteriostatic effect was independent
of milkfat level and strain (Fig. 6.2).

6.4.2. Inhibition of E. coli O157:H7 in Milk By Free and Liposome-Entrapped
Nisin
In the case of E. coli O157:H7 cells exposed to free and liposomal nisin, test
results indicate no inhibition of the Gram-negative pathogen. No statistically significant
differences between the populations of control EC 95 and EC 932 cells and those treated
with either unencapsulated nisin at 50 IU/ml or liposomal nisin were observed at any time
point, regardless of milkfat level (Fig. 6.3).
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Figure 6.2: Growth of LM SA in (A) skim, (B) 1% lowfat, and (C) whole and LM
310 in (D) skim, (E) 1% lowfat, and (F) whole UHT milk at 25°C in presence of 2
mM PC, PC:PG 8:2, and PC:PG 6:4 liposomes with 50 IU/ml entrapped nisin.
Symbols are means of duplicate replications with bars indicating one standard
deviation from mean.
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Figure 6.2: Continued.
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Figure 6.3: Growth of EC 95 in (A) skim, (B) 1% lowfat, and (C) whole and EC 932
in (D) skim, (E) 1% lowfat, and (F) whole UHT milk at 25°C in presence of 2 mM
PC, PC:PG 8:2, and PC:PG 6:4 liposomes with 50 IU/ml entrapped nisin. Symbols
are means of duplicate replications with bars indicating one standard deviation
from mean.
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Figure 6.3: Continued.
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6.4.3. Inhibition of L. monocytogenes in Milk By Free and Liposome-Entrapped
Nisin and EDTA
Nisin in combination with compounds able to chelate divalent cations generally has
greater activity against Gram-positive bacteria and has expanded antimicrobial activity
against Gram-negative bacteria (Boziaris and Adams, 1999; Brul and Coote, 1999; Gill
and Holley, 2003). Nevertheless, no studies were found concerning the utility of coencapsulation of antimicrobial and chelator in nanocapsules formed from lipids or
surfactants. Therefore, 50 IU/ml of nisin was co-encapsulated with 300 µg/ml EDTA, a
concentration reported previously to be effective against E. coli O157:H7 cells (Branen
and Davidson, 2004). LM SA and 310 populations exposed to nisin and EDTA
demonstrated significant reductions in inhibition versus cells exposed to nisin only; cells
exposed to antimicrobial and chelator were reduced to levels below that of the assay
detection level after only 6 hr incubation in skim milk (Fig. 6.4). Conversely, cells grown
in 1% or whole milk underwent an approximate 2 log10 decrease in concentration but
were eventually able to recover and grow to levels not statistically different from that of
control cells grown in the absence of nisin or EDTA (Fig. 6.4).
LM SA and 310 populations exposed to PC, PC:PG 8:2, and PC:PG 6:4 entrapped
nisin and EDTA grew at rates similar to that of control cells (Fig. 6.4). In fact, growth
kinetics of liposome-exposed cells approximated that of control cells. LM SA cells
exposed to PC vesicles achieved final populations of 7.7, 7.6, and 7.7 log10 CFU/ml after
48 hr incubation in skim, 1%, and whole milk, respectively (Fig. 6.4). LM 310 cells
grown in skim, 1%, and whole milk in the presence of 2 mM PC liposomes with
entrapped nisin plus EDTA achieved ~ log10 8.0 CFU/ml (Fig. 6.4).
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Figure 6.4: Growth of LM SA in (A) skim, (B) 1% lowfat, and (C) whole and LM
310 in (D) skim, (E) 1% lowfat, and (F) whole UHT milk at 25°C in presence of 2
mM PC, PC:PG 8:2, and PC:PG 6:4 liposomes with 50 IU/ml entrapped nisin + 300
µg/ml entrapped EDTA. Symbols are means of duplicate replications with bars
indicating one standard deviation from mean.
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157

40

50

F

Equivalent results were observed for LM SA and 310 cells grown in all milkfat
concentrations with PC:PG 8:2 and PC:PG 6:4 liposomes with entrapped bacteriocin and
chelator (Fig. 6.4).

6.4.4. Inhibition of E. coli O157:H7 in Milk By Free and Liposome-Entrapped
Nisin and EDTA
Results of tests of liposomal nisin and EDTA against target E. coli O157:H7
strains indicated ineffectiveness of the liposome co-encapsulated compounds to inhibit
growth of the Gram-negative pathogen (Fig. 6.5). While EC 932 populations achieved
statistically significantly lower populations of cells at 12 hr of incubation in the presence
of liposome formulations, inhibition was overcome by 24 hr as evidenced by insignificant
differences between controls and liposome-treated cells (Fig. 6.5).

6.5.

Discussion

Results correlate with previously reported studies in which researchers detailed initial
decreases in Listeria populations following exposure to nisin, only to experience
subsequent regrowth (Vignolo et al., 2000). In experiments testing the effectiveness of
nisin (2000 IU/ml) and other antimicrobials against L. monocytogenes Scott A in broth,
bacterial counts were reduced ~3 log10 CFU/ml after 2 hr at 30°C; after 24 hr incubation
the bacterial population had regrown to within 0.5 log10 CFU/ml of the starting
population (Vignolo et al., 2000).
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Figure 6.5: Growth of EC 95 in skim (A), 1% lowfat (B), and whole (C) and EC 932
in skim (D), 1% lowfat (E), and whole (F) UHT milk at 25°C in presence of 2 mM
PC, PC:PG 8:2, and PC:PG 6:4 liposomes with 50 IU/ml entrapped nisin + 300
µg/ml entrapped EDTA. Symbols are means of duplicate replications with bars
indicating one standard deviation from mean.
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Others have demonstrated that milkfat can greatly diminish the antimicrobial activity of
nisin, most likely because of hydrophobic interactions with lipophilic side-chains. This
may remove the nisin from the water phase which is likely the primary domain for
bacterial growth (Juneja and Davidson, 1992; Jung et al., 1992).
LM SA and 310 populations inoculated into skim, 1%, and whole milk and
exposed to PC liposomes did not achieve statistically significant differences in final
populations, although on average cells did grow approximately 0.4-0.8 log10 CFU/ml
over 48 hr (Fig. 6.2). Similar results were observed with LM SA and 310 cells exposed to
nisin encapsulated in PC:PG 8:2 and PC:PG 6:4 vesicles (Fig. 6.2). These results indicate
the efficacy of liposome entrapment of antimicrobial polypeptides for the control of
Gram-positive pathogens. As mentioned previously, Were et al. (2004) reported excellent
inhibition of Listeria spp. following exposure to liposomes containing nisin formulated
from PC, PG, and cholesterol. Nonetheless, the inhibition of L. monocytogenes in milk, a
complex medium, by as little as 50 IU/ml nisin at temperatures simulating abuse
conditions represents a significant advancement in the control of this pathogen in RTE
foods.
In the case of E. coli O157:H7, free nisin and liposomal antimicrobial were
ineffective against both pathogenic strains; this lack of activity was not unexpected.
Extensive research has been reported detailing the need for high levels of nisin in order to
achieve effective inhibition of E. coli O157:H7, presumably due to the existence of the
lipopolysaccharide (LPS) outer membrane that shields the cytoplasmic membrane from
the bacteriocin. Branen and Davidson (2004) reported a minimum inhibitory
concentration (MIC) for nisin against E. coli O157:H7 of >46.9 µg/ml for cells in growth
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media. In 2% UHT milk, these researchers reported that nisin up to a level of 62.5 µg/ml
did not inhibit E. coli O157:H7 cells (Branen and Davidson, 2004). Additionally,
Boziaris and Adams reported inhibition of E. coli O157:H7 by nisin was only achieved
by addition of chelator and was dependent on the concentration of the chelator (1999).
Fang and Tsai (2003) reported ineffectiveness of nisin treatments to levels of 10,000 IU/g
against E. coli O157:H7 cells on ground beef samples. Hence, it is likely that a
combination of the protective effects of the LPS and interaction with milk components
functioned to protect EC 95 and 932 cells from the bacteriocin, despite encapsulation.
That free nisin exhibited greater initial reductions in LM SA and 310 populations
in skim milk samples is likely to be a result of increased interaction of the bacteriocin
with growing cells due to the absence of lipids (Fig. 6.2) (Davidson et al., 2005). With
respect to liposomal nisin efficacy against Listeria strains, all liposome preparations
demonstrated bacteriostatic inhibitory effects against both LM SA and LM 310,
regardless of milkfat level (Fig. 6.2). This was not completely unexpected, as
phospholipids are by their very nature emulsifiers; emulsifiers have been shown
repeatedly to enhance the antimicrobial activity of nisin against Gram-positive organisms
in complex media (Jung et al., 1992).
Given that target Listeria populations did not change significantly over the course
of the incubation period, it is hypothesized that liposomes functioned to release entrapped
nisin slowly over the duration of the experiment (Fig. 6.2). Similar findings have been
reported elsewhere (Benech et al., 2002a; Benech et al., 2002b; Hsieh et al., 2002).
Laridi et al. (2003) reported excellent stability of liposomal nisin stored at 4°C for 27
days in whole, lowfat, and skim milk. Based on an antimicrobial activity agar-diffusion
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assay, researchers reported a decrease in liposome-entrapped nisin activity from 288 IU/g
to 263 IU/g after ripening of cheese samples for six months at 7°C; this difference
represented only a 10% loss of antimicrobial activity (Benech et al. 2002a). Free nisin
retained only ~12% of activity following the same incubation period (Benech et al.,
2002a).
The mechanisms underlying why liposome-entrapped nisin and EDTA were
ineffective against the Gram-positive target strains in milk is not fully understood,
especially given bacteriostatic effects observed with L. monocytogenes when exposed to
liposome-entrapped nisin (Fig. 6.2, 6.4). However, given that lipid can interfere with
nisin, this could lead to a situation where EDTA may function as the sole antimicrobial.
If indeed nisin was sequestered from target pathogens by milkfat, 300 µg/ml EDTA in
milk was not likely to be inhibitory to Listeria or E. coli cells as others have reported that
at least 250 µg/ml EDTA was necessary to be inhibitory in minimal growth media such
as TSB (Branen and Davidson, 2004). Further, EDTA antimicrobial activity was very
likely lowered by binding of Ca+2 and Mg+2 ions present naturally at high concentrations
in milk (Boland et al., 2004). It is also possible that both nisin and EDTA from liposomes
interacted with milk components upon release from vesicles (Bhatti et al., 2004; Jung et
al., 1992). Another hypothesis could be that EDTA and nisin interact in liposomes to
neutralize one another; nisin is polycationic at neutral pH due to multiple lysine residues
and EDTA may possess up to four negative charges via four acetate groups, depending
on system pH. EDTA may have acted to neutralize the formation of pores by neutralizing
the cationic charges of nisin reported to be necessary for insertion of the peptide into
membranes prior to porulation (Bonev et al., 2000; El-Jastimi et al., 1999; El-Jastimi and
163

Lafleur, 1997; Giffard et al., 1997). The occurrence of EDTA binding to polypeptides has
been reported previously although not with nisin (Ribou et al., 1999). Thus, were EDTA
actually functioning to neutralize the charge on nisin, liposomes would most likely not
have released entrapped contents, or released only very low amounts, leading to
insignificant inhibition of cells (Fig. 6.4). Finally, the potential for loss of nisin activity
upon mixing with EDTA may have arisen due to loss of bacteriocin solubility. Nisin is
known to be most soluble at ca. pH 2-4; solubility above that of milk (pH 6.5), is
essentially nil (Liu and Hansen, 1990; Thomas and Delves-Broughton, 2005). EDTA has
reported pKa values of ~6.16 and 10.26 (Griko, 1999). As mentioned above,
experimental EDTA was kept at pH 8.0 to maintain solubility; mixing of antimicrobial
and chelator resulted in an increase of solution pH from ~3.6 to ~6.4. This increase in pH
of working solution may have functioned to reduce nisin solubility, thereby reducing its
antimicrobial activity against the target pathogens.

6.6.

Conclusions
In conclusion, results of inhibition assays demonstrate the ability of phospholipid-

derived liposomes with encapsulated nisin to exert a significant inhibitory effect against
the Gram-positive foodborne pathogen L. monocytogenes. Inhibitory effects observed
were sustained through the entire incubation period; unencapsulated antimicrobial
displayed an initial decrease in bacterial concentration with an eventual recovery of cells
was detected in all milk samples. Data also indicate that while liposome encapsulation
can allow for longer-term inhibition of a pathogen known to be sensitive to an
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antimicrobial, it does not necessarily function to increase the spectrum of activity of the
antimicrobial to include organisms normally resistant to its activity.
This research represents the first attempt to co-encapsulate an antimicrobial and
chelator for application to a food product. Data indicate that unencapsulated EDTA acted
in skim milk to enhance the activity of nisin against Listeria strains, but that milkfat
reversed the effect of EDTA with nisin by interacting with one or both or affecting nisin
solubility with a subsequent loss of antimicrobial activity. An understanding of these
mechanisms may allow for vesicles which are active against both Gram-positive and
Gram-negative pathogens, thereby providing a significantly higher level of safety for a
variety of food products.
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